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COMPUTATIONAL MODELLING OF AMINO ACID TRANSFER
INTERACTIONS IN THE PLACENTA
by Nuttanont Panitchob
Placental amino acid transport is essential for fetal development during pregnancy.
Impaired transport has been associated with restricted fetal growth that can potentially
lead to diseases in later life. However, quantitative understanding of placenta transport
remains limited and therefore requires investigation. The aim of this study was to
develop a computational framework that can represent the amino acid transport system
in the placenta as a whole.
The transfer of amino acid across the placenta is mediated by a broad array of
specific membrane transporters. Mathematical models, based on carrier-mediated
transport theory, were developed to mechanistically represent these transporters. These
include accumulative transporters, which use secondary active transport driven by the
sodium electrochemical potential; exchangers (antiporters), which swap one substrate for
another on different sides of the membrane; and facilitative transporters, which transport
substrate along its concentration gradient. The transporter models were thoroughly
investigated and validated with experimental data with respect to their mechanistic
characteristics and parameter sensitivity. Overall, the models were demonstrated to be
adequate in representing the specific transporter behaviours.
There are 20 amino acids, including 9 essential ones, and over 19 different transporters,
all of which act on certain overlapping subsets of these amino acids. All transporters
must work interdependently for successful transfer of the required amino acids from
the maternal to the fetal side; however, this complex process is not fully understood.
A compartmental model of placental amino acid transport incorporating kinetic
transporter models was developed and revealed to be able to sufficiently capture the
integrated transport system. Modelling results clearly demonstrated how modulating
specific transporter activity can increase the transport of certain classes of amino acids,
but that this comes at the price of decreasing the transport of others, which could have
potential implications for developing new clinical treatment options. This integrated
modelling approach along with kinetic models of transporters will help in gaining an
improved quantitative understanding of epithelial transport in the placenta and other
systems and it is ultimately hoped that this will contribute to the development of clinical
applications to intervene or prevent impaired-transport related pathologies.
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Chapter 1
Introduction
The placenta is vital during pregnancy as it serves as the sole interface connecting
the mother to the fetus via the umbilical cord. It is responsible for the supply of
fetal nutrients, gas exchange, and removal of waste products which are continuously
transferred between the two circulations. In normal fetal development, sustaining regular
transport of amino acids across the placenta is an essential process. Amino acids, which
are building blocks of proteins, are required for growth and tissue repair. Impaired
fetal growth has shown to be associated with inadequate placental amino acid transfer
[1–3]. Intrauterine growth restriction (IUGR), which affects about one in every ten
pregnancies, serves as the underlying motivation for this thesis. Although the actual
pathogenesis of IUGR is not well understood, it generally has been linked to limitations
in nutrient availability for the fetus. Since placental transfer serves as the only source
of nutrients for the fetus during pregnancy, IUGR is highly likely to be associated with
placental transport. Studies suggested reductions in many transporter activities in the
placental membranes observed in IUGR pregnancies compared to normal pregnancies
[4]. In order to prevent or ameliorate irregularities in fetal development, it is important
to understand the complex mechanisms underlying the amino acid transport system in
the placenta.
Transfer of amino acids from maternal blood across the placenta and into the fetal
blood is a complex process with many potential rate limiting steps, as well as other
factors that can affect transport; which may include maternal and fetal blood flow,
amino acid transporter expression, or the morphology of the placenta [5]. However,
the transport of amino acids across the maternal and fetal facing membranes of the
placental syncytiotrophoblast will be central to this process, as these provide the main
barriers for amino acid transfer. Transport of amino acids is mediated by specific
membrane transport proteins [6]. These include; i) facilitative transporters, which
allow amino acids to diffuse in the direction of their gradient, ii) exchangers, which
transport one amino acid in exchange of another, and iii) accumulative transporters,
which actively transport amino acids against their gradient with the energy derived
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from electrochemical (sodium) gradients. The ways in which these transporters interact
is complex and hard to predict intuitively, therefore mathematical modelling may be
beneficial by providing an integrated quantitative approach to better understand the
combined effect of their activity [5].
1.1 Aims and objectives
The aim of this thesis is to first exploit mathematical modelling to represent the
underlying mechanisms of individual amino acid transporters independently. This will
provide novel tools that will allow us to examine for the first time how each transporter
type functions mechanistically, which will provide a significant step forwarded compared
to the phenomenological approaches currently used by biologists. Then, the second
aim of the thesis is to develop a new systematic modelling framework to incorporate
these individual transporter models to represent the placenta as a whole functional unit.
This will, for the first time, provide a complete integrated overview of the placental
transport system in all its complexity. Ultimately, this work will contribute to the field
of placental study in terms of providing a better understanding of such complicated
transport mechanisms, leading to assessment tools for clinical and experimental data, or
aiding the development of prevention measures and treatments for nutrient deficiency
disorders like IUGR. In order to achieve these scientific and clinical contributions, the
following objectives of this thesis are defined as follows:
• To develop and refine individual transporter models to represent their underlying
transport mechanisms
• To design new experimental approaches to validate the transporter models
• To develop an integrated model which incorporates individual transporter models
to represent the fundamentals of the complete placental amino acid transport
system
• To determine the key influencing factors for the placental transfer of amino acids
using the integrative model in order to show the model’s immediate implication
• To demonstrate the potential clinical and experimental relevance of both
transporter and integrated system models to highlight the significance of this work
1.2 Thesis structure
In this thesis, the background description of the placenta is presented first to provide
an overview of the complex structure of the placenta. Then, various placental functions
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are outlined including in particular the transport of amino acids, which is the main
focus of this thesis. Pathological conditions are then described, in addition to IUGR,
showing correlations to changes in placental structure and functional characteristics.
Experimental approaches for the study of the placenta are then presented to highlight
strengths and weaknesses of each strategy. The background concludes by reviewing
previous placental modelling efforts, not limited to only amino acid transport. In
the next chapter, the transport model for the thermodynamically passive amino acid
transport by exchanger or facilitative transporters is presented, followed by extensive
model investigation and validation with experimental data. This already illustrates the
short-term applications of this modelling approach. In a similar manner, development
of a model for the accumulative transporter is presented in the following chapter. This
work presents a novel model of the complicated accumulative transporter mechanism and
includes a detailed model exploration and validation with previous literature data. Next,
the integrated model of the placenta is presented, which incorporates all transporter
models introduced in the previous chapters. This includes the systematic exploration of
the model from simple cases to physiological cases, demonstrating how computational
modelling can be used to address such complex scenarios. In addition, an example
of the application of the model is presented for a certain physiological conditions
(phenylketonuria) to show its potential real clinical contribution. Lastly, the main
conclusions of the work are discussed, including suggestions for future work.

Chapter 2
Background
The human body requires twenty distinct types of amino acids, nine of which are essential
amino acids which cannot be synthesized by the body. Instead, these essential amino
acids must come from dietary intake. The fetus receives nutrients from the mother
directly through the placenta. Attached to the maternal uterine wall, the placenta
transports nutrients between the maternal and fetal blood circulation. However, the two
blood circulations do not mix but rather their contents are exchanged via a membrane
barrier, limiting fetal transfer of unwanted substances. Hence, the placenta not only
serves as an interface for nutrient transfer but also as a protective mechanism for the
fetus.
The details of the placental structure and membrane barrier mentioned are explained in
the following section. Furthermore, the principal functions of the placenta are presented,
outlining the importance of the placenta during pregnancy. In addition, an overview of
placental nutrient transport is given. Next, a review of placental abnormalities leading
to pathological conditions that can affect both the mother and the fetus is provided.
Finally, experimental approaches for the study of the placenta are reviewed along with
previous modelling work.
2.1 Structure of the placenta
The human placenta takes on the shape of a disk and grows along with the development
of the fetus. A mature placenta is 20–25 cm in diameter and is about 2–3 cm thick,
weighing approximately 500 grams [7]. Note that in other mammalian species, the
placenta takes a diverse range of structures driven by different evolutionary pressures
[8]. In human placenta, the maternal side attached to the uterine wall is called the basal
plate. The surface closest to the fetus is called the chorionic plate. A photograph of
a delivered placenta is shown in Figure 2.1. The structure between the two sides is a
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complex system of vascular tissues, therefore the placenta should not be thought of as
a simple permeable membrane. Within this complex tissue, the exchange of nutrients,
waste products and gases occurs.
Figure 2.1: Photograph of a placenta after delivery, showing the chorionic plate, with
the basal plate hidden underneath. The umbilical cord is attached in the middle of the
placenta on the chorionic side, and contains two fetal arteries and a vein that branch
out to form the villous tree structures in between the chronic and basal plates.
The umbilical cord connects to the placenta typically in the middle of the chorionic plate
and contains two arteries and a vein conducting the blood flow from and to the fetus,
respectively. On the maternal side, the blood is perfused into the placental intervillous
space through spiral arteries and decidua veins on the basal plate. The schematic cross-
section of the placental structure is shown in Figure 2.2A. The placenta can be divided
into functional subunits called cotyledons which contain 60–70 villous tree structures
[7]. A micro-CT image of one cotyledon is shown in Figure 2.3. Villous trees are an
extension of the vascular network originating from the umbilical cord forming branching
structures within the intervillous space. Placental villi (Figure 2.2B and Figure 2.3) can
be categorised by their size and place in the hierarchy. Thus, starting from the fetal
vasculature, stem, intermediate, and terminal villi can be distinguished. A terminal
villus, which is the smallest branch of the villous tree, is covered by a single layer of cells
fused together called the syncytiotrophoblast. The syncytiotrophoblast, which develops
from the underlying cytotrophoblast layer, is in contact with the maternal blood in the
intervillous space. This barrier layer is the site where the transfer of amino acids and
other essential substances into the fetal circulation is controlled [6]. Allowing only certain
molecules to pass that are diffusible through lipid membranes, the syncytiotrophoblast
protects the fetus from most unwanted molecules. For a molecule to transfer to the fetal
side, it needs to travel across both the microvillous membrane (MVM) and the basal
membrane (BM) of the syncytiotrophoblast. An immunofluorescence image as shown in
Figure 2.4 illustrates the syncytiotrophoblast layer, which contains specific transporter
proteins (LAT1 & LAT2) that mediate the transport of substances across both MVM
and BM. After having crossed the MVM and BM, the molecule is able to diffuse into
Chapter 2 Background 7
fetal circulation through gaps between the endothelial cell layer. Lastly, between the
endothelial and trophoblast (syncytiotrophoblast) cells, the connective stromal tissue
provides the structure of the villi. A confocal projection image of terminal villi showing
the three distinct placental tissue layers is shown in Figure 2.5.
Figure 2.2: Morphology of the placenta: (A) Cross-section of the placenta showing
the branching structure of the villi that contains fetal capillaries stemming from the
umbilical vessels. The villi are surrounded by the maternal blood perfused into the
intervillous space from the network of maternal blood vessels (spiral arteries and decidua
veins). (B) Placental villous tree hierarchy. Adapted from Gray, 1918 [9] & Sibley et
al., 2005 [1].
Although the transport of some small molecules (oxygen/carbon dioxide) is governed by
simple diffusion alone; enabling the transfer of certain molecules, such as amino acids,
is more complex. The subsequent section provides an overview of the various placental
transport processes, including amino acid transport mechanisms which involve protein
transporters mediating the transfer.
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Figure 2.3: Micro-CT image of a vascular perfusion of a functional subunit of the
placenta (cotyledon) showing the vascular structure of the placental villi branching
from the fetal vein to form the stem, intermediate and terminal villi, respectively.
Image courtesy of Dr. Rohan Lewis, University of Southampton.
Figure 2.4: Immunofluorescence image of a placental villi cross section showing
transport protein (transporter) LAT2 localisation (in green) at the microvillous (MVM;
dashed) and basal (BM; dotted) membrane of the syncytiotrophoblast layer. Note
that LAT1 and nuclei localisation are also shown in red and blue, respectively. Image
courtesy of Dr. Kate Widdows, University of Manchester.
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Figure 2.5: Confocal 3D projection images of placental terminal villi showing three
cell layers: The outer layer trophoblast (in blue) that includes the syncytiotrophoblast
where transport proteins are located, connective stroma (in red) that is responsible for
structure, and fetal capillary endothelium (in green). Image courtesy of Dr. Rohan
Lewis, University of Southampton.
2.2 Placental functions
2.2.1 Transfer of substances between maternal and fetal sides
Primarily, the placenta supports selective transfer of various types of molecules which
include nutrients, gases, and waste products (back to the maternal side). While the
placenta transports some molecules to the fetus unaltered, the placenta itself can take
up certain molecules, such as glucose or oxygen. In addition, certain molecules can be
metabolized by the placenta before being transported to the fetus in another form. The
size of the molecule affects the permeability across the syncytiotrophoblast. Smaller
molecules are more likely to successfully reach the fetus. Many small molecules are able
to passively diffuse through the placental tissue. Passive diffusion of molecules occurs
via transcellular and paracellular routes. For example, small molecules like oxygen and
carbon dioxide transfer via the transcellular pathway in response to partial pressure
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differences. While the concept of a paracellular route is not well defined due to the
notion of the syncytiotrophoblast’s lack of obvious space between cells, recent studies
show evidence of such mechanism in the syncytiotrophoblast [10, 11].
Figure 2.6: Schematic diagram depicting the placental amino acid transport interface
in the syncytiotrophoblast layer, showing the microvillous membrane facing the
maternal circulation and the basal membrane facing the fetal circulation. At the
membranes, transport proteins mediating amino acid transport are shown. Categorised
by their transport mechanisms, these transport proteins include accumulative
transporters (Ac), exchangers (Ex), and facilitative transporters (F). Paracellular
diffusion (PD) is also depicted.
Table 2.1: Summary of selected placental transport proteins categorised by
mechanism, membrane localisation, and amino acid specificity. Note this is not an
exhaustive overview.
Name System Mechanism Localisation Amino acid substrates Reference
LAT1 L Exchange MVM, BM GLN, HIS, ILE, LEU, MET, [12]
PHE, TRP, TYR, VAL
LAT2 L Exchange MVM, BM ALA, ASN, CYS, GLN, HIS, [12]
ILE, LEU, MET, PHE, SER,
THR, TRP, TYR, VAL
LAT3 - Facilitative BM ILE, LEU, MET, PHE, VAL [13]
LAT4 - Facilitative BM ILE, LEU, MET, PHE [14]
TAT1 - Facilitative BM ALA, LEU, PHE, TRP, TYR [12, 13]
SNAT1 A Accumulative MVM ALA, ASN, CYS, GLN, GLY, [12]
HIS, MET
SNAT2 A Accumulative MVM PRO, SER [12]
SNAT4 A Accumulative MVM ALA, ASN, CYS, GLN, GLY, [12]
HIS, LYS
Note that amino acid abbreviations can be found in the List of Abbreviations.
Other molecules that are not able to diffuse passively across the syncytiotrophoblast,
such as amino acids, are transported via transporter proteins to mediate the placental
transfer in both MVM and BM (Figure 2.6). These transporters can function using either
energetically active or passive mechanisms. In addition to being characterised by their
transport mechanisms, the protein transporters can also be categorised according to their
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substrate specificity (i.e. specific to each class of amino acids) and localisation on certain
membranes [12]. A table summarising the various placental transporters, categorised
according to their mechanism, membrane localisation, and substrate specificity is
shown in Table 2.1. As shown, this presents a very complex system, involving many
interdependent variables, which is difficult to intuitively understand without systematic
modelling effort. An overview of the various types of placental transporter mechanisms
is presented as follows:
Figure 2.7: Transport protein structural representation and conformational changes
during transport of solute. A) Structural model of transport protein LAT2 (in blue
chains) and its ancillary unit 4F2hc (in green chains) showing molecule binding sites
(in spheres). Image reproduced from Rosell et al., 2014 [15]. B) Schematic of transport
cycle in a facilitative transport process across lipid bilayer membrane. Transport protein
exposes binding site prompting a solute to bind, then undergoes conformational changes
that results in unbinding of the solute to the other side.
Facilitated transporter: Facilitated diffusion can move molecules down their
concentration gradient via carrier proteins or channels. The process is
thermodynamically passive because the carriers or channels do not require energy for
transport, but instead this is driven by the concentration gradient. For the case of
channel transporters, the molecules simply diffuse through the channel once opened.
However, for amino acids, carrier mediated transport is thought to be the main
12 Chapter 2 Background
mechanism, rather than channels. In carrier-mediated transport, the molecule binds to
the transport protein and is then being transported as a result of conformational changes
of the carrier between membrane interfaces. In this process, the solute (substrate) binds
to the carrier to the binding site(s) on one side of the membrane. Randomly, the
carrier undergoes reversible conformational changes, which exposes the solute-binding
sites alternately to either side of the membrane. The carrier can discharge the solute
on the side where the binding sites are exposed. Since the transition between the two
conformational states occurs randomly and reversibly, more solutes bind to the carrier
on the side which has the higher concentration; therefore the net transport of the solute
occurs in the direction of the concentration gradient. A sample of transport protein’s
structural model and schematic of the transport cycle is shown in Figure 2.7. Examples
of molecules that exhibit this carrier-mediated transport behaviour are glucose, fatty
acids, and amino acids. Facilitated transporters are also found at the BM to enable net
amino acid eﬄux to the fetus.
Exchange transporter: Another example of a passive transporter is the exchange
transporter, which allows amino acids between different sides of membranes to be
swapped. An exchanger takes one amino acid molecule and switches it with another
one from the other side of the membrane. Exchange transporters are ubiquitous in both
MVM and BM. The exchange processes do not change the absolute amount of the amino
acids within the syncytiotrophoblast, but instead only affect the relative composition of
each type of amino acid. This is an important regulatory mechanism for the cell that
mediates the uptake of required amino acids to be transported inside, but at the same
time protects the cell from osmotic effects by transferring another molecule out [6, 16].
Accumulative transporter: Additionally, the active uptake of molecules against their
concentration gradient can be achieved by specific types of transporters. In the placenta,
active processes dominate the overall transport of amino acids across the membranes.
This is supported by evidence that the amino acid concentration in fetal plasma is higher
than in maternal plasma [6]. The main transporters that actively transport amino acids
in the placenta are the accumulative transporters. Accumulative transporters actively
regulate the amino acid uptake into the syncytiotrophoblast which leads to an increase in
amino acid concentration, against its gradient. This active process relies on the energy
that is derived indirectly from the sodium-potassium pump Na+/K+-ATPase and is
driven by the transmembrane electrochemical gradient (secondary active cotransport).
The electrochemical potential difference between the two membranes is determined
both by the Na+ concentration gradient and the membrane electrical potential. In
the case of Na+ dependent transporters, which are present in both MVM and BM,
the transmembrane Na+ gradient is sustained higher outside than inside the cell for
the transport to work (i.e. Na+ going down its gradient allows the amino acid to be
transported up). The Na+ gradient is effectively maintained by the primary active
Na+/K+-ATPase transport mechanism.
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The transport process for a Na+ dependent transporter of a given amino acid can be
described by the following steps as follows [17]:
1. The activator Na+ ion binds to the carrier to favour the transport of the amino
acid.
2. The affinity of the extracellular cotransport binding site is increased with the
binding of Na+.
3. Na+/amino acid transporter complex is formed.
4. Delivery of the Na+ and amino acid on the other side of membrane.
5. Release from binding site of amino acid and Na+, respectively.
6. Na+ is separately transported out via Na+/K+-ATPase maintaining low
intracellular concentration.
As shown in Figure 2.6, these placental transporters work together to regulate amino acid
transfer across the MVM and BM at the syncytiotrophoblast layer. Effectively, the net
transport of amino acids across the BM is required to support fetal growth. Exchangers
and accumulative transporters cannot individually move all of the amino acids required
by the fetus across both MVM and BM (refer to Figure 2.6). Accumulative transporters
only move the amino acids into the syncytiotrophoblast and the exchanger can only
change composition. Therefore, there must be another mechanism that transfers the
amino acids across the BM in the placenta in addition to the accumulator and exchanger.
Recent studies suggested the existence of such a mechanism in the form of eﬄux
transporters in the BM [6, 16, 18, 19]. As previously mentioned, the eﬄux transporter
mediates amino acid transport via a facilitated diffusion mechanism.
Thus, while it is clear from the above that all transporters types need to work together,
the combined effect is hard to predict intuitively; therefore, individual studies of each
type of transporter must be carried out. Specific transporter mechanisms are explored
in greater detail to derive each mathematical models, which are presented in Chapter 3
(facilitative and exchange transporters) and Chapter 4 (accumulative transporter).
2.2.2 Endocrine function
In addition to mediating transfer of nutrients and other substances, the placenta also
has other important functions during pregnancy. For instance, it is an endocrine organ,
secreting hormones into both the maternal and fetal circulations. These hormones
are important during pregnancy as they adapt maternal physiology to support the
pregnancy and allow development of the fetus. For example, estrogen, which causes
breast enlargement for preparation for lactation and uterine growth for the fetus, is
being produced by the placenta [20].
14 Chapter 2 Background
2.2.3 Immune function
Moreover, the placenta also acts as an immune barrier for the fetus. The placenta
protects the fetus from being infected with diseases such as sexually transmitted diseases
by providing a protective interface between the two blood circulations without mixing.
This, however, does allow some infective agents to be transmitted to the fetus, thus
the protection offered is not always complete. For instance, transmission of HIV from
infected mother occurs in 14.4%–39% of pregnancies [21]. The reason for this occurrence
is still largely unknown.
2.3 Placental pathology
It is important for the placenta to be operating normally during pregnancy to ensure
positive neonatal outcomes. During pregnancy, the fetus requires adequate nutrition
for growth and development, while nutrient deficiency or surplus supply may result
in diseases for the baby postpartum. Anomalies in the placenta structure and
characteristics have been reported in relation to these pathological conditions. For
instance, in IUGR, which affects 10 percent of all pregnancies, the placenta is reported to
be under-perfused [22], small in overall size [23], with reduced cell volumes in all placental
tissues [24], decreased intervillous space and villous surface area [25], and abnormal
villous angiogenesis [22]. These conditions contribute to reduced overall fetal transfer of
nutrition (e.g. amino acids) and oxygen (hypoxia) causing retardation of fetal growth in
IUGR that can result in disease such as impaired neurological development after birth.
Conversely, oversupply of nutrition may occur in diabetic pregnancies where the glucose
level is too high can drive fetal overgrowth. Structural indications in the placenta that
promote high transfer of glucose were shown in case of diabetic infants. For instance,
increased intervillous space volume, while no change in villous surface area was apparent
[26]. This suggested that the transfer could be increased for larger intervillous spaces,
which reduces the flow resistance (assumed to be flow limited). Moreover, pathological
disorders can also occur to the mother. For example, maternal anemia and preeclampsia
were reported to be related to under-perfused placentas that also have low villous surface
area [27]. Lastly, disorders related to abnormal (usually low) perfusion as a result of
twin-to-twin transfusion syndrome (TTTS) in multiple pregnancy are also reported to
be related to the placental perfusion and distribution of the blood between the fetuses
[28]. A complete overview of the placental alterations in relation to these disorders
mentioned is summarised in Table 2.2.
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Table 2.2: Summary of placental morphological conditions reported per pathological
disorders.
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Reference
IUGR Fetal hypoxia, – – – – i – – – y y [22–25, 29]
hypoglycemia,
malnutrition
Diabetes Hyperglycemia + + + + = [26, 27, 30]
(type 1)
Preeclampsia Uncertain – = = = + – – [24, 27, 31]
placental
anomaly
Maternal Insufficient red – – = = = – [27]
anemia blood cells,
hypoxia
TTTS Disproportionate i/– i i [28, 32]
perfusion
IUGR: intrauterine growth restriction, TTTS: twin-to-twin transfusion syndrome.
+ denotes increase, – denotes decrease, = denotes unchanged.
i denotes irregular, and y denotes affected.
Table 2.3: Transport activity of various substrates under certain pathologies observed
at placental syncytiotrophoblast microvillous (MVM) and basal (BM) membrane.
Adapted from Jansson et al., 2007 [4].
System A Lysine Leucine Glucose
Disorder MVM BM MVM BM MVM BM MVM BM Reference
IUGR – = = – – – = = [33–35]
Diabetes + = = = + = = + [36, 37]
+ denotes increase, – denotes decrease, = denotes unchanged.
Moreover, impaired transfer has been shown to be associated with IUGR and in animal
models impaired amino acid transfer precedes the onset of IUGR suggesting causation.
IUGR and diabetes, which largely involve the disproportionate transfer of nutrients,
can be related to the transport capacity of the transport proteins [2]. In Table 2.3, a
summary of several substrate transport activities that were altered at both placental
membranes for each disorder is presented [4]. This report suggested reductions in most
amino acid transport activities at both MVM and BM, but unchanged activity for glucose
[33–35]. In addition, increased glucose activity is mostly observed at the BM in the case
of diabetes [36, 37].
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In conclusion, as shown in this brief summary, placental morphology can affect the
transport of substances that may result in immediate and future diseases for the baby
or the mother. Related factors will be considered and explored further when the placental
transport model is being developed. It is hoped that this body of work can contribute
to developing treatments or prevention of these complications.
2.4 Experimental approaches for placental transfer studies
For the study of amino acid transport in biological systems, various experimental
techniques can be performed to investigate transport at different levels of observation.
Depending on the question of interest and suitability, each technique possesses various
advantages and disadvantages [17]. These techniques include:
1. In vivo flux technique which measures the net effect on amino acid concentrations
from blood samples
2. Regional perfusion which measures an organ in isolation, ex vivo.
3. Cultured cell methods, which investigate the transport regulation separated from
other cells and other endocrine influences.
4. Membrane vesicle techniques which observe the behaviour of the spherical cell
membranes prepared from the tissue of an organ.
While each method has its own strengths and weaknesses, three of the techniques are
particularly relevant for the study of placental transfer in relation to computational
modelling. While the in vivo flux method may provide the information closest to
the normal operating conditions, the result from the sample may be affected by other
physiological systems and it is difficult to extract the placenta-specific information. In
contrast, in regional perfusion, we can observe the placenta independent of all other
organs in an ex vivo setting. By varying the input and output flow of the placenta, we
can observe the transport by the organ in response to the flow. Modelling of the perfusion
experiments can be done at the organ scale with a compartmental representation of the
placenta coupled to the flow on the maternal and fetal side [16, 38]. Time-dependent
data can be recorded on the scale of minutes up to hours. Though information
from perfusion experiments is important, the placenta still represents a ‘black box’
to some extent and information at the cellular membrane level is equally essential to
complement these studies. Hence, the cultured cell methods and membrane vesicle
techniques are preferred for the cellular transport studies at a smaller time scale. These
experiments can provide parametric data for the kinetic response of specific individual
transporter as well as time-dependent information due to changes in the concentrations.
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In particular, Xenopus oocyte cells are commonly used for observing the transport at
the cell level. Oocytes, which are induced to overexpress specific human transporter
proteins, are used for observing uptake of substrate into the cells from the external
environment while maintaining normal intracellular cell operations (e.g. metabolism
and intracellular concentrations). These influences can be avoided using the membrane
vesicle technique where only the plasma membrane is isolated from epithelia and formed
into a vesicle suspension. Therefore membrane vesicle studies can be appropriate for
exploring placental transport , with the advantage of eliminating confounding influences
such as the effects of placental structure and metabolism at the cellular level and offering
improved control over intracelluar concentrations.
In vesicle studies, placental MVM vesicles have been used to investigate amino
acid uptake activity [39, 40]. The MVM vesicles were prepared from isolated
syncytiotrophoblast layer using centrifugation to form membrane pellets that can then
be resuspended to form vesicles, with the same membrane orientation as in vivo [41]. The
transporters embedded in the MVM vesicles were preserved in the method. However, the
regulation by intracellular components was absent due to the nature of the technique
in which the cell organelles were eliminated. This gave the freedom to measure the
specific activity of the transporters without prior knowledge or involvement of the
cellular regulation of transporter expression. Intra-vesicular and extra-vesicular buffer
solutions were added to maintain a normal environment for the membrane vesicles as well
as to pre-set the desired experimental conditions. Radiolabelled amino acid substrate
was then utilized for tracing the transport activity, which was measured by method of
liquid scintillation counting. Additionally, transporter specific inhibitors can be added
to isolate the particular transporter’s activity. For instance, in observing the uptake of
serine, α-methylamino-isobutyric acid (MeAIB) can be added as an inhibitor in order
to isolate the System A transport component, which uses the accumulative transport
mechanism [39]. In addition, the System L component believed to use the exchange
mechanism can be isolated by using 2-Amino-2-norbornanecarboxylic acid (BCH) as
inhibitor. In some transporters where ionic molecules are required for the cotransport of
the substrate, the isolation of such transporter activity can be achieved by the absence
of that ionic molecule in the experiment. For example, the accumulative transporter’s
activity can be eliminated by not adding the required sodium ions in the experiments.
By having the ability to extract transporter specific uptake data, vesicle studies are
a suitable method to independently investigate individual models for each transporter
mechanism. Moreover, other cellular influences (e.g. metabolism) are omitted which
reduce the complexity of the interpretation of the experimental data.
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Figure 2.8: Schematic diagram of experimental techniques used for the study of
placental transport: (a) Ex vivo perfusion method, which controls flows and input
concentrations; (b) Isolated membrane vesicle experiment with controlled conditions in
the extravesicular buffer (EVB) and inside the vesicles; (c) Cultured cell method using
oocytes overexpressing human transporter proteins to measure tracer uptake or eﬄux.
2.5 Review of placental modelling
In this section, the literature on previous placental modelling efforts is reviewed.
Investigators have developed modelling interests that ranged from the macroscopic
system, such as blood flow in placenta, to transport at the microscopic scale and
individual transporter kinetics. Additionally, transporters can be modelled at the
molecular level to understand the dynamics of the changes in molecular structure during
transport. Previous placental modelling studies have mainly focussed on the topics of
blood flow, oxygen/gas transfer, and solute transport by simple diffusion (as summarised
by [42]). On the other hand, outside the area of placental transport, there have
been numerous studies specifically on membrane transporters, which could be equally
relevant to placental amino acid transport. These studies encompass many different
physiological applications; such as, thyroid hormone transport in the brain [43, 44], drug
transport mediated by ATP-binding cassette transporters [45, 46], or renal transport of
nutrients [19, 47, 48]. Numerous studies in the past have used carrier type models to
obtain an improved insight in transporter mechanisms and activity, for instance; choline
transport in erythrocytes [49], glucose transport in the kidney [50], or the transport of
monosaccharide in tumour cells [51].
Conclusively, the review was intended to show the progression of modelling efforts
building up to the current studies of amino acid transport modelling in the placenta. In
the next sections, several key studies are highlighted and explained in more detail.
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2.5.1 Placental blood flow
Blood flow is an important factor for tissue perfusion. For the placenta, the flow
characteristics are commonly thought to be limiting factors in the quantity of nutrients
being delivered by blood perfusion. Therefore, many efforts have been made to obtain
a better understanding of the flow pattern in the placenta. In the past, experimental
methods of investigation that were based on radiography and casting techniques were
used to graphically mimic the flow pattern in the branching villous structure of the
placenta [52, 53]. However, quantitative information on the villous morphology has
been in dispute, thus the authors suggested random distribution of the venous outflow
openings [42]. Earlier studies simply modelled the maternal spatial flow pattern in the
cotyledon of the placenta as a 2D squared-shape porous medium using the principles from
Darcy’s law, which assume a linear relationship of the flow velocity to the blood pressure
and porosity of the medium [54]. More recent work made an improved representation
of the cotyledon as a hemispherical volume with a branching villous tree structure that
comprises of veins, an artery, and a cavity [42]. In addition, recent models have suggested
a stream-tube flow configuration that models maternal flow between the villi [55, 56].
The study suggested that the resulting heterogeneous maternal blood flow pattern, which
in the past has been simplified to a homogeneous pattern, can have different relative
effects on the transport of substances. The model also addressed the combined effects
of the complex flow, uptake kinetics, and solute distribution patterns, which together
could influence the efficiency of a given transport system (e.g. for oxygen transfer, as
reviewed in the next section). In summary, the findings of blood flow characteristics are
insightful and may be useful when considering the modelling of amino acid transport
coupled to physiological flow conditions.
2.5.2 Oxygen transport
Oxygen is one the most important substances to be transported by the placenta, as
the placenta is the only source of oxygen for the fetus. The placental oxygen transfer
can be summarised as a three-step process [57]. Firstly, from the maternal side, the
oxygenated blood enters the placenta via arteries from the basal plate and occupies the
intervillous space. The blood comes in contact with the terminal villi which act as a
barrier for the flow, prompting the decrease in flow rate from the basal plate to the
chorionic plate. Secondly, the oxygen diffuses across the villous membrane to the fetal
capillaries. This passive process relies on the oxygen gradient between each interface to
drive the transport, which is suggested to be flow limited as flow maintains the trans-
placental gradient [58, 59]. Lastly, the oxygen enters into the fetal blood circulation and
is being used by the fetus.
While many attempted to model the gas exchange process, these studies proved to be
difficult due to the high variability of the placental structures involved. For instance, the
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placenta’s oxygen exchange was modelled at the most basic level with non-dimensional
parameters [60]. Fick’s law for diffusion was implemented, which states that the
flux of oxygen is proportional to the gradient of the oxygen level at the maternal-
fetal interfaces. This work demonstrated basic transport theory without geometric
considerations. However, since oxygen transport is thought to be flow-limited, the
placental morphology should also be accounted for in models as it directly influences
the flow rates. In more recent studies, the oxygen transport was modelled at a single
capillary with gas exchange at the wall [61], which suggested that the oxygenation was
strongly influenced by the thickness of the capillary (proportionally) and the thickness
of the wall (oppositely). Further development was made in another recent study that
considers the effects of various terminal villi shapes [57]. The model was based directly
on 2D digital photomicrographs of cross sections of the placenta, which were used
to represent the geometry of the villous-capillary interfaces at the terminal villous.
It was suggested that crowded capillaries in the placental microstructure reduce the
oxygenation efficiency. In addition, the studies of flow mentioned in the previous section
suggested that when considering the overall macro scale, the optimal configuration of the
villi within the cotyledon should be neither too dense nor too sparse for optimal oxygen
transfer [55, 56]. In general, these studies have demonstrated that diffusion of oxygen
molecules (and also other gases) is highly dependent on the geometry of the placental
morphology, which greatly varies from one to another. The morphology of the placenta
is closely related to the blood flow characteristic which is shown to be a limiting factor
for gas exchange. From these oxygen transport studies we can relate the effect of the
microscopic structures to the macro-scale transfer, which could be applied to amino acid
transport studies. However, it is generally thought that the uptake of amino acids is not
flow limited since it requires transport against the overall higher concentrations in the
syncytiotrophoblast than the maternal side [5]. Hence for amino acids, this implies the
focus on the transporter system rather than flow and structure in detail. Nonetheless,
once the transmembrane transport model is realised, flow models that consider placental
structural features can be combined with the membrane transport models to represent
transport at the macroscopic scale.
2.5.3 Membrane transport of nutrients
There have been efforts in modelling the membrane transport of biologically relevant
solutes across various epithelia. These studies include transport in kidney, liver or
intestines, in addition to the placenta. It is beneficial to review these previous works in
other organs, as the underlying principles of membrane transport are universal and it can
provide additional modelling tools to the placental study. The studies are summarised
as follows:
Membrane nutrient transport experiments are often carried out under the assumption
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that transport can be described as a Michaelis-Menten process due to the simplicity
of this approach [47, 50, 62]. Experimentalists carry out studies to determine the
Michaelis-Menten kinetic parameters by measuring the initial uptake rates across a range
of substrate concentrations, without considering the underlying transport mechanisms
or specific experimental conditions that may result in experimental variations [43, 44].
Most commonly, the configuration of these past experiments, does not include time-
course data [44, 62], which can provide more detailed information on the transporter
response than just initial uptake rates. Hence, it is important to relate these kinetic
experiments to more mechanistic models while considering timecourse data (in addition
to kinetic data based on initial uptake rates). This was evident in previous studies, for
example, carrier-mediated modelling approaches have been used to explain the transport
of various nutrients [17, 50, 63, 64], which was then related back to the interpretation
of transport as a simple Michaelis-Menten process. In carrier-mediated transport, the
substrate is assumed to bind to a carrier (transporter) in order to transport from one side
of the membrane to another. In general, this process is parameterised in terms of the
carrier’s translocation rates across the membrane and its substrate binding/unbinding
activity (i.e. binding affinity). For each transporter type, the basic theory for carrier
mediated transport can be further expanded to represent each transport mechanism.
For instance, in a cotransport model, substrate transport requires an additional
ion (sodium) to be transported simultaneously by the carrier. In past studies,
experimentalists have represented cotransport based on Michaelis-Menten type equations
to carry out membrane transport studies, for instance, in vesicle amino acid uptake
experiments using rabbit intestinal epithelium [62] and rat fibroblasts [47]. Both of
these studies demonstrated the dependency of transport on sodium, represented by a
phenomenological Michaelis-Menten kinetic model. In another study as continuation of
[47], the amino acid proline was investigated by observing uptake in renal brushborder
membrane vesicles [48]. The model assumed the flux of the uptake could be represented
by two superimposed Michaelis-Menten processes, one for each of the sodium-dependent
and -independent components. Notably, the time-dependent experimental results in the
studies of [47, 48] showed an overshoot in the uptake of substrate before reaching the
equilibrium value, which was shown to be related to presence of the sodium gradient.
However, the fitted Michaelis-Menten parameters were not uniquely determined as only
the ratios of such parameters were successfully obtained. This revealed the limitations
of the Michaelis-Menten kinetic representation; since such overshoot phenomena are
essentially dependent on time and internal concentration. Moreover, these studies did
not take electrochemical effects into consideration, as the transport of the ions (sodium)
would change the potential difference which could affect the transport process. A
representative list of the equations used in the literature to model the nutrient transport
across various epithelial membranes is presented in Table 2.4.
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Table 2.4: Nutrient membrane transport equations as modelled in literature.
Model equation Description Reference
JA =
Vmax[A]I
KAKNa
[Na]I
+[A]I
Cotransport: Flux JA is a Michaelis- [62]
Menten process dependent on external
concentration [A]I with maximum
transport rate Vmax and half-
saturation constant as the ratio of
the product of dissociation constants
KA and KNa over the external
concentration of the cotransported
solute sodium [Na]I .
JA =
Vmax[A]I
KAKNa
[Na]I
+[A]I
− Vmax[A]IIKAKNa
[Na]II
+[A]II
Cotransport: Flux JA is the difference [47, 48]
of two Michaelis-Menten processes
governed by the external [A]I and
internal [A]II concentration as
described in [62].
JA =
Vapp[A]I
Kapp+[A]I
Cotransport: Flux JA is an apparent [50, 64]
Michaelis-Menten process as a function
ln [A]
I
[A]II
≤ ln [Na]II
[Na]I
+ F∆ψRT of external concentration [A]
I .
Equilibrium thermodynamics relation
between the concentrations of
substrate A and sodium Na given by
an inverse logarithmic relationship in
combination with the effect of the
electric potential difference ∆Ψ.
JA = Vmax
(
[A]I
KA+[A]I
− [A]II
KA+[A]II
)
Facilitative transport model: Flux JA [63, 65]
from side I to II is driven by the
difference in concentration between the
two sides. The net flux is modelled as
the difference of two Michaelis-Menten
equations.
JA = Vmax
(
[A]I
KA+[A]I
)(
[A]II
KA+[A]II
)
Exchanger: Flux JA from side I to II [16]
is the product of two Michaelis-Menten
processes on the two sides.
In order to consider all driving forces for cotransport (accumulative transporter), in
addition to the chemical driving force arising from the concentration gradients, the
effects of the electric-potential on the ion must be taken into consideration. This was
seen in an improved mechanistic investigation of the cotransport system, which was
conducted on sodium-dependent glucose transport in the rabbit brush border membrane
vesicles [50] and in a similar oocytes study expressing small intestine transporters [64].
The latter model described all the individual transport parameters for each carrier state
(e.g. bound vs empty carrier), including exponential relationships for the effect of the
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membrane potential. For investigating the effects of membrane potential, the chemical
‘voltage clamping’ principle was suggested for the purpose of chemically adjusting the
membrane potential. This is expected to be useful when designing the experiments for
investigating the accumulative transporter. Moreover, the overshoot phenomenon was
confirmed by the results, based on which it was argued that it was driven by the sodium
gradient, rather than just a dependency on the absolute concentration level [50]. This
was illustrated by an example of the uptake profile; where the curve of solute uptake for
the case where sodium ions were present but in equilibrium showed no overshoot effect,
whilst another curve for the case where an initial sodium gradient was present displayed
the overshoot phenomenon. The author also introduced the different approaches used
in vesicle experiments, for example by setting different concentrations on each side of
membrane, in contrast to the common practice of only measuring the zero-trans case
(i.e. zero initial concentration inside the vesicles). The zero-trans condition is often
implicitly assumed and coupled with Michaelis-Menten analysis in vesicles and oocyte
uptake experiments without consideration of any effects resulting from the potential
presence of endogenous (trans) concentrations inside the vesicle/cell. This was presumed
to be a source of variation in the apparent kinetic parameters determined from these
experiments, which needs to be explored by the model. Interestingly, the authors
described the sodium-dependent carriers as being initially negatively charged and to
have the propensity to undergo charge neutralisation with positively charged sodium
ions [50]. From the findings, it was observed that as the membrane potential was made
more negative, the transmembrane translocation of the empty carrier was faster and the
sodium ion’s dissociation rate became more rate-limiting.
In addition, to the cotransport model representing the accumulative transport
mechanism, energetically passive nutrients transporters have been investigated,
specifically with respect to the exchange transporters. Although, there were several
reported apparent Michaelis-Menten kinetic parameters values in placental transporter
studies, their values showed high variation [19, 66, 67]. Again, this is presently
hypothesised to be caused by the implicit assumption of zero-trans conditions, ignoring
any effects of internal concentrations when performing kinetic experiments. In theory,
the exchanger requires the substrate(s) to be present on both sides of the membrane
for the transporter to operate, hence, logically no transport should occur under zero-
trans conditions, contrary to common experimental observations in vesicle studies
[39, 68]. This apparent contradiction needs to be explored further, which requires a
better mechanistic model other than just simple Michaelis-Menten kinetics that cannot
account for internal concentrations. A previous study on placental transport has applied
a phenomenological model for the exchanger as the product of two Michaelis-Menten
processes for each side of the membrane [16]. However, the mechanistic basis for the
exchanger model and its application to experimental data requires further examination.
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2.5.4 Molecular structural modelling
In addition to the kinetic studies, modelling of the transport protein can be done at
the molecular structural level as demonstrated in the study of glucose transporters [69],
which described the conformational changes of the protein during transport and binding
of solutes. While the kinetic models focused on the overall transport mechanism and
the molecular structural models consider the physiochemical behaviour of the transport
protein that influences transport, neither approach can be ruled as superior to another
as they provide complementary information. Hence, combining knowledge from both
modelling approaches is deemed to be beneficial to obtain a better representation of the
transport mechanism in the end.
2.5.5 Organ-scale modelling
The idea of modelling various placental functions has been presented [70], which reviewed
multiple basic and phenomenological models for (diffusive) transfer of different nutrients.
While this serves as good stepping stone for the effort towards a ‘virtual’ placenta,
many nutrients transport systems – such as for amino acid – require more sophisticated
mechanistic models. Furthermore, morphological considerations should be addressed for
each transport system that may contribute to the efficiency of transfer.
2.5.6 Compartmental modelling
Finally, the work by Sengers et al., 2010 on modelling of the amino acid transfer
in the placenta had served as the starting point of the current research [16]. The
investigators developed amino acid transporter specific models based on assumptions
for their transport kinetics and used these to construct an integrated compartmental
model. Ex vivo perfusion experiments of human placenta were used to test the model.
While the work gave excellent insights in how placental transport could work as an
integrated system, the transporter models itself were however largely phenomenological.
Therefore, potential work could be done to account for a more complex mechanistic
representation of the biophysical transport processes.
2.6 Conclusion
From the body of literature reviewed, it can be inferred that improved quantitative
understanding of placental amino acid transfer is essential for possible clinical
applications to treat fetal conditions. Particularly, a systematic computational modelling
approach is crucial in understanding such complex transport interactions for the placenta
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as a whole. However, individual transport components by each transporter must
be investigated and developed first due to the current lack of mechanistic models.
By developing a novel integrative computational-experimental framework building on
recent studies [16, 39], the current work as outlined in the following chapters will
ultimately contribute to the development of a ‘virtual’ placenta to aid the interpretation
of experiments and clinical interventions.

Chapter 3
Exchange and facilitated
transporter – model development
and application to placental
membrane vesicles studies1
3.1 Introduction
Amino acid transfer across the placenta is an important determinant of fetal growth
[68, 71, 72]. It is well known that placental amino acid transport is mediated by a
broad array of specific membrane transporters with overlapping substrate specificity.
However, it is not fully understood how these transporters function, both individually
and as an integrated system. Recent study introduced integrated approach for the
placental transport system [16]; however, an improved mechanistic model is needed for
a better understanding for potential clinical applications such as preventing intrauterine
growth restriction.
Transfer of amino acids from the maternal blood, across the placenta and into the fetal
blood, is a complex process in which amino acids need to cross both the maternal facing
microvillous plasma membrane (MVM) and the fetal facing basal plasma membrane
(BM) of the placental syncytiotrophoblast [6, 73]. Transport of amino acids is
mediated by specific membrane transporter proteins. These include: (i) Accumulative
transporters, which can transport amino acids against their gradient using secondary
active transport driven by the sodium electrochemical gradient, thereby building up
high concentrations in the syncytiotrophoblast [74]. (ii) Exchangers (antiporters), which
transfer one amino acid from outside of the plasma membrane in exchange for an amino
1This work has been published as Panitchob et al., 2015 and Widdows et al., 2015 as shown in the
List of Publications.
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acid from inside. (iii) Facilitated transporters, which enable facilitated diffusion of
amino acids down the concentration gradient, from the placental syncytiotrophoblast
into the fetal circulation, resulting in net transport. As a result, exchangers play an
important role in altering the composition of amino acids, but not the net amount,
which is the responsibility of the facilitative transporters. Transport proteins expressed
at the placental membranes that are thought to function via the exchange mechanism
include LAT1 and LAT2 from the SLC7 gene family, of which the transport activity is
often referred to as system L – the sodium-independent transport of large (LAT1 and
LAT2) and small (LAT2) neutral amino acids [14, 75]. These transporters are common
in cells of various other tissues and their substrates include many amino acids. For
transport proteins displaying the facilitative transport mechanism, LAT3 and LAT4
from the SLC43 family are expressed at the placental basal membrane [14]. Although,
LAT3 and LAT4 share the same Na-independent transport mechanism as LAT1 and
LAT2, their substrate specificity is more restricted, i.e. they have a lower number of
substrates.
While LAT2 is believed to be an obligatory exchanger (strict one-to-one exchange)
[19, 66], one study has reported a non-obligatory (facilitative) component [67]. Sodium-
independent transport of serine, which can be primarily attributed to the transporter
protein LAT2 [39], was used to investigate such transport behaviour that can be found
in the placenta. Experiments using isolated plasma membrane vesicles prepared from
human placental MVM or BM are commonly used to measure in vitro amino acid uptake,
allowing for transporter activity to be studied under controlled conditions. In previous
placental vesicle studies, sodium-independent serine uptake has been observed when
amino acids were initially nominally absent inside the vesicle (zero-trans experiment)
[39]. However, this is incompatible with the concept of obligatory exchange, which
requires amino acid to be present on both sides of the membrane in order for exchange
to occur. Therefore, this gives rise to two alternative hypotheses: (i) That sodium
independent transport of serine may not be fully obligatory, or alternatively (ii), there
is an initial level of endogenous amino acids present inside the vesicle, which could then
enable obligatory exchange.
To investigate these possibilities, a mathematical model for tracer uptake was developed
based on carrier-mediated transport, which can represent either facilitated transport or
obligatory exchange. In vitro measurements of serine uptake by placental microvillous
membrane vesicles were carried out and the model applied to interpret the results based
on the measured apparent Michaelis-Menten parameters Km and Vmax. In order to
relate the model to biological experiments, in which the well-known Michaelis-Menten
equation is most commonly applied to describe saturable transport processes [39, 66, 76].
However, this equation does not fully represent many important transport phenomena,
for instance facilitated diffusion and exchange transporters, which are intrinsically
dependent on substrate concentrations on both sides of the plasma membrane. Thus,
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while this approach is useful to describe apparent transport properties under specific
conditions (e.g. initial uptake rates), more complex mechanistic models are required
to capture transporter behaviour under various physiological conditions. Therefore,
subsequently, model predictions based on this data were used to inform and design an
additional series of time-course experiments to provide a more comprehensive analysis
of transporter behaviour.
3.2 Methods
3.2.1 Transporter model: General carrier model
It was assumed that the kinetics of amino acid transport across the placental membrane
could be described by a carrier-mediated process [50, 63, 77]. An amino acid cannot
traverse the cell membrane on its own, but needs to bind to a specific transport
protein [6]. Once the amino acid is bound, the transporter (carrier) can undergo a
conformational change, exposing the substrate binding site to the other side of the
plasma membrane to allow for transport across. Depending on the assumptions made,
the carrier model can represent both amino acid transport mediated by obligatory
exchangers, as well as non-obligatory (facilitative) transporters. Note that an extensive
treatment of carrier models can be found in the reference work by Stein [63].
Figure 3.1: General carrier model for a single substrate. Schematic including the
different transporter states and the various binding and translocation rate constants.
Transporter X can bind to substrate A to form a complex AX. Depending on
parameters, X can translocate between the outside (I) and inside (II) of the vesicle in
either loaded or unloaded form.
A general carrier model (schematic diagram shown in Figure 3.1) is realised based on the
following assumptions: The transporter, designated as unbound carrierX, is constrained
in the membrane and can adopt two alternative states I and II, with binding sites
exposed on either side of the membrane. The amino acid A can reversibly bind to the
transporter X to form the bound carrier complex AX, which can also alternate between
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two different states on either side of the membrane. It is assumed that each carrier can
only bind a single molecule of amino acid. Translocation or chemical reaction between
each of the four states in Figure 3.1 is governed by the rate constants ki (unit of s−1
or l mol−1s−1). [A]i, [X]i, [AX]i represent the concentration of solute A, carrier X, or
carrier-solute complex AX, where i represents the membrane surface with side I or side
II. Note that concentration has the unit of mole per litre.
The net flux JAX of the substrate-transporter complex AX directed from side I to side
II, can be represented as the net effect of the forward and backward directed fluxes.
The same applies for the net flux JX of unbound transporter X from side I to II.
From Figure 3.1, the fluxes can be written as follows:
JAX = k1[AX]I − k−1[AX]II (3.1)
JX = k2[X]I − k−2[X]II (3.2)
Each flux component is the product of the appropriate linear rate constant and
concentration. Note that the fluxes take the unit of the rate constants and the
concentrations, therefore have the unit of mole per litre per second (mol l−1 s−1).
Rapid equilibrium is assumed, i.e. amino acid binding is fast compared to translocation
across the membrane, which implies that bound and unbound concentrations are
considered to be at equilibrium at each side of the membrane [78, 79]. Therefore, the
rate constants for binding can be replaced by the following dissociation constants (KI
and KII), given by:
KI =
[A]I [X]I
[AX]I
=
k−3
k3
(3.3)
KII =
[A]II [X]II
[AX]II
=
k−4
k4
(3.4)
KI and KII , therefore, by definition have the same unit as the concentration. Note
that this corresponds to the binding (k3, k4) and unbinding rate constants (k−3, k−4)
have the dimensions of mol l−1 s−1 and s−1, respectively.
Within the membrane, the transporters are assumed to be conserved [62–64]. Hence,
the total number of transporters xT is given by:
[X]I + [X]II + [AX]I + [AX]II = xT (3.5)
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Quasi-steady state transport is assumed, i.e. the time scale of binding and translocation
is fast compared to any changes in concentration within the compartments [80]. Thus
quasi-steady state transport implies that the sum of the fluxes of bound and unbound
carrier must be zero [62–64], i.e. they must be equal and opposite for the transport cycle
to continue:
JX + JAX = 0 (3.6)
Substrate A can only cross the cell membrane bound to the transporter, therefore
JA = JAX . Then by rearranging these equations, the general equation for describing
the flux of substrate A into the cell is given by:
JA =
(k−2k1KII [A]I − k2k−1KI [A]II)xT
(k1 + k−1)[A]I [A]II + (k−2 + k1)KII [A]I + (k2 + k−1)KI [A]II + (k2 + k−2)KIIKI
(3.7)
Michaelis-Menten interpretation: In experimental vesicle studies, uptake is usually
reported in terms of apparent Michaelis-Menten parameters. Considering only the initial
flux JA0 , then all initial concentrations are known and for the case of zero-trans uptake,
Equation 3.7 reduces to:
JA0 =
k−2k1[A]I0xT
(k−2 + k1)[A]I0 + (k2 + k−2)KI
(3.8)
Therefore, the apparent Michaelis-Menten parameters can be expressed as follows
[49, 78]:
Kapp =
k2 + k−2
k−2 + k1
KI (3.9)
Vapp =
k−2k1xT
(k−2 + k1)
(3.10)
Thus Kapp is a function of the external substrate dissociation constant KI , as well as
the transporter translocation rates, while Vapp is a function of the translocation rates of
the bound and unbound carrier.
Parameter reduction: For the transporter model, e.g. Equation 3.7, the number
of kinetic parameters in the model can be reduced to lower the complexity of the
model when applied to the experiments. These simplifying steps were made in first
instance to derive the simplest possible model that can still adequately represent the
specific transporter mechanism, only adding further complexity as necessary based on
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the comparison with the experimental data. The rationale for each step is described as
follows:
1. Equal translocation rate: First, it was assumed that the forward (ki) and backward
(k−i) translocation occurs at the same rate. However, note that different rates
could apply for the carrier substrate complex AX and the unbound transporter
X. The translocation rates as defined in Figure 3.1 can be expressed as follows:
k1 = k−1 = k (3.11)
k2 = k−2 = hk (3.12)
Here k represents the translocation rate constant for the bound carrier-substrate
complex AX in either direction. Thus, h denotes the translocation rate of the
unbound carrier X as a fraction of that of the carrier-substrate complex (i.e. the
relative unbound-to-bound translocation rate). Therefore, the fluxes of the bound
and unbound carrier become:
JAX = k([AX]I − [AX]II) (3.13)
JX = hk([X]I − [X]II) (3.14)
2. Microscopic reversibility : The transport mechanisms considered here are passive
in nature, driven by concentration gradients only, without any energy input in the
form of e.g. ATP. Therefore, the principle of microscopic reversibility implies that,
for a cyclic transport process, the product of the clockwise rate constants is equal
to the product of the anti-clockwise rate constants, Equation 3.15 [64, 81] (i.e.
based on the equilibrium of each step in the transport cycle at steady state and
the known internal and external concentrations at equilibrium):
k1k−4k−2k3 = k−1k−3k2k4 (3.15)
Under the assumption of rapid equilibrium Equation 3.15 reduces to:
k1
k−1
=
k2
k−2
KI
KII
(3.16)
Thus if the translocation rate constants in both directions are assumed to be
equal (Equation 3.11–Equation 3.12), then the substrate dissociation constants on
both sides of the membrane also necessarily have to be equal (KI = KII = K).
Conversely, Equation 3.16 also implies that if the dissociation constants were
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assumed to be different on both sides, then all translocation rates cannot be equal.
Consequently, based on these assumptions, the model as given by Equation 3.7
reduces to:
JA =
2VJAhK([A]
I − [A]II)
2[A]I [A]II +K(h+ 1)([A]I + [A]II +K)
(3.17)
where, VJA =
kxT
2 .
Here h is dimensionless, K has unit of concentration (µmol l−1) and VJA is in µmol
m−2 min−1. The rate of change of the concentration within the vesicle d[A]
II
dt can
be obtained by multiplying the flux JA by the area to volume ratio of the vesicle.
In this form, Equation 3.17 represents transport of only a single substrate. A
similar procedure as described above can be adopted for the transport of multiple
substrates. The resulting expression for two substrates is given in Equation 3.25.
Thus, based on these two considerations described above, the number of the model’s
kinetic parameter was cut in half, from 6 to 3. However, any potential asymmetry in
these parameters can affect the transient behaviour of the model, which will be explored
further as outlined in Section 3.2.3.
3.2.2 Exchange/facilitative transporter model: Application of the
model
With the carrier-model realised in the previous section, further model development is
required to apply the model to the experimental conditions, which are described in
Section 3.2.4. In particular the model needs to be extended to account for multiple
substrates. An overview of the model is presented in Figure 3.2. Radiolabelled substrate
was used experimentally to measure uptake, while unlabelled substrate can either be
present inherently, or added as part of the experimental design. Therefore, radiolabelled
substrate A and unlabelled substrate B were distinguished explicitly in the model. The
transporter, designated as unbound carrier X, can adopt two alternative states I and II,
with a binding site exposed either on the outside I or inside II of the membrane. Amino
acids A and B can bind reversibly to the transporterX to form a bound substrate-carrier
complex, AX or BX, which itself can also alternate between the outside and inside of
the plasma membrane (Figure 3.1). It was assumed that each carrier could only bind a
single amino acid molecule at any one time [82].
A number of simplifying assumptions were made to reduce the number of parameters to
the lowest possible to represent the main features of the proposed transport mechanism.
The radiolabelled amino acid A, and unlabelled amino acid B were assumed to have
identical transport characteristics. The translocation rate constants for the loaded
transporter complex were assumed to be equal in forward and backward directions,
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(a) (b)
Figure 3.2: Overview of the exchanger/facilitative experimental system and
transporter model. a) Transporter activity was evaluated by measuring the uptake of
a radiolabelled tracer A into placental microvillous membrane vesicles. b) Transporter
model, schematic showing the different transporter states. Transporter X can bind to
either tracer A or unlabelled substrate B to form a complex AX or BX, which can then
translocate between the outside (I) and inside (II) of the vesicle plasma membrane.
Transporter X can also translocate on its own, depending on the parameter h. The
case h = 0 corresponds to an obligatory exchanger, while for h 6= 0 the transporter will
display facilitative diffusion.
both given by the rate constant k. This then also implied the same binding affinity
on the inside and outside of the membrane, i.e. equal dissociation constants K, based
on thermodynamic arguments (Equation 3.3–Equation 3.4). The bound and unbound
carriers do not necessarily transfer at the same rate. Therefore, in addition, a parameter
h was introduced to represent the relative mobility of the unbound carrierX with respect
to the bound carrier complex AX or BX. This is shown as followed:
From Figure 3.2b, the fluxes can be written as:
JAX = k([AX]I − [AX]II) (3.18)
JBX = k([BX]I − [BX]II) (3.19)
JX = hk([X]I − [X]II) (3.20)
This parameter h is critical in distinguishing obligatory exchange from non-obligatory
transport. As can be observed from Figure 3.2b, for h = 0, the unbound carrier does
not move on its own and only the bound carrier complex can translocate. Therefore
transport is a perfectly obligatory exchange process in which A needs to be exchanged
for B on a 1:1 basis for any net transport to occur. In contrast, if h is not zero then
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the unbound carrier can move on its own. Therefore the process is non-obligatory, as
no substrate is required on the other (trans) side of the membrane in order for the
carrier to return and continue the transport cycle. Thus for h > 0 this can give rise to
facilitated diffusion.
As described in previous section, rapid equilibrium is assumed. Therefore, the rate
constants for binding can be replaced by the following dissociation constants K, which
are assumed the same for both species A and B on both side of the membrane, given
by:
K = KI =
[A]I [X]I
[AX]I
=
[B]I [X]I
[BX]I
(3.21)
K = KII =
[A]II [X]II
[AX]II
=
[B]II [X]II
[BX]II
(3.22)
K, therefore, by definition has the same unit as the concentration. Note that this
corresponds to the binding (k3, k4) and unbinding rate constants (k−3, k−4) have the
dimensions of l mol−1 s−1 and s−1, respectively.
Using conservation of the total number of transporters xT is given by:
[X]I + [X]II + [AX]I + [AX]II + [BX]I + [BX]II = xT (3.23)
In a similar manner as in the previous section, quasi-steady state transport is assumed,
which implies that the sum of the fluxes of the bound and unbound carrier must be zero:
JX + JAX + JBX = 0 (3.24)
Based on the assumptions described earlier, the following equation can be derived for
the uptake of radiolabelled substrate A into the vesicle:
d[A]II
dt
=
2V
(
[A]I([B]II +Kh)− [A]II([B]I +Kh))
2[Tot]I [Tot]II +K(h+ 1)([Tot]I + [Tot]II) + 2hK2
(3.25)
where,
[Tot]i = [A]i + [B]i, for i = I, II.
[A]I0 = A1, [B]
I
0 = B1, [A]
II
0 = 0, [B]
II
0 = B2
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Here h is dimensionless, K has unit of concentration (µmol l−1) and the uptake rate V
is in µmol l−1 min−1. Note that V is in concentration per unit time as it incorporates
the vesicle volume (i.e. flux in mol min−1 divided by vesicle volume). Note that the
initial conditions for each substrate can vary depending on the experimental designs,
which are explained in Section 3.2.4 and 3.2.5. Thus from Equation 3.25, obligatory
exchange and non-obligatory or facilitative transport are essentially based on the same
model, depending on the value of h. Note that the uptake of unlabelled substrate B can
be expressed in a similar manner as A by the following equation:
d[B]II
dt
=
2V
(
[B]I([A]II +Kh)− [B]II([A]I +Kh))
2[Tot]I [Tot]II +K(h+ 1)([Tot]I + [Tot]II) + 2hK2
(3.26)
where,
[Tot]i = [A]i + [B]i, for i = I, II.
[A]I0 = A1, [B]
I
0 = B1, [A]
II
0 = 0, [B]
II
0 = B2
However in the Results, the uptake of B is not shown as substrate A is the only variable
of interest.
Michaelis-Menten interpretation: In most experimental vesicle studies only the
initial uptake rate is measured, with no amino acids added inside the vesicle (zero-trans
conditions). Assuming Michaelis-Menten kinetics, uptake is then usually quantified in
terms of the parameters Vmax and Km, i.e. the maximum uptake rate and half maximum
rate concentration, respectively. If we now consider Equation 3.25 with no tracer inside
at the start of the experiment [A]II0 = 0, then the initial rate of tracer uptake can be
written in the following form:
d[A]II
dt (t=0)
=
Vapp[A]I0
[Tot]I0 +Kapp
(3.27)
where,
Vapp =
2V ([B]II0 +Kh)
2[B]II0 +K(h+ 1)
(3.28)
Kapp =
K(h+ 1)[B]II0 + 2hK
2
2[B]II0 +K(h+ 1)
(3.29)
Thus, for initial uptake the model reduces indeed to a Michaelis-Menten relationship,
where Vapp and Kapp are the apparent Michaelis-Menten parameters. However, critically
it can be observed from Equation 3.28–3.29 that these apparent Michaelis-Menten
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parameters depend directly on the value of the parameter h, as well as the concentration
of any unlabelled substrate [B]II0 that may be present inside the vesicle. Therefore,
Equation 3.27 can be applied to interpret apparent uptake parameters for either
obligatory or non-obligatory exchange.
3.2.3 Asymmetry of the transport parameters in exchanger/
facilitative transporter model
In this section the implications of asymmetry in transport parameters for the model
is explored further. The schematic of the extended model with explicit translocation
rate and dissociation constants is shown in Figure 3.3. The corresponding model
equation, derived based on the same assumptions as in Equation 3.18–3.24, is given
in Equation 3.30.
Figure 3.3: Extended exchanger/facilitative transporter model for two substrates (A
is radiolabelled, and B is unlabelled). Schematic including the different transporter
states and the various dissociation and translocation rate constants. Transporter X
can either bind to substrate A or B to form a complex AX or BX. X can translocate
between the outside (I) and inside (II) of the vesicle in either loaded or unloaded form
with different translocation rate constants in each direction.
JA =
(k1k−1([A]I [B]II − [A]II [B]I) + k−2k1KII [A]I − k2k−1KI [A]II)xT
(k1 + k−1)[Tot]I [Tot]II + (k−2 + k1)KII [Tot]I + (k2 + k−1)KI [Tot]II + (k2 + k−2)KIIKI
(3.30)
where,
[Tot]i = [A]i + [B]i, for i = I, II.
[A]I0 = A1, [B]
I
0 = B1, [A]
II
0 = 0, [B]
II
0 = B2
Asymmetric bound translocation rate and dissociation constants: If
asymmetry in the translocation rate constants of the bound transporters (k1 6= k−1)
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is assumed, then the other model parameters must be adjusted in accordance with
the thermodynamic constraint for a passive process as given in Equation 3.16. If
symmetry in the unbound translocation rate constants (k2 = k−2 = hk) is assumed,
then Equation 3.16 becomes:
KII
KI
=
k−1
k1
(3.31)
Let c = KII/KI be the ratio between internal and external dissociation constants, with
KII = cK and KI = K, then:
k−1 = ck
k1 = k
(3.32)
c is then, by definition, the factor that governs the asymmetry in the translocation rates
constants. Note that c is unity when symmetry is assumed.
Asymmetric unbound translocation rate and dissociation constants: In
addition, asymmetry in the translocation rate constants of the unbound transporter
(k2 6= k−2) was explored, with symmetric bound translocation rate constants (k1 =
k−1 = k). Equation 3.16 then becomes:
KII
KI
=
k2
k−2
(3.33)
Let c = KII/KI again be the ratio between internal and external dissociation constants,
with KII = cK and KI = K, then define:
k2 = chk
k−2 = hk
(3.34)
Asymmetric bound and unbound translocation rate constants, with equal
dissociation constants: Furthermore, the case of asymmetry in the translocation rate
constants (k1 6= k−1 and k2 6= k−2) was explored, with symmetric dissociation constants
(KI = KII = K), Equation 3.16 then becomes:
k1
k−1
=
k2
k−2
(3.35)
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Let c = k1/k−1 be the ratio between forward and backward translocation rate constants
of the bound transporters with k1 = ck and k−1 = k, then define:
k2 = chk
k−2 = hk
(3.36)
3.2.4 Experimental design: Experimental kinetics of 14C-serine uptake
into MVM vesicles
Experiments were conducted by Dr. Kate Widdows, Institute of Human Development,
University of Manchester. Placentas were obtained following written informed
consent with approval of the Central Manchester Research Ethics Committee (REC
12/NW/0574) from uncomplicated singleton pregnancies at term (38–40 weeks
gestation) delivered by Caesarean section. MVM vesicles were isolated from each
placenta using Mg2+ precipitation and differential centrifugation [41, 83]. The final
pellet was resuspended in intravesicular buffer (IVB; 290 mmol l−1 sucrose, 5 mmol l−1
HEPES, 5 mmol l−1 Tris, pH 7.4). MVM fragments were vesiculated by passing 15
times through a 25-gauge needle and stored at -80oC prior to use. 14C-serine uptake
(zero-trans) experiments were performed under sodium free conditions as previously
described [39]. MVM vesicles (diluted to a protein concentration of 10 mg/ml with
IVB) were equilibrated to room temperature (21–25oC) prior to uptake. Uptake of 14C-
serine into MVM vesicles was initiated by the addition of 20 µl MVM vesicle suspension
to 20 µl extravesicular buffer (EVB; 5 mmol l−1 HEPES, 5 mmol l−1 Tris, 145 mmol
l−1 KCl, pH 7.4) containing 14C-serine. An extravesicular tracer concentration of 7.5
µmol l−1 14C-serine after dilution was used throughout the study. Uptake of 7.5 µmol
l−1 14C-serine was confirmed to be linear for up to 15 s for additional unlabelled serine
concentrations of (0, 10, 50, 100, 1000 and 2000 µmol l−1), consistent with previous
reports [39], while uptake for higher concentrations was not significantly different from
zero. To determine the initial uptake rate, tracer uptake into the vesicles was measured
at t = 15 s. The experiment was stopped by the addition of 2 ml ice-cold Krebs
buffer (130 mmol l−1 NaCl, 10 mmol l−1 Na2HPO4, 4.2 mmol l−1 KCl, 1.2 mmol l−1
MgSO4, 0.75 mmol l−1 CaCl2, pH 7.4) and filtered through a 0.45 µm nitrocellulose filter
under vacuum. Filters were washed with 10 ml Krebs buffer and the filter-associated
radioactivity was determined by liquid scintillation counting. To determine the kinetics
of 14C-serine uptake into MVM vesicles, uptake of (extravesicular, [A]I) 7.5 µmol l−1
14C-serine was determined in the presence of increasing extravesicular concentrations of
unlabelled serine [B]I (0.2 µmol l−1–20 mmol l−1). For each placenta (n = 4), individual
measurements were performed at 23 different serine concentrations within this range.
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Table 3.1: Experimental design matrix (EXP 1–7, 4b) for vesicle exchange
experiments, showing the various initial intravesicular and constant extravesicular
unlabelled serine concentrations used while measuring the uptake of 7.5 µmol l−1 14C-
serine tracer ([A]II). Note that the initial intravesicular tracer concentration [A]II0 is
zero.
Intravesicular unlabelled [B]II0 (µmol l
−1)
0 250 1000
0 EXP 1
50 EXP 4b
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In addition, time series experiments were conducted by measuring tracer uptake for
placentas (n = 3) at specific time points (0, 5, 10, 15, 20, 60, 120, 300, 600 s), for
extravesicular concentrations of unlabelled serine [B]I of 0, 250 and 1000 µmol l−1 (no
initial intravesicular concentrations, i.e. [B]II0 = 0). These experiments were aimed to
test if any uptake activity would be observed, and to distinguish if such uptake would
then suggest that there was either a facilitative transport component or initial internal
endogenous exchangeable serine to enable obligatory exchange.
3.2.5 Extended experimental design: Additional time course
14C-serine uptake vesicle experiments with intravesicular
concentrations
Additional time course experiments were designed to comprehensively map the
uptake activity behaviour over a range of conditions for different internal as well
as extravesicular unlabelled serine levels (0, 250, 100 µmol l−1). As shown in the
experimental design matrix in Table 3.1, four extra experimental conditions were
included, in which initial intravesicular unlabelled serine [B]II0 was present at 250 and
1000 µmol l−1, to observe possible trans-stimulation and/or saturation effects. In
addition, an extra condition was added at 50 µmol l−1 external unlabelled serine with
1000 µmol l−1 initial intravesicular unlabelled serine concentrations (EXP 4b) to observe
the uptake at a higher outwards directed gradient (compared to EXP 4).
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3.2.6 Numerical implementation
Model equations were implemented in Matlab (R2013a). To predict the concentration
within the vesicle over time, time series were generated by integrating Equation 3.25
using the ‘ode45’ function (Runge-Kutta (4th, 5th) method) using variable time
step with relative and absolute tolerances of 10−4 and 10−6, respectively. Note
that the integration step was performed with the initial conditions as presented in
Table 3.1 and that extravesicular concentrations were assumed constant due to the
large volume of the buffer. Apparent Michaelis-Menten parameters were determined
by fitting Equation 3.27 to the averaged experimental uptake rate measurements, using
the ‘fminsearch’ minimisation function (Nelder-Mead simplex method) with the cost
function defined as the residual sum of squares of errors between the model simulations
and experimental measurements as described below:
RSS =
n∑
i=1
(
[A]II,Modeli − [A]II,Expi
[A]II,Expi
)2
(3.37)
To account for the difference in absolute values between experimental conditions, for
each data point the difference between model prediction and experiment was normalised
first by the experimental value, squared and then summed over all points to yield the
overall error criterion. Note that the initial guess values for the fitted parameters that
were used by the ‘fminsearch’ minimisation function were chosen within the same order
of magnitude of physical and/or experimentally reported values. Multiple initial guess
values were attempted to confirm that the fitting algorithm converged to a unique
solution. Note that the sample size of the experimental data may be increased (e.g. from
n = 3 as in outlined in Section 3.2.4) to confidently determine the standard deviation
in the data. Variation in the standard deviation of the data can then also be weighted
accordingly in the cost function for the fitting procedure, however this was not done
presently.
An intravesicular volume of 1.6 µl mg protein−1 was used to convert tracer uptake from
units of mol per mg protein to concentration in mol per unit volume. This volume
conversion factor was based on the previously measured equilibrium Na+ uptake (at
60 min) of 1.60±0.20 nmol mg protein−1 (mean±SEM, n = 6), at a Na+ substrate
concentration of 1 nmol µl−1, obtained using MVM vesicles prepared by the same method
[83].
The same procedure was used to fit the time course experiments. A single set of
parameters h and V was fitted to represent all experimental conditions, as specified
further in the results. Parameter K was also fitted in the complete time course
experiments in addition to h and V . The list of parameters for estimation is presented
in Table 3.2.
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A sensitivity analysis was carried out to determine the impact of individual parameters
on the fit quality by fixing these parameters at a range of different levels and then
repeating the full parameter estimation procedure for each case. A relative normalised
error was computed by dividing the total error for each parameter variation case (as
given by the cost function in Equation 3.37) by the reference error determined from the
best-fitted case (e.g. the normalised error takes value of 1 and over, since the reference
error for the best fit case is the lowest). Note that the ranges of each parameter variation
were chosen to cover the entire range of concentrations or feasible parameter values for
the experiments.
Table 3.2: Summary of model parameters estimated using the fitting algorithm.
Symbol Name Unit Description
V Uptake rate µmol l−1 min−1 Maximal transport rate
K Dissociation constant µmol l−1 Substrate binding parameter
h Unloaded carrier mobility - Ratio of unbound-to-bound
transporter translocation rate
3.3 Results
3.3.1 Model behaviour – initial uptake rate
Generic model behaviour (Equation 3.27) is illustrated in Figure 3.4 for parameters V =
1 and K = 0.5. Note that for the purpose of showing clearly the fundamental behaviour
of the transport model, all variables and parameters were used in dimensionless form,
i.e. implying normalisation. It can be observed that both non-obligatory and obligatory
exchange can give rise to Michaelis-Menten-type behaviour (i.e. linear uptake for low and
constant uptake for high external concentrations at saturation), depending on conditions.
For the non-obligatory model in Figure 3.4a, the initial uptake rate of tracer A was
calculated under zero-trans conditions, i.e. internal concentrations were set to zero
[A]II0 = 0 and [B]
II
0 = 0. In addition, for clarity the external unlabelled concentration
was also set to zero [B]I0 = 0. Under these conditions, uptake as a function of external
tracer concentration [A]I0 displayed Michaelis-Menten behaviour depending on the value
of h. The case h = 0 corresponds to obligatory exchange and therefore did not show any
uptake in the absence of internal concentrations, as expected. Similarly, in Figure 3.4b,
results are reported for the case of obligatory exchange (h = 0), but now assuming
the presence of different concentrations of unlabelled concentrations [B]II0 inside the
vesicle, as an internal concentration of amino acids is a prerequisite for obligatory
exchange ([A]II0 = 0 and [B]
I
0 = 0, as before). It can be seen that the initial uptake
rate as a function of external concentration displayed a strong dependence on internal
concentration, with a significant uptake rate already reached for relatively low internal
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concentrations, e.g. [B]II0 = 0.1. Again, for the case [B]
II
0 = 0 no uptake took place, as
would be expected for an obligatory exchanger.
Figure 3.4: Exchange/facilitative model simulations: Initial uptake rate of tracer A as
a function of its external concentration [A]I . a) Non-obligatory transport for different
values of h, with zero internal substrate. b) Obligatory exchanger (h = 0) for different
concentrations of unlabelled substrate [B]II inside the vesicle (arbitrary units). Both
hypotheses display qualitatively similar Michaelis-Menten type behaviour.
3.3.2 Model behaviour – time series
In order to differentiate non-obligatory vs obligatory exchange behaviour, a potential
time series experiment was simulated (Figure 3.5), for a combination of different values
of h and internal concentration levels [B]II0 . It was assumed the extravesicular buffer
volume is large enough so that external concentrations could be assumed constant.
Therefore, a fixed value of external tracer [A]I = 1 and unlabelled concentration [B]I = 0
were used in Equation 3.25, with the same parameters V = 1 and K = 0.5. The initial
tracer inside the vesicle [A]II0 = 0. Figure 3.5a shows that in the absence of initial
internal concentrations ([B]II0 = 0), uptake followed a facilitated diffusion process, in
which the predicted tracer concentration within the vesicle rises up to an equilibrium
level equal to the external concentration. The rate at which this equilibrium is reached
increases with increasing h, while no uptake is observed for the obligatory exchanger
(h = 0), as before.
However, Figure 3.5b shows that no difference between the obligatory and non-obligatory
models could be observed for the case ([B]II0 = 1) where the initial internal concentration
is equal to the external tracer concentration. Furthermore, predictions were not sensitive
to the value of h, i.e. note that all lines in the figure overlap.
In contrast, Figure 3.5c shows clear differences between the obligatory and non-
obligatory model for the case of high internal concentrations ([B]II0 = 5). For the
obligatory exchanger (h = 0) the tracer concentration increases monotonically until an
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Figure 3.5: Theoretical model behaviour for obligatory exchange (h = 0) and
facilitated transport (h > 0). Time series for different values of h (relative mobility of
the unloaded transporter) and initial concentrations [B]II0 inside the vesicle (arbitrary
units). The external concentration of tracer [A]I = 1 in all cases. a) Zero initial
substrate inside; note that no uptake takes place for obligatory exchange. b) Equal
internal and external concentrations; note all lines overlap. c) Higher internal
concentration; note the overshoot dependent on the value of h, with h = 0 corresponding
to obligatory exchange and h > 0 to facilitated diffusion.
equilibrium is reached, which is higher than the external concentration. This is because
at the end of the experiment all internal unlabelled substrate present initially ([B]II0 )
has been replaced by tracer [A]II (i.e. as a result of continued 1:1 exchange with only
tracer present externally and unlabelled substrate assumed to dilute out, [B]I = 0 as
stated previously).
More complex transient behaviour is observed for the non-obligatory model (h 6= 0)
in Figure 3.5c. The large outwardly directed gradient of unlabelled substrate initially
drives tracer uptake via exchange, resulting in a substantial overshoot, which then goes
back to the diffusive equilibrium as the outwardly directed gradient dissipates. The
rate at which the tracer concentration returned to the diffusive equilibrium depended
directly on the value of h, i.e. the mobility of the unloaded carrier. Thus for low values
of h the transporter primarily behaved as a 1:1 exchanger initially, before returning to
equilibrium more slowly via facilitated diffusion.
3.3.3 Model interpretation of serine uptake experiment
Next, to relate the model to the experimental data, the tracer uptake measurements
were fitted using Equation 3.27 as outlined in the Methods (Figure 3.6), resulting in
Kapp = 87 µmol l−1 and Vapp = 131 µmol l−1 min−1. Subsequently, Equation 3.28
and Equation 3.29 were used to determine the actual values of the model parameters
K and V that would correspond to these apparent Michaelis-Menten parameters for
different values of h and [B]II0 , (Table 3.3). In general K and V were higher than the
apparent parameters Kapp and Vapp, but values decreased for increasing internal serine
concentration present. Increasing h also reduced K and V , and in addition decreased
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the sensitivity to the internal serine concentration. For h = 1 the model parameters
became independent of any internal serine concentration present, and moreover K and
V corresponded directly to the apparent Michaelis-Menten parameters Kapp and Vapp.
Figure 3.6: Results of vesicle exchange experiments: Initial tracer uptake as a function
of the total external concentration (labelled + unlabelled substrate). 7.5 µmol l−1
tracer (14C-serine) was used throughout, while the concentration of unlabelled serine
was increased. Data presented as mean and standard deviation (n = 4). Experimental
results were fitted using Equation 3.27 (solid black line, R2 = 0.98).
3.3.4 Model predictions based on experimental parameters
Subsequently, the model was used to predict the uptake behaviour that could be expected
if the experiment were continued beyond the initial phase. Figure 3.7 shows the
time series results generated using the model parameters derived in Table 3.3 for the
corresponding initial conditions and values of h. For the obligatory exchanger (h = 0)
tracer concentrations continued to rise to very high values, until equilibrium was reached
at the level of the initial unlabelled concentration present inside [B]II0 (i.e. all unlabelled
substrate replaced by labelled on a 1:1 basis). For non-zero h in all cases, internal
tracer concentrations eventually reached a diffusive equilibrium equal to the external
tracer concentration of 7.5 µmol l−1. For zero initial internal concentration ([B]II0 = 0),
the tracer concentrations rose monotonically, while for non-zero initial concentrations
[B]II0 , first an overshoot was produced due to trans-stimulation before decreasing again
to the diffusive equilibrium level. In addition, the peak height and rate at which the
concentration returned to equilibrium were determined by the value of h, i.e. the relative
mobility of the unloaded transporter.
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Figure 3.7: Exchange/facilitative transporter model predictions based on the
experimental initial uptake data. Time series were generated for the various scenarios,
including different values of h, internal substrate concentrations [B]II0 and model
parameters based on the experimental measurements (Table 3.3). Note the difference
in timescale for h = 0 (top left).
Table 3.3: Exchange/facilitative transporter model parameters (Equation 3.25)
corresponding to the measured apparent Michaelis-Menten parameters, for different
unloaded carrier mobility h and internal concentration [B]II0 .
[B]II0 = 0 [B]
II
0 = 250 [B]
II
0 = 500 [B]
II
0 = 1000 µmol l
−1
h = 0 no uptake* K = 266 K = 210 K = 190 µmol l−1
V = 201 V = 159 V = 144 µmol l−1min−1
h = 0.1 K = 478 K = 198 K = 177 K = 167 µmol l−1
V = 722 V = 175 V = 152 V = 141 µmol l−1min−1
h = 0.5 K = 130 K = 119 K = 118 K = 117 µmol l−1
V = 197 V = 144 V = 138 V = 135 µmol l−1min−1
h = 1 K = 87 K = 87 K = 87 K = 87 µmol l−1
V = 131 V = 131 V = 131 V = 131 µmol l−1min−1
*The case h = 0 corresponds to an obligatory exchanger and therefore cannot
represent uptake in the absence of [B]II0 .
3.3.5 Time course experiments
The results of the time course experiments are presented in Figure 3.8. Uptake of tracer
alone (EXP 1 from Table 3.1) displayed a rapid rise in internal concentrations up to
constant steady state level. Given the experimental variability, the existence of a small
overshoot could neither be confirmed nor excluded. The internal tracer concentration
at equilibrium (based on the volume conversion factor of 1.6 µl mg protein−1) was
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approximately equal to the external tracer concentration of 7.5 µmol l−1.
Figure 3.8: Exchange experimental results and model fittings. Time course results
for the uptake of 7.5 µmol l−1 tracer [A]I (14C-serine) in the vesicle for various
concentrations of additional external unlabelled serine [B]I . Experimental data is
presented as mean and standard deviation (n = 3). Lines represent the model fit
(R2 = 0.80) for a facilitated diffusion transport process (h > 0) in the absence of initial
internal concentrations in the vesicle ([B]II0 = 0). Note that facilitated diffusion implies
that at steady state the tracer concentrations inside and outside the vesicle are equal.
To further probe the transport behaviour, additional experiments were performed in
which either 250 or 1000 µmol l−1 of unlabelled substrate was added to the extravesicular
buffer (EXP 2&5 from Table 3.1). As can be observed from Figure 3.8, addition
of external unlabelled substrate resulted in a marked inhibition of the initial rate of
tracer uptake, dependent on the amount of substrate added. After the initial phase,
intravesicular tracer levels in the presence of either 250 or 1000 µmol l−1 external
substrate continued to rise at a decreasing rate, but did not reach the level observed for
tracer alone within the time frame of the study.
3.3.6 Model analysis of time course experiments
First, it was evaluated how well the model could represent the experimental data in
absence of internal endogenous substrate ([B]II0 = 0). A single set of parameters h and
V was fitted, while K was derived using Equation 3.29 from the value of Kapp = 87
µmol l−1 determined previously in Section 3.3.4.
The model results in Figure 3.8 show a good overall representation of the initial tracer
uptake for the various external concentrations of unlabelled substrate ([B]I = 0, 250 and
1000 µmol l−1). Furthermore, the time course for 0 and 1000 µmol l−1 was captured
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Figure 3.9: Exchange experiment time course results and model fittings for an
obligatory exchanger (h = 0). Lines represent the model fit (R2 = −0.18) in the
presence of initial internal substrate [B]II0 = 7.5 µmol l
−1. Experimental data (same as
in Figure 3.8) is presented as mean and standard deviation (n = 3). Note that while the
experimental equilibrium tracer level for zero external unlabelled serine ([B]I = 0) could
be matched, the model predicted a disproportional reduction in uptake for additional
external unlabelled serine of 250 and 1000 µmol l−1.
adequately. The main discrepancy observed is the considerable overprediction of uptake
for 250 µmol l−1 unlabelled substrate from 60 s onwards.
In addition, the possibility was investigated of obligatory exchange (h = 0) in the
presence of a small internal level of substrate [B]II0 = 7.5 µmol l
−1, equal to the external
tracer concentration. Only the parameter V was fitted, while K was kept the same value
as determined before in Figure 3.8. The results (Figure 3.9) show that while obligatory
exchange could match the equilibrium level for tracer alone, it could not simultaneously
represent the effect of adding unlabelled external substrate, as this would result in
disproportionally low levels of intravesicular tracer.
To provide a more complete overview, the results of the sensitivity analysis of
the parameter estimation procedure, as described in Section 3.2.6, are presented in
Figure 3.10. The model fit as in Figure 3.8 was repeated, but now for various levels
of initial internal substrate [B]II0 ranging from 0 to 1000 µmol l
−1 (parameters h and
V were fitted, with K determined from Equation 3.29 as before). Overall, the relative
error increased with increasing internal substrate concentration (Figure 3.10a). A very
small dip in the error criterion could be observed for [B]II0 = 50 µmol l
−1, however
investigation of the predicted time course already displayed an overshoot not present in
the experiment (results not shown). Next the sensitivity of the parameter estimation
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Figure 3.10: Exchange/facilitative transporter model sensitivity analysis. The model
fit was repeated for a range of fixed parameters and the overall error expressed relative
to the fit in Figure 3.8a) Effect of initial internal concentration [B]II0 , b) dissociation
constant K, and c) relative mobility of the unloaded transporter h. Note the sharp
peak for h = 0, while the error is approximately constant for any h > 0. d) Combined
effect of h and [B]II0 on the fit quality (values > 2.5 have been omitted). Note the error
is more sensitive to [B]II0 for low values of h.
to the dissociation constant K was investigated over the range of 0 to 1000 µmol l−1
(parameters h and V were fitted with [B]II0 = 0 µmol l
−1). The results in Figure 3.10b
demonstrated that the overall error was not significantly affected by K. Finally, the
effect of the unbound carrier mobility was explored in Figure 3.10c by repeating the fit
for various fixed values of h from 0 to 1 (only the parameter V was fitted with [B]II0 = 0
µmol l−1, while K was kept the same value as determined before in Figure 3.8). This
demonstrated that h did not have a significant impact on the overall error, with the
notable exception of a sharp peak at h = 0. Looking closer at the estimated parameters
revealed that low values of h resulted in high values of V and vice versa, but the shape
of the curves was qualitatively similar for any h > 0 (results not shown). The combined
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effect of h and [B]II0 on the fit quality is displayed in Figure 3.10d, and shows that the
overall error is more sensitive to [B]II0 for low values of h. For high concentrations the
error is highly variable as the fitted time courses cannot represent the experimental data
(results not shown). Note that the results of the sensitivity analysis relate to both the
model as well as the fitting algorithm, since the fitting was repeated with each parameter
fixed in turn. For example, Figure 3.10 shows that for low [B]II0 , h cannot be uniquely
determined from the error criteria since the error was effectively identical for all non-zero
value of h.
3.3.7 Extended time course experiments and model fitting
The model as given in Equation 3.25 was fitted to the extended time course
experimental results, which spanned the eight experimental conditions, to obtain the
model parameters (h, V , and K), as the model should be able to represent the
system for all experimental conditions. Complete time course uptake experiments (with
experimental conditions given in Table 3.1) and model fitting results are shown in
Figure 3.11. The model fits suggested non-obligatory behaviour with h parameter value
of 0.16, which translated to having a 16% facilitative component when compared to the
exchange activity. In addition, a dissociation constant K of 121 µmol l−1 and V of 84
µmol m−2 min−1 were fitted (R2 = 0.69). Note that a revised intravesicular volume
of 1.3 µl mg protein−1 was used to convert tracer uptake from units of mol per mg
protein to concentration in mol per unit volume, which was based on the mean value
obtained from previous experiments that used similar buffer conditions [84, 85]. The
obligatory exchange model was also attempted but could not represent the experimental
data (results not shown). Note that individual data sets were also fitted to observe
the variation in the model parameters, however this did not show significant disparity
compared to the fitting results of the mean values (results not shown).
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Figure 3.11: Extended exchange vesicle experiment; time course results (x) and model
fits (solid lines; R2 = 0.69) for a range of internal and external concentrations of
unlabelled serine according to the experimental design given by Table 3.1. Note that
error bars represent standard deviation of the data (n = 5 for EXP1–7, n = 9 for
EXP4b). A single set of model parameters was used to represent all experimental
conditions.
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3.3.8 Simulations of the asymmetry in model parameters
To investigate the potential impact of asymmetry in transport parameters, the reduced
exchanger/facilitative model, which was applied to the experiments, was explored further
by explicitly including the different individual rate constants k in both directions and
dissociation constants K on each side of the membrane. According to the models
developed in Section 3.2.3, the results of the simulations can be shown for three different
asymmetry assumptions as follows:
Asymmetric bound translocation rate and dissociation constants (k1 6= k−1):
The resulting theoretical predictions for the obligatory exchange model (h = 0) and non-
obligatory (facilitated) transporter model (for the case h = 1) are shown in Figure 3.12,
using the parameter values of k = 1, xT = 1 and K = 0.5 (arbitrary units).
Figure 3.12: Effects of asymmetry in bound transporter (AX and BX) translocation
rate (k1 6= k−1) and dissociation constants (kI 6= kII) according to Equation 3.31–
Equation 3.32. (a–c) Results for obligatory exchange, h = 0. (d–f) Results for the
non-obligatory model, with h = 1. Time series for different values of the asymmetry
factor c and initial concentrations [B]II0 inside the vesicle (arbitrary units). The external
concentration of tracer [A]I = 1 in all cases. a, d) Zero initial substrate inside. b, e)
Equal internal and external concentrations. c, f) Higher internal concentration.
From the results in Figure 3.12 it can be observed that a higher reverse translocation rate
constant for the bound transporter (k−1) has minimal effect on the model predictions
for tracer uptake (c = 10), while a lower uptake rate constant (c = 0.1) leads to
slower uptake for the cases considered. Notably, the value of c shifts the position of
the overshoot in time and affects the peak width, but does not affect the peak height
(Figure 3.12f).
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Asymmetric unbound translocation rate and dissociation constants (k2 6=
k−2): The resulting theoretical predictions for the obligatory and non-obligatory models
are shown in Figure 3.13, using the same parameters as before.
Figure 3.13: Effects of asymmetry in unbound transporter (X) translocation rate
(k2 6= k−2) and dissociation constants (kI 6= kII) according to Equation 3.33–
Equation 3.34. (a–c) Results for obligatory exchange, h = 0. (d–f) Results for the
non-obligatory model, with (h = 1). Time series for different values of c and initial
concentrations [B]II0 inside the vesicle (arbitrary units). The external concentration of
tracer [A]I = 1 in all cases. a, d) Zero initial substrate inside. b, e) Equal internal and
external concentrations. c, f) Higher internal concentration.
For the non-obligatory (facilitative) model, Figure 3.13d shows that in absence of internal
substrate, a higher forward translocation rate constant for the unbound transporter (k2)
has minimal effect on the model predictions for tracer uptake (c = 10), while a lower
uptake rate constant (c = 0.1) leads to slower uptake. Figure 3.13e shows that this
effect of c is reversed in the presence of an initial internal substrate concentration
equal to the external tracer concentration. In addition, for this situation there is
no difference between the obligatory and non-obligatory model (Figure 3.13b, e). In
contrast, marked differences arise for high initial internal substrate concentrations. The
obligatory exchange model in Figure 3.13c displays only minor effects, which are due
to the difference in dissociation constants depending on c, as unbound translocation
rates are zero because h = 0. However, for the non-obligatory (facilitative) model in
Figure 3.13e, a low value of c leads to a higher peak, which decreases more slowly. On
the other hand, a high value of c almost completely eliminates the overshoot, since the
fast unbound forward translocation rate bypasses tracer uptake in the transport cycle
during eﬄux of initial internal substrate.
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Asymmetric bound and unbound translocation rate constants, with equal
dissociation constants (k1 6= k−1 and k2 6= k−2): The resulting theoretical predictions
for the obligatory exchange and non-obligatory (facilitated) transport models are shown
in Figure 3.14, using the same parameters as before.
Figure 3.14: Effects of asymmetry in bound transporter (AX and BX) and unbound
transporter (X) translocation rate constants (k1 6= k−1 and k2 6= k−2), with equal
dissociation constants (KI = KII), according to Equation 3.35–Equation 3.36. Time
series for different values of c and initial concentrations [B]II0 inside the vesicle (arbitrary
units). The external concentration of tracer [A]I = 1 in all cases. a, d) Zero initial
substrate inside. b, e) Equal internal and external concentrations. c, f) Higher internal
concentration.
It can be observed that the results in Figure 3.14 are very similar to those in Figure 3.12,
but note that c has the opposite effect in Equation 3.32 and Equation 3.35, acting either
on the forward or reverse bound translocation rate constants k1 and k−1. However,
this has the same effect on the overall transport cycle where A is exchanged for B
(Figure 3.3).
3.4 Discussion
Placental membrane vesicle experiments are used routinely for the study of exchanger
transporters [33, 39, 86, 87]. However, these experiments consistently display substrate
uptake under zero-trans conditions, which is incompatible with the concept of an
obligatory exchanger mechanism and remains currently unexplained. Therefore,
mathematical modelling was applied to clarify how these experimental observations could
relate to the behaviour of the transporter under investigation. Importantly, for clarity
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and to facilitate biological interpretation the number of parameters in the model was
kept to the minimum required to represent the key transporter mechanisms at play.
Both non-obligatory and obligatory exchanger models could explain the observed initial
rate of serine tracer uptake under sodium free conditions, depending on the initial
substrate concentration inside the vesicle. Previous evidence for an obligatory exchanger,
as opposed to facilitated diffusion, is provided by the 1:1 ratio between amino acid influx
and eﬄux, combined with the observation that no significant amino acid depletion
was detected in oocytes maintained in amino acid free buffer [66]. However, for an
obligatory exchanger to function this would necessarily imply the presence of initial
substrate within the vesicle. In this respect, the dependency of apparent Michaelis-
Menten parameters on internal substrate concentration derived in the current study
(Equation 3.28, 3.29), could potentially help explain variation in reported Km values for
Na+-independent serine uptake in the literature (116–675 µmol l−1) [39, 67]. However,
the internal concentrations cannot affect the apparent Km if the unloaded and loaded
transporters have equal mobility (h = 1) in the carrier model (Equation 3.29, Table 3.3;
i.e. since binding of internal substrate would not affect the return rate of the carrier in
the transport cycle).
3.4.1 Time course experiments
Since a standard uptake experiment did not allow non-obligatory and obligatory
exchange to be distinguished based on initial rate alone (Figure 3.4a, b), the possibility of
continuing the experiment as a time series was explored first theoretically and then tested
experimentally. Based on the model predictions in Figure 3.7, the lack of a pronounced
overshoot observed in the experimental time course (Figure 3.8) indicated the absence,
or only low levels, of internal substrate within the vesicles. In addition, equal internal
and external tracer concentrations at steady state were observed in the experiment
(Figure 3.8), which provided a strong indication for non-obligatory transport leading
to diffusive equilibrium. Furthermore, tracer uptake could be completely inhibited
(Figure 3.6), demonstrating that uptake was transporter mediated as opposed to simple
diffusion, within experimental accuracy. However, similar concentrations on both sides of
the membrane are not conclusive proof of facilitated diffusion, as an obligatory exchanger
would give the same result in the case where internal and external concentrations were
equal (Figure 3.5b). In addition, the vesicle volume conversion factor used here to
determine internal concentration levels may not be known precisely in many cases.
Therefore, the time course experiment was repeated in the presence of additional external
unlabelled serine. This showed that the experimental data could be captured reasonably
well by the model based on facilitated diffusion (Figure 3.8), while obligatory exchange
would predict a disproportionate reduction in steady state concentrations (Figure 3.9).
This is because at equilibrium, obligatory exchange would result in equal ratios of tracer
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to unlabelled substrate inside and outside the vesicle, and 7.5 µmol l−1 tracer represents
only a very small fraction compared to either 250 or 1000 µmol l−1 unlabelled substrate.
Overall, the results of this study supported the existence of a facilitative transport
component in placental MVM vesicles. However, while h was clearly non-zero in the
model, the results of the sensitivity analysis demonstrated that it was not possible
to ascertain the precise value of h with confidence. This is because for a facilitative
transporter, in absence of significant internal concentrations, the tracer uptake depends
on the combined velocity of the unloaded and loaded transporter in the transport cycle,
thus h and V could not be determined independently. Based on previous exchange
and eﬄux experiments in oocytes one would expect h to be low [66]. A relatively
slow unloaded transporter (small h) would increase the potential for trans-stimulation
of the initial uptake rate by internal substrate [88] and display a larger overshoot
(Figure 3.7). Thus further opportunities to determine h could be provided by developing
experimental protocols in which additional high concentrations of substrate are added
within the vesicle. In addition, the presence of an overshoot in such an experiment would
directly demonstrate a non-obligatory transport mechanism (Figure 3.5, Figure 3.7).
This is because a high outwardly directed substrate gradient would promote an
overshoot response for non-obligatory transport (Figure 3.7b–d), while an obligatory
exchanger would be expected to equilibrate at different levels directly dependent on the
concentration added inside the vesicle (Figure 3.7a). Time course data for the sodium
independent uptake of system L substrates in non-preloaded MVM vesicles displayed a
small overshoot for tryptophan, as indicated by the drop in tracer level at 45 min [86],
while in contrast, no overshoot was observed for leucine [33].
3.4.2 Model fitting of extended time course experiments
The extended time course experiments were shown to be in agreement with the non-
obligatory transport behaviour as well, which confirmed the earlier results in the zero-
trans case (i.e. EXP 1-2-5). Importantly, overall transport behaviour over a wide range
of internal and external concentration could be represented by the model using a single
limited set of parameters. Notably, the model was able to describe the overshoot response
in EXP 4, in accordance with the experimental data, although the experimental results
showed a much slower rate of decrease after the peak. The overshoot in the uptake of
radiolabelled serine (substrate A) was due to the initially high outward-directed gradient
of total serine levels, which was confirmed further in EXP 4b, by increasing this gradient
even more, resulting in a higher peak. Note neither responses in zero-trans conditions,
nor the overshoot response can be represented by the obligatory model; hence suggesting
that the transport system is likely to have a non-obligatory mechanism. Though, this
facilitated component was likely to be low, with the relative mobility of the unloaded
transporter h estimated at 16% of the loaded transporter.
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3.4.3 Asymmetry in model parameters
A number of simplifying assumptions were made in the application of the model.
In particular the transport parameters in the model were assumed to be symmetric.
However, in Xenopus oocyte studies asymmetric apparent affinities have been found
[66]. This could be explained by different translocation rates and dissociation constants
according to Equation 3.9 & Equation 3.16. Nonetheless, importantly, relaxing these
model assumptions would not affect the equilibrium substrate concentrations for a
passive transport process. Note, membrane potential was not included as LAT2 is a
sodium independent transporter of neutral amino acids and not known to be electrogenic
[19, 89–91]. The effect of asymmetry on the model predictions was explored further in
Section 3.3.8. This confirmed that the presence of an overshoot would indicate a non-
obligatory as opposed to an obligatory exchange mechanism; however the reverse is not
true as such an overshoot depends both on model parameters and internal concentrations
(Figure 3.13). The model assuming asymmetry in parameters values were also fitted
to the extended time course experimental data; however, this did not result in an
improvement to the fits when compared to the reduced symmetric model.
3.4.4 Vesicle size distribution
An average vesicle volume conversion factor was used to determine intravesicular tracer
concentrations, while vesicles in suspension appear heterogeneous in size [83] and thus
would display a range of area to volume ratios, potentially smoothing out the response.
In addition, the vesicle volume was assumed to be constant over time, while any changes
in volume might for example contribute to explaining the overprediction observed for 250
µmol l−1 external unlabelled serine in Figure 3.8. A brief investigation of the effect of the
vesicle suspension having a non-uniform size distribution can be found in Appendix A,
the results of which suggested that larger-sized vesicles contribute more to the overall
uptake behaviour.
3.4.5 Parallel transport components
Based on current understanding, a single transporter (LAT2) was proposed to represent
the sodium independent transport of serine, and all known Na+ independent serine
transport systems are exchangers. However, if multiple transport mechanisms were to
be present (e.g. a previously unidentified facilitative serine transporter) this would give
rise to a mixed response which would be more difficult to interpret, e.g. an obligatory
exchanger in combination with an unknown diffusive transport route in parallel could
give rise to a qualitatively similar response as a non-obligatory transporter.
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3.4.6 Timescle for the model behaviour
The transport model can be analysed analytically on both a short term and long term
basis. In this chapter, the exchanger model was explored in terms of the Michaelis-
Menten equation looking at the initial transport rates. In addition, thermodynamic
equilibrium was considered in the model which determines the concentrations and their
ratios at steady state.
3.5 Conclusion
Mathematical modelling was applied to better understand the underlying mechanisms of
how transporters mediate placental amino acid transport, which is important in clinical
applications to prevent or treat impaired fetal growth during pregnancy. It was also
shown that the carrier-based transport model could be used to analyse the transport
behaviour of transport proteins by contributing to the design and interpretation of
experiments. In this study the sodium-independent transport of serine by the LAT2
protein was suggested to agree better with the non-obligatory exchange mechanism.
Moreover, the interpretation of vesicle experiments such as those with placental MVM in
reality may be complicated by non-zero internal substrate concentrations. In addition,
actual transporter behaviour may deviate from idealised behaviour such as perfectly
obligatory exchange. Modelling could allow quantification of these effects in order
to reveal their impact. New experimental procedures using comprehensive time series
uptake experiments were proposed and implemented in place of the common Michaelis-
Menten setup, which does not provide a complete description of transport phenomena.
An iterative approach has proven to be vital, in which the model is used to predict
various potential transport scenarios, which can then be tested experimentally, leading
to model refinement and new experiments. In this way, modelling could help to interpret
and design uptake experiments and contribute to a more complete understanding
of the behaviour of specific transport systems. Lastly, this study served as robust
foundation for subsequent studies incorporating multiple transporters to investigate
placental transport as a whole system, which is presented in Chapter 5.
3.5.1 List of contributions
Summary of novel contributions made in this chapter:
• A new combined exchange/facilitative transporter model was developed with only
a single parameter distinguishing between each mechanism
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• The model can give rise to different apparent Michaelis-Menten constants as a
function of internal concentration, which could explain the variation in parameters
found in previous experimental literature
• The transport model clearly suggests a non-obligatory exchange mechanism for
LAT2 (with a slow facilitative component), while up to now LAT2 has been
commonly thought to be an obligatory exchanger

Chapter 4
Accumulative transporter – a
development of cotransport model
4.1 Introduction
During pregnancy, essential nutrients such as amino acids required for fetal development,
are supplied from the mother via the placenta. The maternal blood perfused in the
placental intervillous space surrounds the villi containing the fetal capillaries, with
the syncytiotrophoblast layer acting as an interface between the two circulations.
The transport of amino acids across the placental syncytiotrophoblast is regulated
by different transport proteins (or transporters) which can be found at the maternal-
facing microvillous (MVM) and fetal-facing basal membranes (BM). As categorised by
transport mechanism, the transport proteins that work together in mediating amino
acid transfer across epithelia include; accumulative transporters which actively pump
amino acids across the MVM, exchangers which swap one amino acid for another, and
facilitative transporters which transport amino acids along their concentration gradients
[6, 73]. Particularly in the placental transport system, the accumulative transporters are
important for getting amino acids to the fetus as these transporters can actively transfer
against the concentration gradient, as fetal levels are normally higher. Thus, without
the accumulative transporters, the fetus cannot maintain high levels of amino acids
required for fetal growth, as the other two transporter types are passive – therefore
do not transport against the concentration gradient. The accumulative transporters
expressed at the placental epithelia belong to the SLC38 gene family and include the
proteins SNAT1 and SNAT2. These accumulative transporters and their activities in
general are often referred to as system A, because of their substrate preference for alanine
and other similar small neutral amino acids [92]. Not limited to placental tissue alone,
these transport proteins are also present at other epithelia that fulfil specific regulatory
functions such as in the brain and liver [19].
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The accumulative transporters inherently have a more complex transport mechanism
compared to other passive transporters, as it requires the amino acid substrate to
be co-transported with a sodium ion with a 1:1 stoichiometry [93–95]. As a result,
the substrate movement together with a positively charged sodium ion also causes an
electrical current. Hence, the accumulative transporters are electrogenic and amino acid
transport is coupled to the driving forces of both the chemical and electrical gradient of
sodium.
In this chapter, first the electrochemical effects on transport in general are explored
with a simple carrier model. Next, a cotransport model is developed to represent the
mechanism of the accumulative transporter, which is then extended to incorporate the
effects of electrical potential. Finally, the validation of the model is performed with
literature data, followed by discussion.
4.2 Methods
Transport by the accumulative transporter has been shown to be dependent on sodium.
Therefore, the electro-chemical potential effects due to the charged sodium ion must be
considered. The following section first illustrates the potential dependency for transport
of a charged solute for a simple carrier model, which can then be applied to the sodium
cotransport model to account for the electro-chemical potential effects due to sodium.
Figure 4.1: Carrier model schematic showing the transport of charged substrate C
by carrier X across the membrane.
For transmembrane carrier mediated transport of a charged substrate C from membrane
side I to II at the electrical potentials ψ1 and ψ2, respectively, with respect to a reference
potential, the driving force for transport of the solute is given by
µ2 − µ1 = RT (ln[C]II − ln[C]I) + zF (ψ2 − ψ1) (4.1)
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where µi denotes electrochemical potential of side i, and [C]i is the concentration of
charged substrate C at side i. Note that R is the gas constant, T is temperature, and
F is Faraday constant. z denotes the electrical charge of the charged solute.
Hence, when the electrochemical potential difference is zero at equilibrium, the charged
solute concentration ratio is given by the following expression:
[C]IIeq
[C]Ieq
= e(
−zF
RT
(ψ2−ψ1)) (4.2)
Now consider the carrier model in Figure 4.1. When the net flux of the charged substrate
is zero at equilibrium, then the ratio of the concentrations can be expressed in terms of
substrate translocation rates and dissociation constants as:
[C]IIeq
[C]Ieq
=
k1k−2KII
k−1k2KI
(4.3)
where, KI =
k−3
k3
, and KII =
k−4
k4
.
Therefore, combining Equation 4.2 and Equation 4.3 yields;
k1k−2KII
k−1k2KI
= e(
−zF
RT
(ψ2−ψ1)) (4.4)
From Equation 4.4, the electrochemical potential is shown to affect the transport process
as a whole. When the electrical gradient is zero, the ratio of the translocation rates and
dissociation constants is unity. However, one may assume that only conformational
changes of the carrier that move charges across the membrane are potential dependent
[63]. Hence, the only translocation rates governing such step, k1 and k−1, are affected
by the potential gradient term. Hence, the following statement can be assumed for the
ratio of the translocation rates of the charged substrate:
k1
k−1
=
k01
k0−1
e(
−zF
RT
(ψ2−ψ1)) (4.5)
Here k01 and k
0−1 denote reference rates in absent of membrane potential.
Furthermore, if one assumes a parameter β to define the transmembrane potential
effects, explicitly, to the translocation rates in each direction (k1 and k−1), the following
statements can be made about the individual translocation rates:
k1 = k01e(
−βzF
RT
(ψ2−ψ1)) (4.6)
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k−1 = k0−1e
“
(1−β)zF
RT
(ψ2−ψ1)
”
(4.7)
4.2.1 Cotransport model
As it was shown that the transmembrane potential effect can be explicitly identified
as part of the translocation rates for the case of the transport of a charged solute, the
same principle can be applied to the cotransport model to describe the active sodium-
dependent accumulative transport mechanism of a neutral solute. Firstly, a cotransport
model is explored without considering the electric potential, to show only the driving
force due to the chemical (concentration) gradient of the co-solute. Then, in the following
section, the effect of electrical potential is incorporated.
In the cotransport model, the substrate is transported together with the sodium ion in a
1:1 stoichiometry [93, 94, 96]. The cotransport model also assumes that the sodium ion
binds prior to the solute [17, 19]. The schematic of the carrier model for co-transport of
a neutral substrate A with a sodium ion is shown below in Figure 4.2.
Figure 4.2: Carrier model of sodium-dependent accummulative transporter for a
neutral substrate with explicit translocation rates and dissociation constants for each
binding/unbinding step. Transporter, Xi requires a Na ion to form XNai before
binding to amino acid A to allow translocation in the form of transporter-sodium-amino
acid complex, AXNai
Consistence with the general rationale on the carrier model, the following assumption
can be made:
1. Rapid equilibrium at both sides of the membrane: It is assumed that amino
acid reversible binding/unbinding is instantaneous. This implies that bound
and unbound concentrations are at equilibrium at each side of the membrane
[78, 79]. Therefore, the rate constants for binding can be replaced by the following
dissociation constants K, given by:
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KNaI =
[Na]I [X]I
[XNa]I
=
k−5
k5
(4.8)
KNaII =
[Na]II [X]II
[XNa]II
=
k−6
k6
(4.9)
KI =
[A]I [XNa]I
[AXNa]I
=
k−3
k3
(4.10)
KII =
[A]II [XNa]II
[AXNa]II
=
k−4
k4
(4.11)
K, therefore, by definition has the same unit as the concentration. Note that this
corresponds to the binding (k3, k4, k5, k6) and unbinding rate constants (k−3, k−4,
k−5, k−6), which have the dimensions of l mol−1 s−1 and s−1, respectively.
2. Conservation of transporters: Within the membrane, the transporters are assumed
to be conserved [62, 63]. Hence, the transporters are always in one of the six states.
The total number of transporters contained in the membrane, xT , is given by:
[X]I + [X]II + [XNa]I + [XNa]II + [AXNa]I + [AXNa]II = xT (4.12)
3. Quasi-steady state applies since the time scale of binding and translocation
is relatively fast compared to any changes in the concentration within the
compartments [80]. Thus quasi-steady state transport implies that the sum of
the fluxes of bound and unbound carrier must be zero (i.e. the rate of transporters
going forward across the membrane must be the same as for those returning, in
order for the transport cycle to continue) [62, 63].
JX + JAXNa = 0 (4.13)
4. The net flux JAX of the substrate-transporter complex AXNa directed from side
I to side II, can be represented as the net effect of the forward and backward
directed fluxes. The same applies for the net flux JX of unbound transporter X
from side I to II.
JAX = k1[AXNa]I − k−1[AXNa]II (4.14)
JX = k2[X]I − k−2[X]II (4.15)
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By definition, the solute of interest, amino acid A, can only cross from side I to II in
the form of transporter-sodium-amino acid complex AXNa; therefore the flux of A, JA,
is essentially equal to the flux of AXNa, JAXNa. By substitution from Equation 4.8 to
Equation 4.15, the flux equation JA of a cotransport model can be expressed in terms
of solute and ion concentrations as:
JA =
(k1k−2[A]I [Na]IKIIKNaII − k2k−1[A]II [Na]IIKIKNaI )xT
Denom
where,
Denom = [Na]I [Na]II
{
(k1 + k−1)[A]I [A]II + (k1KII [A]I + k−1KI [A]II)
}
+
(
k−2KNaII [Na]
I + k2KNaI [Na]
II
)
KIIKI + (k1 + k−2)[A]I [Na]IKIIKNaII
+(k−1 + k2)[A]II [Na]IIKIKNaI + (k2 + k−2)KIKIIK
Na
I K
Na
II
(4.16)
[A]I0 = A1, [Na]
I
0 = Na1, [A]
II
0 = 0, [Na]
II
0 = Na2
From Equation 4.16, equilibrium of the net flux of substrate co-transported with sodium
ion yields:
[A]I
[A]II
=
[Na]II
[Na]I
(
k−1k2
k1k−2
KIK
Na
I
KIIKNaII
)
(4.17)
This illustrates that the transport process, will reach equilibrium when the sodium
gradient becomes thermodynamically balanced by the amino acid substrate gradient
[50, 63]. Fundamentally, to achieve accumulation in the cotransport system, the co-solute
gradient must be coupled in opposite direction to that of the amino acid substrate.
4.2.2 Transmembrane potential effects in the cotransport model
When the transmembrane potential difference is included in the cotransport model, the
same opposite coupling applies between the amino acid substrate and co-solute ion. At
equilibrium, the transmembrane electrochemical potential difference must be equal but
opposite for the solute and co-solute. Hence, the electrochemical potential difference of
the substrate A and sodium ion can be expressed as [63]:
∆µA = ∆µNa
µAI − µAII = µNaII − µNaI
(4.18)
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where µSi represents the electrochemical potential of solute S at side i.
Then, the corresponding electrochemical potentials for substrate and sodium at each
side of the membrane, as defined in Equation 4.1, can be substituted in Equation 4.18
as follows:
RT (ln[A]I − ln[A]II) + zAF (ψ1 − ψ2) = RT (ln[Na]II − ln[Na]I) + zNaF (ψ2 − ψ1)
ln
(
[A]I [Na]I
[A]II [Na]II
)
=
F
RT
(zNa + zA)(ψ2 − ψ1)
[A]I
[A]II
=
[Na]II
[Na]I
e
“
(zNa+zA)F
RT
(ψ2−ψ1)
”
(4.19)
where zNa is the charge of sodium and zA is the charge of substrate A. However, for
substrate A – a neutral amino acid – the charge is zero.
Hence from Equation 4.19, for zero transmembrane potential difference (i.e. ψ2−ψ1 = 0),
the substrate and sodium are directly coupled without the electrical driving force. For
negative potential difference (i.e. ψ2−ψ1 < 0), the exponential term is positive and less
than one, which means that the transport of both substrate and sodium are coupled
in favour of the transport to side II. Oppositely, for positive transmembrane potential
difference, the transport of the substrate and sodium is coupled in favour of the transport
to side I.
By combining the equilibrium condition in Equation 4.17 with the electrochemical
potential coupling equation in Equation 4.19, the thermodynamic constraint for the
cotransport model with transmembrane potential difference can be found as follows:
k−1k2
k1k−2
KIK
Na
I
KIIKNaII
= e
“
zNaF
RT
(ψ2−ψ1)
”
(4.20)
As shown in Equation 4.20, the electro potential bias term is equal to the ratios of the
translocation rates and the dissociation constants of the substrate and sodium. However,
if it were assumed that the dissociation constants are not electrogenic, then the electrical
bias term is applied to the ratios of the translocation rates only. However, in order
to specify the electrical bias term explicitly and relate this to the translocation rates,
another assumption on the transporter charge must be made. The following section
shows two different transporter charge assumptions and how they affect different sets of
translocation rates as a function of the electrical gradient term:
Transporter has negative charge: From the cotransport model schematic in
Figure 4.2, if we assume the transporter is negatively charged, which then binds to
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sodium neutralising the charge, and then binds to neutral substrate; then only affected
translocation rates by the transmembrane potential are k2 and k−2. Therefore, the ratio
of the translocation rates affected by the potential difference can be expressed as:
k2
k−2
=
k02
k0−2
e
“
zNaF
RT
(ψ2−ψ1)
”
(4.21)
where k02 and k
0−2 denote the translocation rates at zero potential difference.
Now, let β be the parameter to explicitly define the transmembrane potential effects for
the translocation rates in each direction, the following statements can be defined for the
individual translocation rates:
k2 = k02e
“
βzNaF
RT
(ψ2−ψ1)
”
(4.22)
k−2 = k0−2e
“
(β−1)zNaF
RT
(ψ2−ψ1)
”
(4.23)
Transporter charge is neutral: However, if it were to be assumed that the transporter
is neutral instead and then binds with the positively charged sodium and then the neutral
substrate, this would lead to the formation of a positively charged complex overall.
Therefore, the only translocation rates affected by the transmembrane potential are k1
and k−1, according to Figure 4.1. The ratio of the translocation rates affected by the
potential difference can then be expressed as:
k−1
k1
=
k0−1
k01
e
“
zNaF
RT
(ψ2−ψ1)
”
(4.24)
where k01 and k
0−1 denote the translocation rates at zero potential difference.
Then, let β be the parameter to explicitly define the transmembrane potential effects to
the translocation rates in each direction, the following statements can be made about
the individual translocation rates:
k−1 = k0−1e
“
βzNaF
RT
(ψ2−ψ1)
”
(4.25)
k1 = k01e
“
(β−1)zNaF
RT
(ψ2−ψ1)
”
(4.26)
As a result, depending on the transporter charge assumption, the electrical potential bias
terms could be specified for either the empty transporter or substrate-bound transporter
translocation rates.
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4.2.3 Model parameter reduction for application
As we have now established all aspects of the active cotransport model, including
explicitly specifying the electrical contributions to the translocation rates, the next step
is for the model to be simulated and explored. Further simplifying assumptions are
made for the model application in order to reduce the number of parameters. For each
transporter charge hypothesis, the following assumptions were adopted:
Equal zero-potential translocation rates and dissociation constants: Firstly,
the translocation rates k at zero potential difference and electrically unaffected
translocation rates are assumed to be equal. In addition, the substrate dissociation
constants are treated to be equal at the each side of the membrane. The same also
applies for sodium dissociation constants. These assumptions were justified in first
instance since it was demonstrated in the previous chapter that any asymmetry in both
translocation rate and dissociation constants would only affect the transient response of
the uptake and would not fundamentally change the underlying transport mechanism.
Electro potential bias terms definition: Let ε and ε
′
represent the electrical
potential bias terms for the affected translocation rates in opposite direction, defined as
[97]:
ε = e
“
βzNaF
RT
(ψ2−ψ1)
”
(4.27)
ε
′
= e
“
(β−1)zNaF
RT
(ψ2−ψ1)
”
(4.28)
Hence, with these assumptions for model application, the flux equation from
Equation 4.16 of substrate A co-transported sodium ion can be expressed as shown
in Table 4.1 for each case of transporter charge assumptions.
4.2.4 Michaelis-Menten interpretation
The apparent Michaelis-Menten interpretation of the cotransport model can be derived
by assuming zero-trans conditions. From Equation 4.16, the instantaneous flux of solute
A is then as follows:
JA0 =
k1k−2xT [A]I [Na]I
k−2KI [Na]I + (k1 + k−2)[A]I [Na]I + (k2 + k−2)KIKNaI
(4.29)
Therefore, the apparent Michaelis-Menten parameters of the solute A can be derived
from Equation 4.29 as the follows:
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JA0 =
k1k−2xT [A]I
k−2KI + (k1 + k−2)[A]I + (k2 + k−2)
KIK
Na
I
[Na]I
∴ V Amax =
k1k−2xT
(k1 + k−2)
,
∴ KAmax =
KI
(k1 + k−2)
[
k−2 + (k2 + k−2)
KNaI
[Na]I
]
(4.30)
Similarly, the Michaelis-Menten interpretation can be derived for the coupled sodium
molecule. From Equation 4.29, the instantaneous flux of sodium and the corresponding
apparent Michaelis-Menten parameters are then given by:
JNa0 = JA0 =
k1k−2xT [A]I [Na]I
(k−2KI + (k1 + k−2)[A]I) [Na]I + (k2 + k−2)KIKNaI
∴ V Namax =
k1k−2xT
(k1 + k−2) + k−2 KI[A]I
∴ KNamax =
(k2 + k−2)KNaI
k−2 + (k1 + k−2)
[A]I
KI
(4.31)
4.2.5 Numerical implementation
The transporter models as presented in Table 4.1 were implemented in Matlab (R2013a)
to simulate the concentrations of amino acids by time integration of the flux equations,
which were non-linear ordinary differential equations. The ‘ode45’ function (Runge-
Kutta (4th, 5th) method) was used for time integration, which uses a variable time
step with relative and absolute tolerances of 10−4 and 10−6, respectively. Note that
time integration was performed with various initial conditions (of substrate A and Na)
depending on the experimental conditions and that all extravesicular concentrations
were assumed constant due to the large volume of buffer.
4.2.6 Parameter estimation
An automated parameter estimation algorithm was applied to find the best-fitting
combination of the cotransport model parameters, which included the total transport
rate (kxT ), electrical bias parameter (β), and dissociation constants of substrate (K)
and sodium (KNa). The model parameters were fitted based on the relative (normalised)
error between the model predictions and characteristic literature data of alanine
uptake into oocytes expressing the accumulative transporter SNAT2 [98]. Oocytes are
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commonly used for uptake experiments because of their ability to overexpress human
transporter proteins and their large size, which allows them to be injected easily. The
fitting procedure was implemented using the ‘fminsearch’ function in Matlab (Nelder-
Mead method) with the cost function defined as the residual sum of squares of errors
between model simulations and experimental measurements (all data points equally
weighted) as described below:
RSS =
n∑
i=1
(
[A]II,Modeli − [A]II,Literaturei
[A]II,Literaturei
)2
(4.32)
To account for the difference in absolute values between experimental conditions, for each
data point the difference between model prediction and literature was normalised first by
the literature value, squared and then summed over all points to yield the overall error
criterion. Note that the initial guess values for the fitted parameters that were used by
the ‘fminsearch’ minimisation function were chosen within the same order of magnitude
of physical and/or experimentally reported values. Multiple initial guess values were
attempted to confirm that the fitting algorithm converged to a unique solution.
4.3 Results
Simulations of the cotransport model implementation are presented below. This includes
the examination of the cotransport model dependencies on the sodium driving force due
to the chemical gradient and electrical charge gradient. Lastly, the model parameter
fitting of previous literature data are presented. Note that the results of both transporter
charge assumptions are offered in contrast where applicable.
4.3.1 Cotransport model simulation
Firstly, the simple cotransport model dependent on only the chemical gradient of sodium
was explored. Figure 4.3 shows the uptake rate of solute A (fixed at 1) from outside (side
I) to inside (side II), as given by the flux equation in Equation 4.16, co-transported with
different levels of sodium (Na) over a range of external concentrations of A. Figure 4.3a
shows the simulation results for the case of zero-trans where there was nothing on the
inside with various levels of sodium externally, whereas Figure 4.3b shows results for
when the sodium level was fixed at 1 outside with various level of sodium internally.
Note that all transport rate and dissociation constants (of both A and Na) were set
to 1. In addition, for the purpose of showing clearly the fundamental behaviour of the
transport model, each variable and parameters were used in dimensionless form, implying
normalisation. Both plots suggested Michaelis-Menten behaviour where saturation
occurred at maximum concentrations. The results show that the uptake of substrate
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A is higher when the sodium gradient is high. This illustrates that in the cotransport
model, co-solute and substrate are directly coupled. It was also shown that although
sodium is required for transport, it is not required at both sides of the membrane, only
externally.
Figure 4.3: Simulation of simple cotransport model uptake rates: The plots show
uptake rates of solute A at each external concentration for (a) different sodium levels
externally with nothing inside (zero-trans) and (b) different internal sodium level with
external sodium fixed at 1.
Next, time integration was applied to the simple cotransport model to show changes
in substrate A concentration over time for various sodium levels. External substrate
A was fixed at a value of 1. Figure 4.4 shows the plot of internal substrate A over
time, at various external sodium levels, with internal sodium level initially at 1. Again,
each transport rate and dissociation constant (of both A and Na) were set to 1. The
simulation results suggested different equilibrium levels of uptake of A for different
sodium levels. It was reaffirmed that the uptake level is dependent on the magnitude of
the sodium gradient and no sodium to be co-transported with from the same side would
result in no uptake. However, importantly, note that uptake of A still occurs even if the
internal and external sodium are initially equal at 1. This is because the gradient of A
drives uptake until the substrate and sodium ratios balance according to Equation 4.17.
The effects of transmembrane potential were then explored. It was shown in the
model derivation that the driving force due to the electrical-potential difference can
be applied to different individual transport rates depending on the assumption for the
transporter charge. Therefore, the following results are shown for both transporter
charge assumptions in comparison. Note that following constants and parameter values
were used in the model simulations: ideal gas constant, R = 8.314 VC K−1 mol−1, room
temperature, T = 298 K, and Faraday constant, F = 9.65 x 104 C mol−1.
The effects of transmembrane potential difference were simulated in Figure 4.5 for the
transporter charge assumption as negative (a,b) and neutral (c,d). In order to separate
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Figure 4.4: Simulation of cotransport model uptake level: Uptake levels of substrate
A were shown over a time for various external sodium levels, with internal sodium level
initially at 1. Note uptake of A still occurs even for initially equal internal and external
sodium.
out clearly only the electrical effects, all initial substrate and sodium levels inside were
set at 1 to match the fixed external levels, ensuring no chemical gradients. Again,
each transport rate and dissociation constants (of both A and Na) were set at 1. In
Figure 4.5a and Figure 4.5c, it was shown that without electrical potential difference
(∆ψ = ψ2−ψ1), there would be no uptake. Note that the electrical bias term, β, was set
at 0.5 here. Moreover, high potential difference (i.e. higher potential outside) was shown
to promote the steady state uptake level. In Figure 4.5b and Figure 4.5d, the model
simulated various values for the electrical bias term for a fixed transmembrane potential
difference of -60 mV. The results suggested that the electrical bias only affected the
transient uptake, but did not affect the equilibrium uptake level. Higher β values were
shown to give slower uptake. In addition, the results showed that equilibrium uptake
levels are unaffected by which transporter charge assumption is made.
Next in Figure 4.6, the cotransport model simulated the uptake rates of 20 mmol l−1
alanine over a range of sodium levels externally for comparison with the literature
data [99]. The internal sodium was set at physiological level of 15 mmol l−1. The
parameters were chosen as the following: dissociation constant of alanine at 100 µmol
l−1, transmembrane potential at -60 mV, and the transport rates at 1 µmol l−1 s−1.
The results in Figure 4.6 shows the uptake of A with various β value, for both negative
(a to c) and neutral (d to f). The substrate A uptake rates were shown to follow
Michaelis-Menten process across the sodium concentration levels. Higher uptake rates
of substrate were observed for lower β value, as low β value means that the bias on
the transport rates in favour of back-transport of substrate is lowered (i.e. k2 is lowered
in negative transporter charge assumption, or k−1 is lowered in neutral transporter
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Figure 4.5: Effects of trans-membrane potential on the cotransport model assuming
transporter charge as negative (a, b) or neutral (c, d): Uptake of substrate A is shown
for various transmembrane potential differences (∆ψ = ψ2−ψ1) for fixed electrical bias
term β at 0.5 (a, c) and for different β with fixed ∆ψ at -60 mV (b, d). Chemical
gradients of substrate A and sodium were initially zero with all concentrations equal
to 1.
charge assumption case). When compared with the literature data, the prediction curves
suggested that the dissociation constantKNa is in the same order as 100 mmol l−1 rather
than the same order as the substrate K in the 100 µmol l−1 range.
Furthermore, it was shown in the model simulations that the uptake behaviours of
substrate A by the cotransport model are in fact Michaelis-Menten processes with respect
to substrate and sodium concentration levels, therefore the corresponding apparent Km
parameters were explored in response to the electrical potential. Figure 4.7 shows the
Km parameters for alanine (a, c) and sodium (b, d) as a function of transmembrane
potential difference for various β parameters under the negative (a, b) and neutral
(c, d) transporter charger assumption. The results were generated under zero-trans
condition with 500 µmol l−1 alanine as substrate and 100 mmol l−1 sodium [98] with
dissociation constantK of 100 µmol l−1 andKNa of 100 mmol l−1. It was shown that the
transmembrane potential affected the Km parameter of both alanine and sodium in all
cases except for when β is one under the neutral transporter charge assumption (shown
in c, d). In general, the Km parameters increased as the transmembrane potential
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Figure 4.6: Uptake rate of alanine (20 mmol l−1) over a range of external sodium,
as predicted by the cotransport model. Two cases were considered, assuming the
transporter charge as either negative (a to c) or neutral (d to f). A fixed dissociation
constant K of 100 µmol l−1 for alanine was used, with varying KNa of: 100 µmol l−1
(a, d); 100 mmol l−1 (b, e); and 1 mol l−1 (c, f).
difference becomes less negative. However, in Figure 4.7a, it was shown that Km
of alanine responded to the transmembrane potential difference differently depending
on the value of β. For a β value equal to zero, the Km of alanine increased as the
transmembrane becomes more negative and then appeared to be reaching a constant
plateau. In contrast, when β is unity the Km value appeared to be exponentially
increasing when the transmembrane potential difference became less negative.
Lastly, the uptake rate of alanine was explored in response to both chemical and electrical
potential gradient driving effects. In Figure 4.8 the flux equation from Equation 4.16 was
plotted over a range of transmembrane potentials for various electrical bias parameter
values (β of 0 (a, d), 0.5 (b, e), and 1 (c, d)) and sodium levels (4, 10 and 60 mmol l−1)
for the negative (a to c) and neutral (d to f) transporter assumption. The cotransport
model simulated uptake of 200 µmol l−1 alanine, assuming zero-trans conditions with
dissociation constants K of 100 µmol l−1 and KNa of 100 mmol l−1, and transport rate
of 1 µmol l−1 s−1. In general, the results showed an increase in the uptake for more
negative transmembrane potential differences, with eventual saturation. Moreover, the
results showed that saturation at high negative potential difference lagged behind for
β values closer to 1. This can be seen clearly under the neutral transporter charge
assumption (d, e). However, constant low levels of uptake were observed when β was
1 in case of the neutral transporter charge assumption, which is similar to Figure 4.7.
Higher external sodium translated to higher uptake rates as expected.
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Figure 4.7: Simulation of transmembrane potential effects on the apparent Michaelis-
Menten half-saturation parameters Km, of alanine (a, c) and sodium (b, d) under the
negative (a, b) and neutral (c, d) transporter charge assumption. 500 µmol l−1 of
alanine and 100 mmol l−1 sodium were used under zero-trans conditions [98], and
dissociation constants K of 100 µmol l−1 and KNa of 100 mmol l−1.
4.3.2 Parameter estimation results
In this section, the cotransport model as investigated in the previous section was applied
for parameter fitting based on the literature data. The simulations in Figure 4.7 were
configured in line with uptake experiments of alanine into Xenopus oocytes [98] and
now this data was used to fit the dissociation constant parameters K and KNa and the
electrical bias term β. Note that the total transport rate, kxT , was also fitted in the
routine, however, its value was not reported since this parameter affects only the relative
scaling of the uptake curve. The results were obtained for both the transporter charge
assumptions for comparison.
In Figure 4.9, the fitting of the apparent Michaelis-Menten parameters Km as a function
of the transmembrane potential difference was attempted. Both the Km of alanine and
sodium showed an upwards trend as the transmembrane potential difference increased
and approached zero. For the negative transporter charge assumption (4.9a, b), this
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Figure 4.8: Cotransport model simulation of transmembrane potential effects on the
uptake rate of 200 µmol l−1 alanine for various sodium inputs and electrical bias
parameters: β = 0 (a, d), β = 0.5 (b, e), and β = 1 (c, d) under the negative (a
to c) and neutral (d to f) transporter charge assumptions.
could only occur at high β value (approaching one) as any other value would not give
the corresponding trend. This resulted in a bias of one for the back transport rate k−2 of
the empty transporter and low bias for the forward transport rate k2, which translated
to overall promoting transport of the substrate. From the fit results (R2 = 0.50), the
β value was confirmed to be at the limit of 1. The dissociation constant of alanine
and sodium were fitted to be 176 µmol l−1 and 156 mmol l−1, respectively, which
were impressively close to what was previously suggested by the simulation results
in Figure 4.6 (values in the order of 100 µmol l−1 and 100 mmol l−1, respectively).
However, for the neutral transporter charge assumption (Figure 4.9c, d), a high β value
approaching 1 would not correspond to the experimental Km trend, as suggested by
the flat line in the model simulation in Figure 4.7c, d. The fitting results (R2 = 0.62)
indeed suggested a midrange β value of 0.65, while the dissociation constant of alanine
and sodium were fitted to be 740 µmol l−1 and 25 mmol l−1, respectively. However, the
results of the fittings for either transporter charge assumption case did not conclusively
suggest one is better than the other, as evidenced by similar reported R-squared values.
Next, the flux equation of the cotransport model was applied to fit the uptake data
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Figure 4.9: Model fitting of apparent Km parameters at different transmembrane
potentials for the cotransport model simulation as shown in Figure 4.7 under the
negative (a, b; R2 = 0.50) and neutral (c, d; R2 = 0.62) transporter charge assumption.
from literature, which was measured in terms of electrical current proportional to
the flux of alanine transported with sodium, in opposite direction. Under the same
conditions as the simulation results in Figure 4.8, the flux equation of alanine in the
cotransport model was fitted for different sodium levels assuming zero-trans conditions
(Figure 4.10a and Figure 4.10c). For the model assuming negative transporter charge,
the result in Figure 4.10a showed a poor fit in general (R2 = 0.18). The model appeared
to be insensitive to different sodium levels, as it produced the same fit for all three
sodium concentrations. In addition, the model was also fitted assuming an intracellular
sodium level for oocytes set at 10 mmol l−1 [100]. The results shown in Figure 4.10b,
suggested that changes in the sodium level improved the overall fit to the data to some
extent (R2 = 0.58), but the effect of external sodium concentrations still could not be
captured. In contrast, when the model for the neutral transporter charge assumption was
evaluated, the model fits appeared to be in good agreement with the data (R2 = 0.99).
In Figure 4.10c, the model parameters fitted for the zero-trans condition were: 0.33 for
β, and 1561 µmol l−1 and 32 mmol l−1 for the dissociation constants of alanine and
sodium, respectively. For the case of 10 mmol l−1 internal sodium (Figure 4.10d), the
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model parameter values fitted were: 0.33 for β, and 2263 µmol l−1 and 25 mmol l−1 for
the dissociation constants of alanine and sodium, respectively.
Figure 4.10: Cotransport model fits (solid lines) of electrical current data (x), as a
measure proportional to the flux of alanine together with sodium in oocytes. Model
predictions in response to transmembrane potential and different external sodium
concentrations based on the simulations as shown in Figure 4.8 under the negative
(a, b) and neutral (c, d) transporter charge assumption with no sodium (a, c) and 10
mmol l−1 sodium (b, d) initially present internally. R2 values for each plot are: a) 0.18;
b) 0.58; c) 0.99; d) 0.99.
4.4 Discussion
Novel cotransport models were developed to represent the accumulative transporter,
which is a secondary active transporter that derives its energy indirectly through
the sodium gradient and transmembrane potential. Cotransport models based on
carrier-mediated transport, were explored in terms of both the chemical and electrical
gradient, which provide the underlying physical driving forces. This more mechanistic
approach served as an essential improvement compared to a previous study in which
the accumulative transporter was simply modelled phenomenologically as a Michaelis-
Menten process [16]. The model was also shown to be capable to achieve active
amino acid build-up. However, importantly, in contrast to a simple Michaelis-Menten
model, it did not suggest perpetual uptake, as equilibrium levels were reached when the
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electrochemical potential differences of sodium and substrate were balanced.
The fundamental cotransport model with no electrical driving force was developed
similar to other passive transporter classes using carrier-mediated transport theory. The
process assumed binding of sodium as the cotransport solute prior to the amino acid
substrate in order to be transported across the membrane. It was shown that the sodium
gradient directly promoted the transport of the substrate as anticipated. Interestingly,
the model simulations showed that sodium is only required to be present on the cis side
for transport to occur (i.e. no sodium present on the trans side). Importantly, substrate
transport down its gradient occurs even if sodium concentrations are initially equal on
both sides of the membrane, which may be unexpected and could have implications for
the interpretation of experiments.
In this chapter, for the first time a cotransport model for the accumulative transporter
was developed specifically including the effect of electrochemical potential. In order to
consider the driving forces due to the electro potential, further model development was
undertaken based on the principle of carrier-mediated transport of a charged substrate.
The model utilized the biasing effects of electrochemical potential on the transport rates
as additional terms to actively drive the transport process. However, it was shown by
the model that depending on the transporter charge assumption, different individual
transport rates are affected by the electro potential bias. Therefore, simulation results
were presented to provide a comparison between the negative and neutral transporter
charge assumptions, which suggested variations in the initial uptake rate, but not
equilibrium uptake levels. Interestingly, this is consistent with varying the electrical
bias parameter β which leaves the equilibrium uptake levels unaffected. Hence, it could
be inferred that if the interest is solely in the absolute levels of amino acid accumulation
at steady state, then the assumptions on the accumulative transporter charge and the
degree of the electrical biasing of the individual transport rates would not be important.
In addition, the uptake rates and the apparent Michaelis-Menten Km parameters were
shown to be affected by variations in the transmembrane potential; however these would
not result in changes of the equilibrium uptake levels either.
4.4.1 Cotransport model parameter fitting
Initial model validation was performed by fitting the model using previous literature
data, which included the fitting of the Michaelis-Menten Km parameters and the uptake
rates in response to variations in electrical parameters. The results of the fitting of
the Km did not conclusively suggest any transporter charge assumption is better than
another as shown by the reported R-squared values. For the negative charge assumption,
the results of the fitting suggested a β value of one, which meant that the forward
transport rate of the empty transporter (k2) had a value less than one, while the
backward transport rate (k−2) was kept at unity. The results indeed demonstrated
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this resulted in promoting the transport of the substrate. However, it appeared that
the value of β was forced to the limit of one since from the simulation it was clear that
under the negative transporter assumption this was the only value that would result
in an exponentially increasing trend for increasing transmembrane potential difference,
as seen in the data. While the fitting of the data for the Km of alanine was able to
replicate the data points well, the fitting of the Km of sodium was not. This was due
to the fitting algorithm that equally weighted all data points from both Km plots to
fit one set of parameter values. Note that the fitted value of dissociation constant of
alanine 176 µmol l−1 agrees well with the reported half-maximal concentration constant
(Km) 200 µmol l−1 in a separate study [95]. Considering the other case of the neutral
transporter assumption, it appeared that the fit of both Km parameters could not to
be made to match well to the data points; however, the reported R-squared values
were slightly higher than for the negatively charged case. Overall, this indicated that
the model equation for the Km parameters did not correspond well to the data under
either assumption. Note that in each case, the fitting algorithm estimated a single set of
parameters for bothKm equations for sodium and alanine simultaneously and the results
in each graph, therefore, represent a compromise determined by the minimisation of the
total error.
In addition, the model parameters were also fitted to the uptake rate curves as
a function of transmembrane potential differences. For the negative transporter
assumption under zero-trans condition, the model was unable to represent the data,
as predictions appeared to be identical despite different external sodium concentrations.
However, in oocytes experiments an internal sodium level should be initially assumed
(at the intracellular level). This meant that the curves appeared to vary slightly for
different external sodium. However, despite this assumption, the quality of fits did
not considerably improve, suggesting that the negatively charged transporter case could
not account for the behaviour observed experimentally. In contrast, for the neutral
transporter assumption, the model generated good fits of the data for both zero-trans
and intracellular sodium cases. The model’s dissociation constant for alanine was fitted
to be within acceptable ranges of approximation – although one order of magnitude
higher than the reported value in a separate study [95]. However, the fit was shown not
to be very sensitive to the dissociation constants, as changes of theses parameters did
not significantly affect the fit to the data.
As a result, different Km values we obtained depending on the transporter charge
assumption and data set used for fitting, indicating the complexity of the accumulative
transporter behaviour. Nonetheless, based on the excellent fits of the latter data set in
Figure 4.10, it was suggested that the model hypothesis of the neutral charge transporter
assumption was better suited to mechanistically explain the data. However, the choice
of either hypothesised mechanism becomes insignificant if the model is observed at
equilibrium, since they produce identical steady state responses.
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4.4.2 Cotransport model and experimental design
Preliminary experiments were carried out to further investigate the accumulative
transporter behaviour in comparison to the model, as presented in Appendix B. The
vesicle uptakes experiments were designed using the model to systematically consider
different levels of driving forces due to either the electrical potential difference or
the sodium gradient across the membrane. However, while the model made logical
predictions of the behaviour, a more thorough experiment must be carried out in the
future as the pilot results (n = 1) did not entirely agree with the model predictions and
what would be expected based on physical considerations. This indicated the sensitivity
of the experimental protocol and complexity of the cotransport system as there are
many contributing factors that can affect the uptake results. Hence, a well-defined
experimental protocol is needed to improve the model validation.
4.5 Conclusion
A model for an accumulative amino acid transporter was developed, to mechanistically
integrate the effects of the chemical and electrical potential driving forces related to
the cotransport of sodium ions. This cotransport model was investigated in detail,
including the effect of different assumptions depending on the charge of the transport
proteins. However, it was suggested by the simulation results that the ultimate level
of accumulation at steady state is essentially indifferent to the transporter charge
assumption, since this is determined by the electrochemical potential differences. This
study also acted as a significant improvement on a previous study where the accumulative
transporter was modelled as simple Michaelis-Menten type behaviour. Finally, together
with the exchanger/facilitative model from the previous chapter, the cotransport model
representing the accumulative transporters will be used in the integrated study of the
placental amino acid transport system in the next chapter.

Chapter 5
Integrated model of placental
amino acid transport system
5.1 Introduction
The placenta is important for fetal development as it mediates the transfer of all
essential nutrients, such as amino acids, required by the fetus. Insufficiency of amino
acids during pregnancy as a result of impaired placental transport mechanism is
associated with poor fetal growth, which can lead to chronic disease in adult life
[2, 4, 35, 72, 101]. While currently there are no treatments for intrauterine growth
restriction, a better understanding of the placental transport system could potentially
contribute to advancement in treatment strategies for intervention and prevention. The
transport of amino acids from the maternal blood through the placenta to the fetal
circulation is a complex process and difficult to understand intuitively. This is because
amino acids do not simply diffuse through the placental membranes, but instead their
transfer is mediated by transport proteins or transporters, which have different passive
or active transport mechanisms and substrate specificities. Chapter 2 provides further
background on each transporter mechanism. Furthermore, there are over twenty amino
acids (nine of which are essential), which can either inhibit or promote each other’s
transport. Additionally, the transport system is influenced by physiological factors
including placental blood flow, metabolism, and placental morphology [5, 102]. Hence,
given this inherent complexity a systematic approach using mathematical modelling is
necessary to help describe the transport system.
While many studies of amino acid transport across epithelia have focussed on individual
transporters, the integrated study of the interactions between multiple transporters is
limited [19, 73]. We have previously introduced an integrated model of the placental
amino acid transport system, applied to the uptake and exchange of serine and alanine
[16]. However, a systematic analysis of the transport system as a whole is required,
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including more mechanistic transporter models [5, 103], which have been explored
extensively in Chapter 3 and Chapter 4. This chapter will present for the first time
such a systematic fully-integrated approach, with the aim of understanding how the
composition of amino acids and transporter activity can drive the overall net transfer of
all amino acids to the fetus. This modelling framework represents an important novel
contribution to the field by describing the placenta as a whole system, allowing us to
capture for the first time the fundamental interactions between different transporters
and amino acids transferred across the placenta.
Ultimately, this knowledge can lead to treatment that is administered to the mother and
designed to stimulate the transport of specific amino acids as required. The treatment
can be in a form of an intravenous supply of amino acids to the mother or gene therapy
to regulate the placental transporters [104]. Without such mechanistic insights into
how placental amino acid transport functions as a system, these treatments are deemed
difficult, if not impossible. Moreover, this systematic model can also provide predictive
information on transport behaviour in response to certain pathological conditions, which
can help clinicians understand disease mechanisms better. Finally, this type of modelling
framework could also be applied to other epithelial transport systems, such as in kidney,
intestine, and brain
The chapter will start by explaining the placental amino acid transport system and its
model implementation. This is followed by the results using simplified model situations
to explain step by step the processes of how amino acids are transferred to the fetus
across each placental membrane individually. Subsequently, both placental membranes
are combined, producing a complete representation of how amino acids get across
the placenta to the fetus. Sensitivity analyses of model parameters are presented to
understand the transport system as a whole and how this affects different classes of
amino acids. Lastly, an example of the impact of a certain genetic condition with
elevated phenylalanine levels on the amino acid transport system is explored by the
model.
5.1.1 The placental amino acid transport system
The placenta serves as an interface between the maternal and fetal blood circulations.
The maternal blood perfused in the intervillous space becomes in contact with the fetal
villi at the syncytiotrophoblast, which is the barrier layer that prevents the mixing of the
two circulations. At the syncytiotrophoblast, the microvillous membrane (MVM) acts as
the first barrier for amino acids to cross from the maternal side. Secondly, once inside the
syncytiotrophoblast amino acids then need to get across the basal membrane (BM) to
reach the fetal side. Amino acids, as with other nutrients, do not simply diffuse through
these membranes; instead, their transfer is mediated via specific transport proteins [5].
The schematic in Figure 5.1 shows the different transporter classes localised at each
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placental membrane, as included in our model. These different transporters operate
using distinct mechanism, and all of these types of transporters need to work together
to get all the required amino acids to the fetus, as it is not possible for one to do so
without the others. Accumulative transporters (Ac) actively pump amino acids into
the placental syncytiotrophoblast against their concentration gradient, using secondary
active transport driven by the sodium electrochemical potential gradient. This serves as
an important driving force for the transport system as a whole since the fetal amino acid
levels are higher than the maternal levels in general [6, 74]. Another significant class of
transporter are the exchangers (antiporters), which take an amino acid from one side of
the membrane and swap it for another from the other side, resulting in changes in the
amino acid composition but not the overall net amount. This exchange process allows
amino acids that are not substrates of the accumulative transporter to be transported
the other side. In combination, both accumulative and exchange transporters account
for the amino acid transports across the MVM [5, 6, 73]. Meanwhile, a facilitative
transporter has recently been identified at the BM, in addition to the exchangers, for
producing net transport to the fetus, via facilitative diffusion dictated by the amino acid
gradients [6, 18, 73]. Similarly, the exchangers at the BM assist the transport of amino
acids that are not substrates of the facilitative transporter across to fetus. Note that
the accumulative transporters are not being considered at the BM because their role is
thought to be insignificant, since the only known amino acid that is being transported
actively from the fetus into the placental syncytiotrophoblast is non-essential glutamate
[73]. Within these three general classes of transporter, different individual transporters
can be distinguished, each of which is specific to certain overlapping subsets of amino
acids, and all of these transporters work together as a system to transport all the amino
acids required by the fetus.
5.2 Methods
5.2.1 Compartmental model
For an integrated representation of the placental amino acid transport system, a
compartmental model was implemented based on our previous study [16]. The schematic
of the compartmental model, as shown in Figure 5.1, described the transport system as
consisting of three volume compartments: maternal, syncytiotrophoblast, and fetal. The
compartments were assumed to be well mixed and do not include any geometric features
to reduce complexity, as the focus here is on the transporter interactions. The transfers
of amino acids between the compartmental volumes were modelled as fluxes mediated
by various transporters as previously defined [73]. The transporter localisation at the
microvillous membrane (MVM) was given by the accumulative-exchange configuration,
and at basal membrane (BM) the facilitative-exchange configuration. Changes in
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Figure 5.1: Compartmental model of the placental amino acid transport system.
The schematic shows three compartments representing the maternal intervillous space,
placental syncytiotrophoblast, and fetal capillaries. The fluxes between compartments,
which produce changes in the concentration of amino acids, are assumed to be via
transporter-mediated routes only. Amino acid transporters included at the maternal-
facing microvillous membrane (MVM) are active accumulative transporters (Ac) and
exchangers (Ex), and those at the fetal-facing basal membrane (BM) are facilitative
transporters (F) and exchangers. Flow inputs and outputs are modelled for the
maternal and fetal compartments. [Y ]i and [Y ]iin denote concentration and inlet
concentration of substrate Y in compartment i, respectively (only substrate A and B
shown in figure). Fi and vi represents constant flow rate and volume of compartment
i, respectively.
concentration of amino acid levels in each compartment are observed in response to
different amino acid compositions, blood flow inputs/outputs, and transporter activities.
Note that placental metabolism is not considered in the model, therefore mass is
conserved and there is no net loss of amino acids. Another aspect not included in
the model is transport via paracellular route that can be represented by simple diffusion
which bypasses the placental tissue – which is poorly understood anatomically [105];
since, the main focus is on the transport and flow relationship. Note that paracellular
diffusion will reduce the efficiency of the system because of high fetal amino acid levels
causing net diffusion in the fetal to maternal direction. As a result, changes in the
concentration of a certain amino acid A within each compartment are given by:
d[A]m
dt
=
1
vm
(
JmA,flow − Jm→sA,ac − Jm→sA,ex
)
(5.1)
d[A]s
dt
=
1
vs
(
Jm→sA,ac + J
m→s
A,ex − Js→fA,ex − Js→fA,fa
)
(5.2)
d[A]f
dt
=
1
vf
(
JfA,flow + J
s→f
A,ex + J
s→f
A,fa
)
(5.3)
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where [A]i denotes concentration (in mol l−1) of substrate A in compartment i, vi
represents volume of compartment i (in l), J iA,flow denotes net molecular flux of substrate
A due to flow in compartment i, J i→jA,x represents the net molecular flux of substrate A
from compartment i to j mediated by transporter x. i and j can either be m, s, or f ,
which represent the maternal, syncytiotrophoblast, or fetal, compartments, respectively.
x can either be ac, ex, or fa for accumulative, exchange, and facilitative transporters,
respectively.
5.2.2 Representative amino acids concentrations
For the purpose of the model the amino acids transported across the placenta were
categorised according to their transporter specificity into four generic groups. As
shown in Table 5.1, these representative amino acid groups were AcEx – substrate
of the accumulative and exchange transporters, Ex – exchange-only substrate, ExF –
substrate of exchange and facilitative transporters, and, finally, AcExF – substrate of
all transporter classes. The inclusion of these four amino acid groups for the integrated
model represents a novel contribution of this chapter and a significant step up in
complexity compared to previous work [16], in which the exchange between only two
amino acids was considered. Measurements for each amino acid concentration from
the placental tissues [74] and fetal circulation [106] at normal physiological levels were
listed for each compartment, and the amino acid levels were summed per representative
group. These values were used for the initial conditions for the time integration of the
transporter models for each amino acid in each compartment.
5.2.3 Transporter models
Transporter models were developed based on carrier mediated transport as described
previously [63, 103]. These mechanistic transporter models describing the amino acids
fluxes due to the various transporter mechanisms represented significant improvements
over previous simple phenomenological models. Briefly, parameters describing the
transporter’s kinetic properties were kept to the minimum required to represent the
function of each transporter class. Therefore, in first instance, transporter translocation
rates were assumed symmetric and binding affinities equal on both sides of the
membrane. In addition, all substrates of a certain transporter were assumed to
have identical kinetic and binding properties. To allow interactions between different
amino acids and specific transporters as required in the compartmental model, the
transporter models were configured to account for multiple amino acid substrates. For
passive transporters (i.e. facilitative and exchange), the flux equations representing the
transporter models are expressed only in terms of substrates concentrations and kinetic
parameters, of which the model derivation can be found in published work [103] and
in Chapter 3. However, for the accumulative transporters, the model has to consider
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Table 5.1: Amino acid concentration measurements as categorised by transporter
specificity.
Amino Acid Name Maternal Syncytio- Umbilical Umbilical
Group concentration trophoblast artery vien
(Transporter concentration
specificity) (µmol l−1)* (µmol l−1)∧ (µmol l−1)* (µmol l−1)*
AcEx Arginine 51 320 101 108
(Accumulative Glutamine 368 1135 428 494
and Exchange) Glycine 107 1655 217 218
Histidine 85 74 108 119
Lysine 131 508 317 343
Serine 84 721 144 142
sum 826 4413 1369 1424
Ex (Exchange) Threonine 170 786 258 270
ExF Isoleucine 43 105 56 63
(Exchange and Leucine 81 305 105 120
Facilitative) Phenylalanine 39 173 63 65
Tyrosine 34 220 59 59
Valine 141 342 200 216
sum 338 1145 483 523
AcExF Alanine 215 1987 238 282
(Accumulative
Exchange and
Facilitative)
∧ denotes measurements from Philipps et al., 1978 [74]
* denotes measurements from Cetin et al., 2005 [106]
additional parameters for the effects of the electrochemical potential as specified below,
which as shown in Chapter 4 led to the development of a much more sophisticated
mechanistic model than the phenomenological Michaelis-Menten type equations used
previously [16]. The flux equations for each transporter model are given as follows:
Exchanger model
For the multiple-substrate exchanger model, the net flux of substrate A from
compartment I to II (unit of mol min−1) is expressed by:
JI→IIA,ex = Vex
[A]I [R]II − [A]II [R]I
Kex([Tot]I + [Tot]II)/2 + [Tot]I [Tot]II
(5.4)
where [A]i denotes the concentration of substrate A in compartment i, [Tot]i denotes
the sum of all exchanger substrates in compartment i, while [R]i denotes the sum
of all exchanger substrates, but excluding substrate A in compartment i. Note that
all concentration terms have unit of mol l−1. Kex is the dissociation constant for all
substrates of the exchanger (unit of mol l−1), and Vex is the maximum transport rate
(in mol min−1).
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Facilitative transporter model
For the multiple-substrate facilitative transporter model, the net flux of substrate A
from compartment I to II (unit of mol min−1) is expressed by:
JI→IIA,fa = Vfa
(
[A]I
Kfa + [Tot]I
− [A]
II
Kfa + [Tot]II
)
(5.5)
where [A]i denotes concentration of substrate A in compartment i, [Tot]i denotes the sum
of the concentrations of all substrates of the facilitative transporter in compartment i.
Note that all concentration terms have unit of mol l−1. Kfa is the dissociation constant
for all substrates of the facilitative transporter (unit of mol l−1), and Vfa is the maximum
transport rate (in mol min−1).
Accumulative transporter model
To represent sodium-driven secondary active transport by accumulative transporters
(system A), a cotransport model was adopted in which sodium ion was assumed to bind
to the transporter first, followed by the amino acid [17]. For the model distinguishing
two different amino acid substrates, the net flux of substrate A from compartment I to
II (unit of mol min−1) is expressed by:
JI→IIA,ac =
Vac
D/2
{
εε
′
[Na]I [Na]II([A]I [B]II − [A]II [B]I) +KacKNa(ε′ [A]I [Na]I − ε[A]II [Na]II)
}
where,
D = [Na]I [Na]II(ε
′
[Tot]I([Tot]II +Kac) + ε[Tot]II([Tot]I +Kac))
+KacKNa
{
(ε
′
+ 1)[Tot]I [Na]I + (ε+ 1)[Tot]II [Na]II
}
+K2acKNa([Na]
I + [Na]II) + 2(KacKNa)2,
and,
ε = e(
βzF
RT ∆ψ), and ε
′
= e(
(β−1)zF
RT ∆ψ),
(5.6)
where [A]i and [B]i denote concentration of substrate A and B in compartment i,
respectively, [Tot]i denotes the sum of substrates A and B in compartment i. Note that
all concentration terms have unit of mol l−1. Kac and KNa represent the dissociation
constants of the amino acid substrates of the accumulative transporter and sodium,
respectively (unit of mol l−1), and Vac is the transport rate (in mol min−1).
Note that this model assumed that the transporter was neutrally charged, binding to
the sodium ion and then the neutral amino acid to form an overall positively charged
complex. Hence, it was assumed that only the translocation of the carrier-sodium-
substrate complex was electrogenic. As described in the previous chapter, the electrical-
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potential induced bias in the cotransport model was given by ε
′
and ε for the forward
and backward transport rate, respectively [97]. β represents the degree of such electrical
bias, z represents the charge of sodium, F is the Faraday constant, R is the gas constant,
T is temperature and ∆ψ is the membrane potential difference between side I and II.
5.2.4 Flow modelling
Blood flows are being modelled as constant in and outputs of the maternal and fetal
compartments. For the flow characteristics inside the compartments, it was assumed
that the compartments were well mixed for simplicity. For this study, this was
deemed justifiable since observations were only based on steady state values. In the
compartmental model, flows result in a net molecular flux of amino acid in compartment
i (in mol min−1) as follows:
J iA,flow = Fi([A]
i
in − [A]i) (5.7)
where [A]i and [A]iin denote concentration and inlet concentration (in mol l
−1) of
substrate A in compartment i, respectively, Fi represents the constant flow rate in
and out of compartment i (unit of l min−1). Note that the flow rate and the inlet
concentrations were kept constant implying no change in the either maternal or fetal
input.
5.2.5 Compartmental and transporter model parameters
Baseline model parameters are reported in Table 5.2, which includes the parameters
for the compartmental and transporter models along with corresponding references.
In general, the parameters were chosen for normal physiological conditions. A single
functional unit of the placenta (cotyledon) was modelled with a weight of 30 grams,
which can be scaled easily for the placenta as a whole since cotyledons operate in parallel.
The placental cotyledon was partitioned into three compartments by volume with the
largest being the maternal compartment (34%), followed by the syncytiotrophoblast
(15%), and then the fetal compartment (7.5%), as described previously [16, 107]. Blood
flow rates were set at physiological levels in the maternal and fetal compartments to 2
and 0.2 ml min−1 g−1, respectively [108, 109]. For the transporter models, the transport
rates V , were initially taken equal at a value of 0.005 mmol l−1 min−1 for each class
of transporter to clearly evaluate their influence on the system [16]. The dissociation
constant of the exchanger substrate, Kex, was chosen at 200 µmol l−1 in the same order
of the reported half-saturation constants (Km) [67, 89], while a higher value was chosen
for the facilitative transporter (Kfa = 1000 µmol l−1) [73]. For the accumulative model,
the dissociation constants of the substrate and sodium and electrical bias constants were
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fitted from experimental data [98], as explored in the previous chapter (Kac = 2.26 mmol
l−1, KNa = 25.07 mmol l−1, β = 0.33).
Table 5.2: Reference parameter values for the compartmental and transporter models.
Parameter Value Unit Reference
Compartmental Model:
Total placental cotyledon volume 30 ml [16, 18]
%maternal compartment (intervillous space) 34% - [16, 107]
%syncytiotrophoblast compartment 15% - [16, 107]
%fetal compartment (fetal capillaries) 7.5% - [16, 107]
Maternal blood flow rate 2 ml min−1g−1 [108]
Fetal blood flow rate 0.2 ml min−1g−1 [109]
Transporter Model:
Accumulative
Effective transport rate, Vac 0.005 mmol min−1 [16]
Charge of sodium ion, z 1 - -
Faraday constant, F 9.65 x 104 C mol−1 -
Gas constant, R 8.314 VC K−1mol−1 -
Body temperature, T 310 K -
Transmembrane (MVM) potential difference, ∆ψ -21 mV [110]
Maternal sodium level 134 mmol l−1 [111]a
Syncytiotrophoblast sodium value 15 mmol l−1 [112]b
Individual transport rate’s electrical bias 0.33 - [98]c
constant, β
Substrate dissociation constant, Kac 2.26 mmol l−1 [98]c
Sodium dissociation constant, KNa 25.07 mmol l−1 [98]c
MVM Exchanger
Effective (maximum) transport rate, Vex,mvm 0.005 mmol min−1 [16]
Substrate dissociation constant, Kex 200 µmol l−1 [67, 89]d
BM Exchanger
Effective (maximum) transport rate, Vex,bm 0.005 mmol min−1 [16]
Substrate dissociation constant, Kex 200 µmol l−1 [67, 89]d
Facilitative
Effective (maximum) transport rate, Vfa 0.005 mmol min−1 [16]
Substrate dissociation constant, Kfa 1000 µmol l−1 [13]d
a Mean of lower and upper later pregnancy values. b Intracellular value for different cell
type as no specific information available. c Fitted based on data Yao et al., Fig.5f.
d Representative value based on weighted average dissociation constants.
5.2.6 Numerical implementation
The compartmental model and transporter models were implemented in Matlab
(R2013a). To predict the concentrations of amino acids in each compartment, time
integration of the flux equations, which were non-linear ordinary differential equations,
was performed using the ‘ode45’ function (Runge-Kutta (4th, 5th) method), which
used a variable time step with relative and absolute tolerances of 10−4 and 10−6,
respectively. Note that time integration was performed with the initial conditions
for each amino acid group in each compartment as reported in Table 5.1 for the
physiological case. In addition, to clearly illustrate the fundamental transporter
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behaviour, various hypothetical conditions were evaluated as stated in the tables above
each plot. Sensitivity analysis of the model parameters was carried out to determine the
impact of the model parameters, which included the transporter activities, flow rates,
and initial as well as arterial inlet amino acid concentrations. The analysis was done by
plotting the net fetal transfer (umbilical venous-arterial difference) of each amino acid
group in response to variation in the parameter values. Note that the range for each
parameter was selected to cover an adequate interval to show clear trends or saturation
in the transfer response.
5.2.7 Parameter estimation
An automated parameter estimation algorithm was applied to find the best-fitting
combination of the model’s transport rates for each transporter. The effective transport
rate parameters for each transporter class (Vac, Vex,mvm, Vex,bm, and Vfa) were fitted
based on the relative (normalised) error between the model’s net fetal transfer and
the fetal venous-arterial difference levels from literature, using a least square criterion
with all amino acid groups weighted equally. The fitting procedure was implemented
using the ‘fminsearch’ function in Matlab (Nelder-Mead method) with the cost function
defined as the residual sum of squares based on the errors between model simulations
and experimental measurements as described below:
RSS =
n∑
i=1
(
[A]Fetal,Modeli − [A]Fetal,Literaturei
[A]Fetal,Literaturei
)2
(5.8)
To account for the variation in absolute values between experimental conditions, for each
data point the difference between model prediction and literature was normalised first
by the literature value, squared and then summed over all points to yield the overall
error criterion. Note that the initial guess values for the fitted parameters that were
used by the ‘fminsearch’ minimisation function were chosen within the same order of
magnitude of physically feasible and/or experimentally reported values. Multiple initial
guess values were attempted to confirm that the fitting algorithm converged to a unique
solution.
5.3 Results
5.3.1 Fetal delivery of amino acids: Transport interactions across the
basal membrane
The exchange and facilitative transporters localised at the basal membrane are
responsible for the final delivery of the amino acids to the fetus. While the exchangers
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are important in regulating the composition of the amino acids delivered to the fetus,
the facilitative transporter is crucial in getting the overall net amount of amino acids
from the syncytiotrophoblast to the fetus. The interactions of these transporters were
explored and shown in Figure 5.2. The compartmental model implemented to study
the BM distinguished only two types of amino acids: BMEx, which was the exchanger-
only substrate and BMExF, which was the substrate for both transporters. The initial
concentration in the fetal compartment was set to the same as for the fetal inflow.
Since both transporters are passive, both amino acid levels in the syncytiotrophoblast
compartment were set to be 10 times the inlet concentrations of the fetal compartment,
to ensure net transport to the fetus. The syncytiotrophoblast concentrations were held
constant throughout the simulation, to provide a clear overview of BM transport alone.
Note that the relative fractions of both amino acid groups were the same (50%) in both
compartments. The summary of the inputs is shown in Table 5.3. Intuitively, when
only the facilitative transporters were active, only BMExF was transported to the fetal
compartment along its concentration gradient. Conversely, when only the exchangers
were considered, both amino acids levels in the fetal compartment showed no net changes
since the amino acid compositions were already at equilibrium. Hence, for either case
where only one type of transporter was localised at the basal membrane, the system
was unable to transport both types of amino acids across to the fetus. However, when
both the facilitative and exchange transporters were present, BMEx was successfully
transported to the fetus along with BMExF (Figure 5.2). This is because the eﬄux of
BMExF via the facilitative transporter, altered the relative amino acid composition on
the fetal side, and the resulting lower fraction of BMEx in the fetal compartment then
in turn enabled the exchanger activity to produce net transport of BMEx into the fetal
compartment.
Furthermore, the effect of the relative transport activity was explored using the model.
As shown in Figure 5.3, changing each transporter’s relative activity can influence
the steady state uptake levels in the fetal compartment for both amino acid species.
In Figure 5.3a, the model implemented various exchange rates relative to a constant
facilitative rate. The results suggested that fast exchange activity would result in
equalising the ratio of both amino acids in the compartments. In addition, Figure 5.3b
shows the results generated by the model assuming various facilitative activities with
respect to the exchange activity, which suggested that having fast facilitative activity
could indirectly drive transport of the exchanger substrate BMEx.
As passive transporters, both exchangers and facilitative transporters are dependent
on the substrate concentration gradients to drive transfer across the membrane. The
effects of varying the relative amino acid concentration levels were examined (according
to inputs in Table 5.4) and shown in Figure 5.4. As mentioned previously, it is
the difference in the relative compositions of amino acids in each compartment that
determines transfer via the exchangers, rather than the absolute concentrations on each
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side of the membrane. As can be observed in Figure 5.4a for an exchanger alone, varying
the syncytiotrophoblast concentration as a fraction of the total for a certain species to be
higher than the fetal ratio would lead to net transfer into the fetal circulation. If the ratio
is lower, reverse transport occurs. When the ratios on both sides were equal, no change
occurred on the fetal side. However, when both facilitative and exchange transporters
were considered (Figure 5.4b), a positive uptakes into the fetal circulation was observed
in all cases for BMExF, which was due to the facilitative transport pathway. For BMEx,
however, the fetal net transfer was shown to be positive when the ratio of BMEx was
equal or higher, while the lower ratio of BMEx would result in negative transfer. Net
transport of BMEx occurred even for equal initial fractions of BmEx, since the facilitated
transport of BmExF reduces the fraction of BmEx in the fetal compartment, leading to
a favourable ratio for transport of BMEx by exchange at steady state.
Table 5.3: Amino acid concentration inputs for each group at the BM: Fetal values
represent both the initial and inlet concentrations, while the syncytiotrophoblast
concentrations were kept constant throughout the simulation.
Amino acid Syncytiotrophoblast Fetal
group compartment compartment
BMEx 100 µmol l−1 10 µmol l−1
(ratio of total) (0.5) (0.5)
BMExF 100 µmol l−1 10 µmol l−1
(ratio of total) (0.5) (0.5)
Figure 5.2: Fetal amino acid concentrations from simplified model simulations across
the BM for the conditions described in Table 5.3: The concentrations of amino acid
group BMEx and BMExF in the fetal vein were simulated using the compartmental
model as shown in Figure 5.1.
Next, the model considered physiological amino acid levels from Table 5.1, which
were grouped according to their transporter specificity at the BM (as summarised in
Table 5.5). BMEx was then considered to consist of AcEx and Ex, while BMExF
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(a)
(b)
Figure 5.3: Model simulations of the effects of variation in transporter activity at the
BM. Each amino acid concentration in the fetal compartment was modelled to show
the transport interactions across the BM, with conditions given in Table 5.3, over a
range of relative exchange (a), or facilitative (b) transport activities.
included ExF and AcExF. Figure 5.5 illustrates an increase in fetal uptake for BMExF
only, however with a slight decrease of the fetal concentration of BMEx, which would
imply reverse transport into the syncytiotrophoblast. As shown before, this was due to
the higher input ratio of BMEx in the fetal compartment and the baseline facilitative
transporter activity was inadequate to offset this effect. Hence, as previously explored,
increasing the facilitative activity (e.g. by 10 fold, as shown in the figure) can indirectly
boost the fetal BMEx uptake to obtain positive transport. However, this resulted in a
substantial increase in the fetal BMExF level that is much higher than the physiological
level in the umbilical vein.
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Table 5.4: Amino acid concentration inputs for each group at the BM with variation in
the composition: Fetal values represent both the initial and inlet concentrations, while
the syncytiotrophoblast concentrations were kept constant throughout the simulation.
Amino acid Syncytiotrophoblast Fetal
group compartment compartment
BMEx [10,100,200] µmol l−1 10 µmol l−1
(ratio of total) (0.09,0.5,0.67) (0.5)
BMExF 100 µmol l−1 10 µmol l−1
(ratio of total) (0.91,0.5,0.33) (0.5)
Figure 5.4: Model simulations showing the effects of various amino acid levels
on transport interactions across the BM: The compartmental model simulated fetal
concentrations with various input conditions as in Table 5.4 for the case when (a) only
the exchangers were active and (b) when both facilitative and exchange transporters
were active.
5.3.2 Uptake of amino acids into the placenta: Transport interactions
across the microvillous membrane
After having demonstrated the mechanisms underlying the transfer of amino acids
from the syncytiotrophoblast to the fetal compartment, the next step was to explore
how syncytiotrophoblast concentrations are established as a result of uptake of amino
acids from the maternal circulation. As shown in Figure 5.1, the transport of
amino acids across the MVM is mediated by the accumulative transporter and the
exchanger. While the accumulative transporters actively pump the amino acids into the
syncytiotrophoblast, the exchangers are responsible for equalising the composition of the
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Table 5.5: Physiological amino acid concentrations for each group at the BM: Fetal
values represent both the initial and inlet concentrations, while the syncytiotrophoblast
concentrations were kept constant throughout the simulation. From Table 5.2, amino
acid group BMEx comprises of AcEx and Ex, while BMExF comprises of Ex and AcEx.
Amino acid Syncytiotrophoblast Fetal
group compartment compartment
BMEx 5199 µmol l−1 1627 µmol l−1
(ratio of total) (0.62) (0.69)
BMExF 3132 µmol l−1 721 µmol l−1
(ratio of total) (0.38) (0.31)
Figure 5.5: Physiological model simulations of transport interactions across the BM
for equal exchanger and facilitative transporter activity (solid), and results for 10x
increased facilitative transport activity (dashed line) using compartmental model with
inputs from Table 5.5.
amino acids. Amino acid substrates were categorised for the model into two groups as:
1) accumulative and exchange transporter substrate, MVMAcEx, and 2) exchanger-only
substrate, MVMEx. The compartmental model was then implemented to explore the
uptake interactions across the MVM, assuming a constant inlet concentration of amino
acids into the maternal compartment with values shown in Table 5.6. Furthermore,
transport across the BM was disabled to clearly demonstrate the potential for uptake
across the MVM. As shown in Figure 5.6, the model simulated uptake in to the
initially empty syncytiotrophoblast compartment (i.e. zero-trans), which showed the
high accumulation of both amino acids in the syncytiotrophoblast compartment over
time. The accumulative transporters and exchangers configuration allowed uptake of
both amino acid MVMEx and MVMAcEx, while the exchanger only substrate would not
have been transferred if only the accumulative transporters were considered. Note that
the initial dip in concentrations on the maternal side was the result of placental uptake,
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which goes to zero as steady state is approached. The uptake profile of MVMEx slightly
lagged behind, which was due to initial absence of exchangeable MVMEx in the placental
compartment. Once MVMAcEx was pumped in to the placenta, then the exchangers
start to operate in conjunction with the accumulative transporters. Steady states were
reached when the difference in accumulative transporter substrate and sodium electro-
chemical potential were equilibrated and the fraction of exchanger substrates equalised
in both compartments.
Table 5.6: Amino acid concentration inputs for each group at the MVM: The maternal
values represent inlet and initial concentrations, while in the syncytiotrophoblast
compartment is zero.
Amino acid Maternal Syncytiotrophoblast
group compartment compartment
MVMAcEx 100 µmol l−1 0 µmol l−1
(ratio of total) (0.5)
MVMEx 100 µmol l−1 0 µmol l−1
(ratio of total) (0.5)
Figure 5.6: Syncytiotrophoblast amino acid concentrations for the simplified model
simulations of transport across the MVM with conditions from Table 5.6. The
concentrations of amino acid group MVMAcEx and MVMEx in the maternal vein and
placental syncytiotrophoblast layer were simulated using the compartmental model in
Figure 5.1.
The model simulated the effects of varying the transporter activity, which is shown
in Figure 5.7. The results suggested that changes in the activities did not affect the
steady levels, but only the uptake rate and thus the speed at which the equilibrium was
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reached. In similar manner as in the previous section, high relative exchanger activity
resulted in bringing amino acids profiles together (shown in Figure 5.7a). However,
a small lag in the transfer of MVMEx was still present. For low relative exchange
activity, the transfer of MVMEx into syncytiotrophoblast compartment occurred at a
slower rate. Also, it reduced the amount of MVMAcEx exchanged back to the maternal
side, which resulted in the faster accumulation of MVMAcEx in the syncytiotrophoblast
compartment. Moreover, the model showed that with increased relative accumulative
activity (Figure 5.7b), the uptake rate of MVMEx also increased along with MVMAcEx.
Note that, the effects of MVMEx uptake rate lagging behind MVMAcEx was also
amplified when relative accumulative activity increased.
Figure 5.7: Model simulation of the effects of variation in transporter activity at
the MVM. The model shows each amino acid concentrations in the maternal and
syncytiotrophoblast compartment for the interactions across the MVM with input
conditions given in Table 5.6 over a range of relative (a) exchange or (b) accumulative
transport activities.
In addition, different maternal amino acid input levels (as shown in Table 5.7) in the
maternal compartment were modelled, which is shown in Figure 5.8. By keeping the
MVMAcEx level constant, the model suggested that an increase in MVMEx results in
an increase in its concentration in the syncytiotrophoblast compartment and the uptake
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of MVMAcEx reaches steady state slower. In particular when the maternal level of
exchange-only MVMEx was higher (than MVMAcEx), it was shown that the uptake in
the syncytiotrophoblast compartment of MVMEx could surpass that of the accumulative
substrate, MVMAcEx. This was due to the continuation of exchange over time until
syncytiotrophoblast concentration ratios matched those of the maternal inlet. Note that
in all cases, the uptake levels in the syncytiotrophoblast compartment of both species
were higher than the maternal levels.
Table 5.7: Amino acid concentrations for each group at the MVM to investigate
variations in the composition: The maternal values represent inlet and initial
concentrations, while the initial concentration in the syncytiotrophoblast compartment
is zero.
Amino acid Maternal Syncytiotrophoblast
group compartment compartment
MVMAcEx 100 µmol l−1 0 µmol l−1
(ratio of total) (0.91,0.5,0.33)
MVMEx [10,100,200] µmol l−1 0 µmol l−1
(ratio of total) (0.09,0.5,0.67)
Figure 5.8: Model simulations showing the effects of various amino acid concentration
levels on transport interactions across the MVM: The compartmental model simulated
syncytiotrophoblast concentrations with various input conditions as given in Table 5.7.
For the physiological levels of the amino acid groups as prescribed in Table 5.1, the
amino acids concentrations can be further grouped according to their transporter
specificity at the MVM. MVMAcEx was then considered to consist of AcEx and AcExF,
while MVMEx included Ex and ExF. With these values as inputs (summarised in
Table 5.8), the model simulated the physiological uptake for these amino acid groups
in to the syncytiotrophoblast, which suggested high uptake levels for both MVMAcEx
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and MVMEx (shown in Figure 5.9). The uptake profile in the syncytiotrophoblast
compartment of MVMEx and MVMAcEx showed monotonic increase. Although it
was difficult to see, a slow increase of MVMAcEx initially was observed, which can
be explained by the exchanger working against the accumulative transporter since the
initial concentration ratio of MVMAcEX was higher in the syncytiotrophoblast. The
model showed that the syncytiotrophoblast concentrations of both species continued to
rise well above physiological values, however it is important to note that the model here
only considered the MVM and did not include the eﬄux transport across the BM, which
would lead to a lower equilibrium.
Table 5.8: Physiological amino acid concentrations for each group at the MVM: The
maternal values represent inlet and initial concentrations, while the syncytiotrophoblast
values represent the initial concentration. From Table 5.2, amino acid group MVMAcEx
comprises of AcEx and AcExF, while MVMEx comprises of Ex and ExF.
Amino acid Maternal Syncytiotrophoblast
group compartment compartment
MVMAcEx 1041 µmol l−1 6400 µmol l−1
(ratio of total) (0.67) (0.77)
MVMEx 508 µmol l−1 1931 µmol l−1
(ratio of total) (0.33) (0.23)
Figure 5.9: Physiological model simulations of transport interactions across the MVM:
The amino acid concentrations in the maternal vein and placental syncytiotrophoblast
layer were simulated using the compartmental model with input conditions in Table 5.8.
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5.3.3 Transport across the placenta to the fetus
As we have now separately established the mechanisms of transport at the microvillous
membrane (separating the maternal and syncytiotrophoblast compartments) and basal
membrane (in between the syncytiotrophoblast and fetal compartments), the next step
was to simultaneously consider all transporters at both membranes. All three placental
compartments were considered (Figure 5.1) and the model simulations of the four
classes of amino acids were generated using the maternal and fetal arterial physiological
input levels from Table 5.1. Similarly, initial conditions were set at the physiologically
maternal, syncytiotrophoblast and umbilical artery values. Choices of parameters for
the model were made corresponding to the values in Table 5.2, which included the
assumption that all transport rates were equal (i.e. same transport activity for all
three transporters). The results of the model simulation are shown in Figure 5.10 and
Table 5.9, which suggested that all four amino acids were successfully transferred to
the fetal compartment as evident from a net increase in their concentrations. For the
physiological input values used, the model also indicated to be operating near steady
state, especially in the maternal compartment. All amino acids showed reductions
from the initial levels in the syncytiotrophoblast compartment, inferring that they were
net-transported to either maternal or fetal compartments. From the simulations, net
concentrations delivered to the fetus of each amino acid were computed from steady
state levels in the fetal compartment, which are shown in Table 5.10 in comparison
with the umbilical venous-arterial difference from literature. The overall simulated and
the experimental results appeared to correspond reasonably well, without any tuning
of the model parameters. More specially, two amino acid groups under-predicted the
literature’s net transfer values: AcEx by 9 µmol l−1 and Ex by 9.3 µmol l−1. AcExF
was over-predicted by 25.5 µmol l−1 and ExF by 3.6 µmol l−1.
Table 5.9: Initial physiological input levels and model simulated concentrations at
steady state for each amino acid group including the ratios per as a fraction of total
amino acid in each compartment.
Maternal Syncytiotrophoblast Fetal
µmol l−1 Initial Steady Initial Steady Initial Steady
(ratio of total) and inlet state state and inlet state
AcEx 826 821 4413 4209 1369 1415
(0.53) (0.54) (0.53) (0.62) (0.58) (0.56)
Ex 170 170 786 725 258 261
(0.11) (0.11) (0.09) (0.11) (0.11) (0.10)
ExF 338 334 1145 1090 483 527
(0.22) (0.22) (0.14) (0.16) (0.21) (0.21)
AcExF 215 208 1987 735 238 305
(0.14) (0.14) (0.24) (0.11) (0.10) (0.10)
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Figure 5.10: Compartmental model simulations of physiological amino acid levels in
each compartment with steady state levels reported in Table 5.9.
Table 5.10: Comparison of net fetal transfer levels at steady state of each amino acid
group for baseline simulated results, umbilical venous-artery difference as reported by
the literature, and generated by model fitting of transporter activities.
Amino acid Baseline simulation Literature value Fitting*
group (µmol l−1) (µmol l−1) (µmol l−1)
AcEx 46 55 53
Ex 2.7 12 9.3
ExF 43.6 40 32.5
AcExF 67.4 44 70
*Note that model fitting suggested the following transporter activities
with respect to the baseline values: 2.8x exchange at MVM,
59x Exchange at BM, 1.3x facilitative, and 0.75x accumulative activity
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5.3.4 Sensitivity analysis of transporter activities
The effect of variation in relative transporter activity on the net fetal transfer of
each amino acid group was analysed. The impact of variations in transport activity
parameters for each transporter class (Vac, Vex,mvm, Vex,bm, and Vfa) was explored
and shown in Figure 5.11 for the accumulative, MVM exchange, BM exchange,
and facilitative transporter separately. Reference transport activity parameters, as
mentioned in Table 5.2 were varied using a multiplier factor to explore the response
across a wide range of each transporter’s activities. The results showed the net fetal
transfer of the different amino acid classes plotted as a function of the transport activity
multipliers. The results in Figure 5.11a, d suggested that the activities of accumulative
and facilitative transporters promote the fetal transfer for all amino acids. In addition,
saturation levels in the fetal transfer were achieved when the transporter’s activities were
high. The results also suggested that an increase in the activity of particular transporters
can promote transfer of certain substrates at the price of decreasing the transfer of others.
Specifically, as shown in Figure 5.11c, increasing BM exchanger activity would result in a
decrease in fetal transfer of amino acids that are transportable by facilitative transporters
(i.e. ExF, AcExF). This could be explained by equalisation of the composition of
the amino acids in the syncytiotrophoblast and fetal compartments as a result of
high BM exchanger activity (as was previously demonstrated), which subsequently
reduces the net fetal transfer of these substrates by promoting back exchange into the
syncytiotrophoblast compartment. Similarly, in Figure 5.11b, increasing MVM exchange
activity would result in equalising the composition of amino acids in maternal and
syncytiotrophoblast compartments. As expected, increased MVM exchange activity
promoted uptake of those amino acids that are transported by exchange only at the
MVM (Ex and ExF), resulting in increased fetal delivery. This comes at the price of
the reduction in fetal transfer of AcEx demonstrated, since increasing exchange activity
across the MVM promoted back transfer of the substrate into the maternal compartment.
However, surprisingly an increase in fetal transfer was observed for AcExF, which has
the same transporter specificity at the MVM. This is because the syncytiotrophoblast
ratio of AcExF, which was high initially, dropped to a ratio lower than on the maternal
side at steady state (Table 5.9), for the baseline simulations. Increasing MVM exchange
activity would then promote AcExF uptake in the syncytiotrophoblast compartment
and in turn increase transfer to the fetal compartment via facilitated transport. Thus
MVM exchangers affected BM transfer indirectly, and in opposite manners depending
on how the overall transport system shifted the concentration ratios of each amino acid
in the three compartments. Lastly, it can be noted from Figure 5.11a–d that the fetal
transfer of amino acid Ex (transported by exchanger only) could be driven by increasing
any transporter activity, but only to a small degree. Negative net fetal transfer, which
translated to amino acids transport out of the fetal compartment, can occur for AcEx
at very low facilitated (Figure 5.11d) or accumulative (Figure 5.11a) activity.
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Figure 5.11: Transporter activity sensitivity analysis: Net fetal transfer values for
each amino acid were simulated in response to a range of variations in individual
transporter activity.
In addition, dual transport activity sensitivity tests were performed in which two activity
parameters were varied simultaneously. As previous, net fetal transfer of each amino
acid was observed in response to various transport activity multipliers. At first, the
overall impact of exchanger activity was explored. Net transfer of each amino acid
was simulated, varying both exchanger activities at the MVM and BM simultaneously
(shown in Figure 5.12). The 3D plot suggested that for amino acid AcEx, increasing
exchange activity at the BM while reducing exchange activity at the MVM would result
in optimal fetal delivery. This was the result of promoting exchange across to the fetal
compartment while reducing back exchange to the maternal compartment. In contrast,
for ExF and AcExF, both of which are facilitative substrates, increasing BM exchange
activity would lead to reuptake in to the syncytiotrophoblast compartment. However,
for AcExF, the BM exchanger activity has opposite effects on net transfer depending on
whether the MVM exchanger activity is high or low. Interestingly, it was shown that in
addition of having both exchanger activities high, additional high AcExF transfer could
be maintained when both activities were low. (Note that a separate maximum peak in
transfer of AcExF could even occur under certain conditions, as can be seen in the results
in Figure C.7 in Appendix C for the case in which the accumulative transporter charge
was assumed to be negative). This scenario could be explained because for effectively low
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exchange activities the accumulative and facilitative transporters would dominate the
transfer, and back exchange into the maternal and syncytiotrophoblast compartments is
essentially limited. Also, the transfer of AcExF, regardless of the exchange activities at
both membranes, would always result in positive net transport. For substrate Ex, it was
shown that higher fetal uptake can be achieved by increasing both exchange activities,
however, the relative change is small. These results were consistent when compared to
previous individual sensitivity analyses (in Figure 5.11b and c).
Figure 5.12: Dual transport activity sensitivity analysis: MVM vs BM exchange
activity. Net fetal transfer values for each amino acid were simulated in response to
varying the exchange activities at the MVM and BM simultaneously.
Next the case for how transport is affected by the transporters on the MVM was
explored. The simulation, as shown in Figure 5.13, modelled net fetal transfer in
response to simultaneous variation of the accumulative and exchange activities in
the MVM. The results suggested that maximal fetal transfer of amino acid AcEx or
AcExF occurs when the accumulative activity is high, which promotes uptake in to
the syncytiotrophoblast, and the exchange activity is low, which limits back-exchange.
For amino acids Ex and ExF, the maximum delivery in the fetal compartment was
achieved when both transporter’s activities at the MVM were high. This is because both
transporters promote uptake via exchange into syncytiotrophoblast for these substrates,
either directly or indirectly by increasing the intracellular levels of the driving substrates.
Note that negative net fetal transfer (transport out of the fetal compartment) could occur
under certain conditions; for instance, when the accumulative activity is significantly low
in amino acid AcEx. This occurred because of the substrate AcEx was swapped out of
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the fetus by the exchanger due to higher ratio of AcEx in the fetal compartment in
combination with inadequate inputs by the accumulative transporter from the maternal
side to offset the ratio in the syncytiotrophoblast in favour of the net positive fetal
transfer direction.
Figure 5.13: Dual transport activity sensitivity analysis at the MVM. Net fetal
transfer values for each amino acid were simulated in response to varying the MVM
exchange and accumulative transport activities simultaneously.
Finally, in the same manner, the impact of the transporter activities on the BM was
simulated. As shown in Figure 5.14, the simultaneous variation in transport activities
of the exchangers and the facilitative transporter were examined. The model suggested
that for ExF and AcExF, the fetal uptake was optimal when the facilitative activity
was high and the exchange activity at BM was low. This combination appeared to
promote fetal transfer while, at the same time, limiting reuptake. Additionally, it was
shown that for AcEx and Ex, which are not substrates of the facilitative transporter,
the fetal transfer was increased when all of transport activities were high at the BM.
These substrates must be exchanged to transport across the BM, therefore promoting
exchange will directly increase the fetal transfer. Also, increasing the facilitative rate will
indirectly increase the fetal transfer, since it leads to a more favourable concentration
ratio for exchange.
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Figure 5.14: Dual transport activity sensitivity analysis at the BM. Net fetal transfer
values for each amino acid were simulated in response to varying the BM exchange and
facilitative transport activities simultaneously.
5.3.5 Flow Sensitivity
The compartmental model implements constant flow inputs in the maternal and fetal
compartment. The flow can potentially affect the transfer of the amino acids, hence, the
flow sensitivity was analysed in response to variations in maternal and fetal flow. From
Table 5.2, the current baseline values for maternal and fetal flow rates were 6 x 10−5
m3/min and 6 x 10−6 m3/min, respectively. A flow multiplier ranging from zero to two
was used to model the fetal transfer for each amino acid. As shown in Figure 5.15, the
system appeared to be more sensitive to the changes in the fetal flow due to the small
volume proportion. While in the larger-volume maternal compartment, the flow rate did
not appear to be affecting the fetal delivery (unit of mol min−1) as much. The model
suggested that a slow fetal flow rate translated to high fetal delivery for amino acid group
AcEx and Ex (not facilitative substrate), while faster fetal flow rate would stimulate fetal
delivery of amino acid ExF and AcExF (facilitative substrate). This is because for the
facilitative substrate, high fetal flow maintains the BM concentration gradients driving
facilitated transport. While for amino acids that cannot be transported by facilitative
transporters, high fetal flow would maintain the less favourable inlet concentration ratios,
which determine transport via the exchangers.
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Figure 5.15: Flow sensitivity analysis: Net fetal delivery values for each amino acid
were simulated in response to varying the maternal and fetal flow inputs simultaneously.
5.3.6 Model sensitivity to amino acid input concentrations
Lastly, the analysis of the model sensitivity was implemented to investigate the effect on
fetal transfer due to changes in the overall amino acid inputs in the maternal and fetal
compartments. The test performed variation in the initial amino acid levels and inputs
by using a single multiplier for all four amino acid groups with respect to the baseline
levels as prescribed in Table 5.1. The results, as shown in Figure 5.16, suggested that
low fetal amino acid levels and high maternal amino acid levels would generally promote
fetal transport. In addition, the maternal amino acids became limiting at low levels.
The results also suggested that negative net transfer could occur when maternal levels
are extremely low and fetal levels are high.
5.3.7 Coordinated regulation of transporter activity
The fitting algorithm was performed to find which combination of all the transporter
activities would provide the best overall fit when compared to the fetal venous-arterial
difference from literature. The simulated and model fitting results, along with the
comparison to the literature values, are shown in terms of the net fetal transfer in
steady state for each amino acid group (Table 5.10). The baseline simulated results
showed reasonably good overall correspondence when compared to the literature’s values.
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Figure 5.16: Amino acid level sensitivity analysis: Net fetal transfer values for each
amino acid were simulated in response to varying the overall maternal and fetal amino
acid concentration levels simultaneously.
Specifically, amino acid group ExF showed an insignificant discrepancy. The baseline
model slightly under-predicted AcEx and Ex, while over-predicting AcExF. The model
fitting results showed some improvements when compared to the baseline simulation,
especially for the substrates that were initially under-predicted. Impressively, the fit was
able to almost match amino acid AcEx to the literature values (within 3.7%). Also, the
fit made significant improvement in bringing up the low-level amino acid Ex. However,
for AcExF the values remained nearly unaffected, while ExF deviated more than the
original baseline results. The model fitted the following adjustments to the baseline
transporter activities parameters: 0.75 times the accumulative, 2.8 times exchange at
MVM and 59 times exchange at the BM, and 1.3 times the facilitative activity.
5.3.8 Elevated maternal phenylalanine level
The compartmental model was also implemented to explore the effects of a specific
clinical condition on the amino acid transport system. For instance, the model simulated
the genetic condition of maternal phenylketonuria – where lack of a specific enzyme
causes an excess level of phenylalanine that can affect fetal development and function
[113]. As shown in Figure 5.17, net transfer of each amino acid group was modelled over
a range of multiple levels of maternal ExF relative to the baseline value, since this is the
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amino acid group phenylalanine belongs to. The results suggested that the elevated level
of ExF in the maternal compartment reduces the net transfer level of all other amino
acid groups as anticipated by the condition. Moreover, the model predicted negative net
transfer levels of other amino acids at high maternal level of ExF (e.g. at 5x the baseline
value), which inferred that the amino acids were transported out of the fetus.
Figure 5.17: Effects of elevated maternal amino acid ExF level (Phenylalanine) on
the fetal transfer of each amino acid.
5.4 Discussion
This study served as novel integrated approach for modelling the amino acid transport
system in the placenta. The compartmental model incorporated carrier models for three
different classes of amino acid transporters to represent the placental transport system.
The model for the transport system consisted of three compartments, separated by two
placental membranes where transporters are located to mediate amino acid transport.
The results demonstrated the application of this modelling framework to address the
complexity of the interactions arising when multiple amino acids were considered, which
proved to be difficult to fully comprehend without the model.
The study successfully demonstrated the fundamental interactions at each of the
placental membranes to explore the transport behaviour of how amino acids
are transferred to the fetus (across the BM) or accumulated in the placental
syncytiotrophoblast (across the MVM). While the model suggested that the facilitative-
exchange transporter configuration at the BM was sufficient in transferring amino acids
to the fetus, the arterial composition of the amino acid levels proved to be important in
determining the transport efficiency. In addition, indirect stimulation of amino acids that
were not a substrate of the facilitative transporter was shown to be possible by increasing
the facilitated transport activity. Moreover, the accumulative-exchange transporter
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configuration at the MVM proved to be effective in mediating transport of different
types of amino acids into the syncytiotrophoblast. It was shown that high accumulations
in the syncytiotrophoblast were achievable; however, eventually the syncytiotrophoblast
amino acid levels were shown to be approaching steady state. This suggested that
the transport across the MVM, even with active accumulative transporter, should not
be generally thought of as perpetual uptake. The syncytiotrophoblast uptake levels
of both accumulative and exchange amino acid species were higher than the maternal
levels. This accumulation against the gradient is enabled by the energy required to
maintain the constant sodium gradient whose electrochemical potential provides the
driving force for the system. Indirect stimulation of amino acids that were not a substrate
of the accumulative transporter across the MVM was also shown possible via exchange.
However, in contrast to the fetal transport across the BM, the compositions of amino
acids did not solely dictate the direction of transport of all amino acids across the MVM.
Amino acids that were substrates of the accumulative transporter were ensured active
transport in to the syncytiotrophoblast, even with unfavourable concentration ratios and
gradients.
Overall, the MVM’s accumulative-exchange transporter configuration allows a large
accumulation of amino acids into the placenta, while the facilitative-exchange
configuration at the BM permits the transfer to the fetus governed by the
syncytiotrophoblast concentration levels. When the overall transport across the placenta
was considered under physiological conditions, the integrated model showed a favourable
net transfer of all amino acid groups to the fetus. This indicated a perhaps surprising
level of robustness, considering that the amino acid transport rates and kinetic
parameters were assumed equal and highly simplified per amino acid group. In addition,
the predicted uptake and delivery profiles appeared to be near steady state, which was
encouraging given that the amino acid concentration inputs were from normal pregnancy
levels, which should be maintained stable. However, it was evident that there were
discrepancies in the net fetal transfer levels and the literature’s umbilical venous-arterial
difference levels for each amino acid. Hence, a fitting algorithm was then applied, which
suggested that by changing transport activities for each transporter these discrepancies
could be improved. Though, it appeared difficult to adjust levels of certain amino acid
groups without affecting the others. In particular, improving the prediction for the
exchange only substrate required a disproportional increase in BM exchanger activity
(Table 5.10).
As we have explored the possibility of adjusting the transporter activities to achieve
improved overall results across all amino acids. It was also important to consider the
several factors and simplifying assumptions made in the current compartmental model
that could contribute to the discrepancies in the results. For instance, these would
include the simplified transporter representation, where generic values were used instead
of different transport affinities for each substrate at each interface. Also, the grouping
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of amino acids, approximations and experimental variation in amino acids levels from
literature, and absence of amino acid metabolism, could all contribute to the relatively
limited discrepancy in the simulated results. In particular, as was previously shown, the
composition of the input concentrations plays an important role in fetal transfer. Despite
these limited discrepancies, our current model has shown to be robust in representing
the key features of transport and a valuable first approach in the study of the placental
amino acid transport as an integrated multivariable system.
5.4.1 Model assumptions to reduce number of parameters
In this study, certain simplifying assumptions were made for the model application to
help generalise parameters together. This included the transporter translocation rates,
which were assumed symmetric and binding affinities, which were chosen to be equal
on both sides of the membrane and the same for all substrates of each transporter.
Although, these parameters could be otherwise separately explored in the model, the
simulations could only result in minor changes in the transient uptake responses. Since
for current study where steady state uptake values were examined, it was reasonable
to make generalised assumption on these parameters as other option was thought
unnecessary.
5.4.2 Sensitivity of the model variables and parameters
Sensitivity analyses of the compartmental model’s parameters were examined in order
to observe the changes in the transfer level in response to each parameter. Initially,
the parameter for each transporter activity was observed individually. The results
in Figure 5.11 clearly showed how increasing the activities of each transporter would
affect the transfer; however, the effect on transfer would eventually be limited by other
factors. It was also logical to see how the accumulative and facilitative activities
were directly promoting the transfer of all amino acids; since the first transporter is
responsible for the uptake of substrate into the placental syncytiotrophoblast while the
latter is for delivering substrate to fetus. However, it was interesting to see how the
exchange activities at each membrane affected the transfer differently for each amino acid
substrate, which was clearly simulated by the model. This highlights the importance of
our model for investigating the transport interactions. Moreover, this point was again
emphasized when simultaneous dual parameter variation studies were performed. One
of the benefits of the computational model was that it allowed multiple factors to be
analysed concurrently, which would otherwise be hard to intuitively visualise. Also, the
dual sensitivity analysis pointed out that multiple optimal transfer configurations can
occur (as shown in Figure 5.12 for AcExF), which might be overlooked had it not been
demonstrated using the model. The model’s sensitivity analyses also suggested that the
amino acid groups displayed different transport behaviour at the different membranes.
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For instance, those amino acids that were substrate of the accumulative transporter
behaved in the same way when considered at the MVM, in clear contrast with to
those that were not an accumulative transporter substrate (as shown in Figure 5.13).
Similarly, the amino acids that can be taken up by the facilitative transporter displayed
the same response when observed at the BM, showing a distinctly different response
compared with those that were not taken up by the facilitative transporter (Figure 5.14).
In addition, a sensitivity analysis was performed on the flow inputs of the maternal
and fetal compartment. The results implied that the flow rate can significantly affect
the fetal transfer of the amino acids, and it is important to consider that this is in
relation to the volume of the compartment (more sensitive to flow for a smaller volume).
Additionally, the flow rates were shown to be rate limiting when both maternal and
fetal flow rate approach zero. Interestingly, the flow rates were affecting the various
amino acid groups differently. It appear that, with the current amino acid concentration
inputs, the transfer of the amino acids that were substrates of the facilitative transporter
show a direct relationship to the flow rates, whereas the other group showed an opposite
relationship. This novel finding suggested the potential effects of lower than normal
physiological flow rates (e.g. in placental disorders) affecting the amino acid transfer
and this should be addressed in future experiments. For instance, further investigation
with the current compartmental model can consider various heterogeneous flow patterns
as in previous models [55, 56] that took the geometry and structural organisation of the
placenta into account (as described in Section 2.5.1). Lastly, in regards to the amino
acid levels, a sensitivity analysis was performed with varying overall maternal and fetal
amino acid levels. As shown by the results, it was inferred that the transfer of amino
acids is promoted when the mother has a high level of amino acids while the fetus
has low amino acid levels, which was deemed logical. However, as was shown, at a
certain point the amino acid transfer appeared to be reaching saturation. This could
potentially be thought of as a preventive mechanism to protect the fetus from excessive
transfer of amino acids despite high levels in the maternal circulation. In conclusion, the
sensitivity analyses of the model are important in understanding the transport behaviour
of the amino acids in the placenta, especially when considering multiple parameters
simultaneously. Dual parameters analyses implemented in this study effectively provide a
fundamental understanding of the transport behaviour. However, additional parameters
or variables can be added to the analyses to further investigate the multi-variability of
parameters on the transport system. Nonetheless, at the current stage, the model was
shown to be able to capture the main features of the placental transport system based
on the principal underlying transport mechanisms.
5.4.3 Coordinated regulation of transporter activity
As shown by the model, the system using baseline parameters already appeared to be in
reasonable agreement with the literature. This implied that our compartmental model
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realisation, despite many simplifying assumptions, was able to represent robustly the
placental amino acid transport system. Moreover, with our knowledge of the model
sensitivity and kinetic behaviour, possible refinements to the model can be made. The
model’s transporter activities were fitted in an attempt to match the literature data.
However, the transport model appeared to be restricted as the change in transfer of
some amino acids was limited by and indirectly dependent on one another. For instance,
for the low level amino acids (Ex), the fit was able to increase the fetal transfer,
however, at the expense of decreasing the fit quality of others (i.e. ExF). However,
this shouldn’t be discouraging considering the inherent experimental variation in amino
acid concentrations used for comparison and the approximations made in deriving the
model such as the grouping together of individual amino acids with different transport
affinities. In addition, the model fitting results suggested that the rates of transport by
the exchanger should be high. Specifically, the model inferred much higher exchange
activity at the BM from the fit. This also suggested that the system is not sensitive to
the transport rate of the BM exchanger for the given inputs. It is worth noting that our
simulations were performed with given constant inputs which could contribute to the
system’s response being restricted. While in reality, varying levels in the inputs could
occur which the fetus will determine what recirculates back.
5.4.4 Elevated maternal phenylalanine level
The robustness of the model was again assured in the ability to address certain
circumstances that are thought to affect the amino acid transport system. This was
exemplified in the case of elevated maternal phenylalanine in phenylketonuria. The
model was able to confirm the effects of the condition as a result of restricted fetal
delivery of all other amino acids that are essential for fetal development and function.
This serves as the motivation for future applications where the model can be used for
disease screenings by clinicians, or predictive medicine design in the pharmaceutical
industry.
5.5 Conclusion
Our integrated modelling framework served as novel approach for simulating the amino
acid transport system in the placenta. The implementation of the compartmental model
that combines carrier models for various classes of amino acid transporters was shown
to be robust in representing the transport system as a whole. At the present stage, the
model was shown to be able to capture successfully the principal features of the transport
system in spite of simplifying assumptions that were made. Further improvements to the
model could distinguish individual transporters, their kinetics and substrate specificity
in greater detail as informed by experimental data available, which would ultimately
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contribute to a better understanding of placental transport as a whole and hopefully
lead to the development of new clinical applications.
Chapter 6
Discussion
Placental transport of amino acids is highly complex as it incorporates many
interdependent mechanisms and factors, including numerous amino acid transport
proteins and a wide variety of different substrates. In this thesis, a new computational
modelling approach has been developed and proven to be valuable in the gaining a
better understanding of the transport system as a whole. This serves as an important
development in the effort to create a ‘virtual’ placenta. A systematic understanding of
the placental transport systems could provide insightful contributions to the design of
intervention or treatment for pathological conditions, such as IUGR. In addition, the
placental transport models can also be applied in a similar manner to other epithelial
tissues, such as transfer of pharmaceuticals across the blood-brain barrier.
6.1 Model contributions
The transfer of amino acids across the placenta is mediated by transport proteins
in the membranes of the syncytiotrophoblast layer. As described (in Section 2.2.1),
this carrier-mediated process fundamentally requires binding of the substrate to the
transport protein to allow translocation between the two sides of membrane. These
transport proteins were categorised according to their transport mechanisms and
modelled as: 1) exchanger, 2) facilitative transporter, and 3) accumulative transporter.
As reviewed (in Section 2.5.3), previous studies have mainly investigated the transport
of nutrients using uptake experiments described as a Michaelis-Menten process. The
commonly-used Michaelis-Menten kinetic representation was then shown not to provide
a full mechanistic representation of transporter behaviour, as it does not account
for intracellular concentrations and thus cannot meaningfully describe experimental
scenarios other than initial uptake in zero-trans experiments (Chapter 3).
The exchange-facilitative transporter model derived was able to address
experimental variations: A more mechanistic carrier-mediated transport model was
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developed to represent both the exchanger and facilitative transporter, with only a single
parameter controlling the relative contribution of these two transporter mechanisms
(Section 3.2.2). It was shown for the first time how this model could give rise to different
apparent Michaelis Menten constants as a function of internal concentration, which may
help explain variation in experimental literature.
The model suggested a non-obligatory exchange mechanism for the LAT2
transport protein: Subsequently, the exchange-facilitative transport model was
implemented to design experiments and comprehensively test the behaviour of the
transport protein LAT2 over a wide range of conditions. LAT2 has been widely
reported to have a 1:1 obligatory exchange mechanism. However, the model fitted to
the vesicle experiments clearly suggested a slow non-obligatory component. Although
it is not possible to distinguish for certain whether the transporter itself has a non-
obligatory pathway or if there is a presently unknown facilitative transporter working
in parallel. In addition, an extensive investigation of the model was carried out that
included a sensitivity analysis of the model parameter estimation (Section 3.3.6) and
an exploration of the impact of asymmetric kinetic parameters (Section 3.3.8). Given
the data available, this supported the application of the model using only a minimum
number of parameters (with symmetric kinetic parameters) to successfully represent
overall transporter behaviour for a wide range of experimental conditions.
A cotransport model was successfully developed to address the electro-
chemical potential effects of sodium: For the accumulative transporter, a new
carrier-mediated cotransport model was developed (Chapter 4) that incorporated the
effects of the driving forces due to the sodium chemical and electrical potential. The
model was able to demonstrate active transport behaviour, as evident from its ability
to transport against the gradient. The cotransport model was investigated extensively
based on various model assumptions, such as the transporter charge, since the effect
of this on transport is currently unknown. The cotransport model also served as
significant improvement compared to a previous study [16], which simply modelled the
accumulative transport process as Michaelis-Menten kinetics and could not account for
the thermodynamics limitations to substrate accumulation.
The integrated compartmental modelling framework demonstrated the
fundamental amino acid interactions and key factors regulating placental
transfer: Finally, an integrated model of the placental amino acid transport system
was developed and examined in detail (Chapter 5). The model incorporated all the
transporter models derived in the previous chapters into a three-compartment model
of the placenta with four amino acid subgroups and flow inputs in the maternal and
fetal compartments. The compartmental model behaviour was investigated in detail,
starting from simple cases with transport across the BM and MVM separately, followed
by the complete physiological configuration. The results confirmed that the model
design and transporter configuration were adequately capable of fetal transfer of all
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amino acids subgroups under physiological conditions. In addition, sensitivity analyses
of the compartmental model parameters and conditions were performed (Section 5.3.4–
5.3.6), which included transporter activities, blood flow rates, and amino acid levels.
Importantly, this revealed that it is difficult to adjust levels of certain amino acid groups
without affecting the transfer of others. This has clear implications for designing clinical
intervention strategies to prevent unwanted side effects.
6.2 Recommendations for future work
Although the current integrated model framework was sufficient in representing
the overall transport behaviour, it was implemented based on several simplifying
assumptions. In particular, the amino acids were grouped together by their specificity
for the various transporter types and each transporter type was modelled as a single
representative transporter. For future studies, the model can be extended by including
many individual transporters that can be distinguished for each transporter type, each
of which is specific to certain overlapping subsets of amino acids, with different affinities
[19]. Moreover, the transporter model parameters (e.g. asymmetry of translocation and
binding parameters in the exchanger/facultative model) were configured to be relatively
simple to reduce the number of parameters but still capture the fundamental transport
mechanisms. However, as determined by our studies, to lift this restriction may not
dramatically change the overall model behaviour, although this can be done readily
in the future if model refinement is found necessary in the light of experimental data.
For the accumulative model, future experiments to investigate specific transport protein
should be carried out systematically to validate the cotransport model, as suggested in
Appendix B. In addition, placental metabolism should be included in future models,
which could potentially change the amount of amino acids and their composition.
However, placental metabolism is still not well characterised and therefore this study
was focused on transport alone in first instance. Another aspect that can be included
further in the model was paracellular transport, which is poorly understood anatomically
[105]. Paracellular diffusion will reduce the efficiency of the system because of high fetal
amino acid levels, causing net diffusion in the fetal to maternal direction. Finally, the
current compartmental model was for the placenta alone and did not include influences
by the fetus. Hence, refinement of the model by considering variation in amino acid
concentration inputs due to fetal metabolism could improve the response of the system.
6.3 Further model applications and prospects
The transport models developed for each type of transporters were applied to the
transfer of amino acids across the placenta, but these carrier based models can also
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be readily adapted to other substances in various epithelia. For instance, nutrient
transport across brush border membranes in the intestine could be modelled as carrier
based transport process [47, 48]. In another example, a recent study has suggested
the use of carrier-mediated models to investigate the oral uptake of pharmaceuticals
[114]. However, only simple Michaelis-Menten kinetics were used. The work stressed
the importance of the model but requires further improvements in the kinetic parameter
determination. It could be suggested that our transporter modelling approach can be
applied instead, to potentially give a more comprehensive representation of transport
phenomena, without necessarily needing more parameters. Furthermore, the integrated
modelling framework – addressing the complex interactions between multiple species of
amino acids and various transporters – will prove to be instrumental in determining
the contribution of specific transporters to epithelial transport in the placenta and
other systems. If successful, this can potentially lead to the design of targeted
interventions in epithelial transport disorders. For example, strategies to target placenta
to deliver pharmacological or genetic therapies are being explored [104]. The modelling
approach could also be used to suggest clinical considerations in relation to epithelila
transport. For instance, the model can test whether simply increasing certain maternal
amino acid levels can improve fetal transfer, or determine rate-limiting factors in drug
transport that are essential for pharmaceutical development process. To exemplify
the potential applications of the model for representing pathological scenarios, the
case of phenylketonuria was modelled, which demonstrated how elevated maternal
phenylalanine restricted fetal delivery of all other amino acids (Section 5.3.8). Lastly,
the detail of any newly discovered individual transporters, their kinetics and substrate
specificity, can be readily included in the model framework in the future to study their
role in the transport process as a whole.
6.4 Conclusion
In conclusion, the current body of work, which utilized computational modelling
approaches to investigate the placental amino acid transport system, serves as an
important effort towards a better understanding of complex placental functions.
The systematic modelling approach adopted has proven to be highly valuable in
both exploring fundamental transporter behaviours and designing and interpreting
experiments to reveal inherent characteristics of specific transporter mechanisms. This
is equally applicable to different transport systems in various epithelia, including kidney,
liver and gut. In moving forward, this thesis reaffirms the importance of computational
methods for designing experiments in biology to get optimal results. Finally, this work
is ultimately hoped to be useful in facilitating clinical assessment, or the development
of treatments or preventive measures for nutrition related fetal pathologies.
Appendix A
Effects of vesicle size distribution
in amino acid uptake experiments
In a vesicle experiment, when considering a vesicle solution consisting of vesicles of all
the same size, the mean effect of uptake must be the same as the uptake level in a single
vesicle of the same size. However, this is not the case when considering a vesicle solution
that is inconsistent in vesicle size. The weighted average of the substrate uptake can
be computed according to the volume of the vesicles and their solute content could be
computed as follows:
[A]AV G =
∑n
j=1 volj · [A]j∑n
j=1 volj
(A.1)
where, volj = 43pi ·r3j . [A]AV G has unit of mol l−1. volj represents the spherical volume
of the vesicle with radius rj .
The weighted average for the concentration takes the ratio of the sum of the product
of the each vesicle volume and its corresponding uptake concentration [A]IIj , over the
sum of the vesicle volumes. For each vesicle of radius r, the uptake concentration can
be expressed in terms of surface area over volume and the flux per unit of area. The
uptake concentration is directly proportional to the surface area of the vesicle, whereas
for the volume it is inversely proportional.
For the uptake concentration in the facilitated diffusion model, the individual uptake of
a single vesicle of size r was given, for example, by the following:
[A]IIj =
areaj
volj
·
∫
DxT
2
(
[A]I
K + [A]I
− [A]
II
K + [A]II
)
dt (A.2)
where, volj = 43pi · r3j , areaj = 4pi · r2j .
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An example simulation of the effects of weighted average in uptake concentration with
inconsistent vesicle sizes is shown in Figure A.1. The figure shows the individual uptake
curves for single vesicles of various sizes in solid and the weighted average of the uptake
concentration in the dashed curve. Various radii for the vesicle size were evaluated,
ranging from 1 to 5 in arbitrary units. A sample distribution of the number of vesicles
for each radius was chosen as 100 for the case of r = 1, 10 for r = 5, and 1 for each of
the rest. Parameters and the concentration of solute A at side I were kept constant at
[A]I = 15 and K = 10.
Figure A.1: Simulated uptake concentration curves with the effects of vesicle size
variation.
Notice the average uptake curve was located between the uptake of the vesicles of radius
sizes of 4 and 5, despite the much larger number of vesicles that had a radius of 1
(n = 100), compared to those with a radius of 5 (n = 10). Consequently, from the
result it could be concluded that the larger-sized vesicles contribute to the weighted
average uptake more significantly than smaller-sized vesicles, which yield a lesser effect.
Additionally, the result showed that the smaller the vesicle size, the faster it was to
react (i.e. faster uptake), as observable by the curves representing the uptake for each
individual vesicle of the various sizes.
Appendix B
Accumulative transporter
experiment; design and
preliminary results
In this appendix, a validation of the accumulative transporter model by experimental
procedures is presented. The design of the experimental procedures was aimed to
observe the uptake of the substrate by the accumulative transporter over various
electrical conditions and levels of sodium which is the co-solute in the coupled
transport mechanism. Experiment procedures are planned to systemically investigate
the isolated effects of the two driving forces of accumulative transporter; which are
sodium concentration and potential difference created by the ions. In order observe
the uptake response at various electro-potential difference levels, the ‘voltage clamping’
technique is employed to chemically set the membrane potential to the desired values
[50]. The principle behind this was to use the ionophore valinomycin to increase the
permeability of potassium ions, which in turn would dominate the membrane potential.
Hence, the membrane potential is simply dependent only on the potassium ions, instead
of all of the ions present.
Placental membrane vesicles are prepared with specific conditions so that the internal
and external levels can represent two electro potential levels (one at physiological level,
another at lower level) and two sodium gradient levels (at zero net gradient and at high
net gradient). Additionally, the specifications of the experimental protocol are shown in
Table B.1, listing the specific amounts of the ionic solutions in the buffers for the vesicle
uptake. Note that the cell’s osmolality in buffer solutions was carefully considered in
protocol. In the experiments, various amount of potassium sulphate solution was added
to achieve physiological (-17.6 mV) and lower (-2.7 mV) membrane potentials. For the
zero net gradient cases, 10 mmol l−1 sodium sulphate is added in both inside and outside
of the vesicles netting in zero gradient in EXP 1 and 3, and 40 mmol l−1 more was added
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to the outside for the net sodium gradient of 80 mmol l−1 in EXP 2 and 4.
In Figure B.1, the model predictions (a) and pilot experiment results (b) are presented
for the uptake of substrate MeAIB (methylaminoisobutyric acid), which is a unique
substrate for System A transport. The model prediction was based on the cotransport
model from Table 4.1 under the negatively charged transporter assumption in Chapter 4.
Note that following constants and parameter values were used in the model simulations:
ideal gas constant, R = 8.314 VC K−1 mol−1, room temperature, T = 298 K, Faraday’s
constant, F = 9.65 x 104 C mol−1, electrical bias term, β = 0.5, and dissociation
constants of substrate and sodium of 100 µmol l−1 and 10 mmol l−1, respectively, with
total transport rates of 10 (arbitrary unit). For the experimental pilot results (n = 1) in
Figure B.1b, 165 µmol l−1 C14-labelled MeAIB was used to observe the uptake into the
vesicles over time. The model simulated logical predictions showing distinct uptake
levels for each of the experimental conditions. For the control, the model showed
no uptake as sodium is required for cotransport. However, low uptake was shown in
the experiment suggesting leakage. For zero net gradient (equal sodium internally and
externally), the model predicted uptake at physiological transmembrane potential (EXP
1) to be higher than for the low transmembrane potential (EXP 3), which corresponded
to the experimental results, although the difference was very small. However, when
the chemical driving force by sodium gradient was high, the model logically predicted
higher uptake in the case of physiological transmembrane potential (EXP 2a) than the
case of low transmembrane potential (EXP 4), which is opposite to the experimental
results. These counterintuitive experimental results may be caused by experimental error
or leakage. Lastly, a higher uptake level was observed for the case when the external
substrate level was increased three-fold higher (EXP 2b) than normal (EXP 2a), which
is correctly predicted by the model.
In conclusion, while this study served as a functional preliminary experimental approach
in the investigating of the accumulative transport mechanism, further experimental
procedures must be carefully carried out in future studies, since there are many
factors that can contribute to error in the uptake results. It was shown that the
cotransport model can provide a quantitative understanding of the accumulative
transport mechanism.
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128 Appendix B Accumulative transporter experiment; design and preliminary results
Figure B.1: Cotransport model predictions (a) and pilot vesicle experimental results
(b) for the uptake of substrate MeAIB by the accumulative transport mechanism.
Vesicle experiments were carried out by Dr. Kate Widdows at Institute of Human
Development, University of Manchester.
Appendix C
Integrated model simulation of
placental amino acid transport
system: Alternate accumulative
transporter model results
In this appendix, additional compartmental model simulations are presented. The
compartmental model implemented accumulative transporter model, which assumed
the transporter to be negatively charged. The results are shown in the same manner
as explored in Chapter 5, which assumed the accumulative transporter to be neutrally
charged. Overall, only minor transient variations are observed, especially when complete
integrated model were concerned. The compartmental model appeared to be reaching
the steady state value faster than the results in Chapter 5. In general, the compartmental
model simulated the same characteristic behaviour as the other assumption.
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Figure C.1: Syncytiotrophoblast amino acid concentrations for the simplified model
simulations of transport across the MVM with conditions from Table 5.6. The
concentrations of amino acid group MVMAcEx and MVMEx in the maternal vein and
placental syncytiotrophoblast layer were simulated using the compartmental model in
Figure 5.1. (Accumulative transporter assumed negatively charged).
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Figure C.2: Model simulation of the effects of variation in transporter activity. The
model shows each amino acid concentrations in the maternal and syncytiotrophoblast
compartment for the interactions across the MVM with input conditions given in
Table 5.6 over a range of relative (a) exchange or (b) accumulative transport activities.
(Accumulative transporter assumed negatively charged).
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Figure C.3: Model simulations showing the effects of various amino acid concentration
levels on transport interactions across the MVM: The compartmental model simulated
syncytiotrophoblast concentrations with various input conditions as given in Table 5.7.
(Accumulative transporter assumed negatively charged).
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Figure C.4: Physiological model simulations of transport interactions across
the MVM: The amino acid concentrations in the maternal vein and placental
syncytiotrophoblast layer were simulated using the compartmental model with input
conditions given in Table 5.8. (Accumulative transporter assumed negatively charged).
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Figure C.5: Compartmental model simulations of physiological amino acid levels
in each compartment with steady state levels reported in Table 5.10. (Accumulative
transporter assumed negatively charged).
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Table C.1: Model simulated amino acid concentrations at steady state for each
group including the ratios as a fraction of total amino acid in each compartment.
(Accumulative transporter assumed negatively charged).
Concentration, µmol l−1 Maternal Syncytiotrophoblast Fetal
(ratio of total)
AcEx 822 3790 1408
(0.54) (0.61) (0.56)
Ex 170 665 261
(0.11) (0.11) (0.10)
ExF 334 1026 523
(0.22) (0.17) (0.21)
AcExF 208 710 308
(0.14) (0.11) (0.12)
Table C.2: Comparison of net fetal transfer levels at steady state of each amino acid
group for baseline simulated results, umbilical venous-artery difference as reported by
the literature, and generated by model fitting of transporter activities. (Accumulative
transporter assumed negatively charged).
Amino acid Baseline simulation Literature value Fitting*
group (µmol l−1) (µmol l−1) (µmol l−1)
AcEx 39 55 50
Ex 2.5 12 8.5
ExF 40 40 33
AcExF 69.5 44 69
*Note that model fitting suggested the following transporter activities
with respect to the baseline values: 3x exchange at MVM,
43x Exchange at BM, 1.6x facilitative, and 0.7x accumulative activity
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Figure C.6: Transporter activity sensitivity analysis: Net fetal transfer values for each
amino acid were simulated in response to a range of variations in individual transporter
activity. (Accumulative transporter assumed negatively charged).
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Figure C.7: Dual transport activity sensitivity analysis: MVM vs BM exchange
activity. Net fetal transfer values for each amino acid were simulated in response to
varying the exchange activities at the MVM and BM simultaneously. (Accumulative
transporter assumed negatively charged).
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Figure C.8: Dual transport activity sensitivity analysis at the MVM. Net fetal transfer
values for each amino acid were simulated in response to varying the MVM exchange and
accumulative transport activities simultaneously. (Accumulative transporter assumed
negatively charged).
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Figure C.9: Dual transport activity sensitivity analysis at the BM. Net fetal transfer
values for each amino acid were simulated in response to varying the BM exchange
and facilitative transport activities simultaneously. (Accumulative transporter assumed
negatively charged).
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Figure C.10: Flow sensitivity analysis: Net fetal transfer values for each amino acid
were simulated in response to varying the maternal and fetal flow inputs simultaneously.
(Accumulative transporter assumed negatively charged).
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Figure C.11: Amino acid level sensitivity analysis: Net fetal transfer values for
each amino acid were simulated in response to varying the overall maternal and fetal
amino acid concentration levels simultaneously. (Accumulative transporter assumed
negatively charged).
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